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Dedicated to iny family
"Do they give Nobel prizes for attempted chemistry? Do they!?"
from 'The Simpsons' 
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Summary
We have been developing an assay for a Diels-Alderase enzyme. The assay is 
based on the proposed biosynthesis of chalconnoracin iv, a natural antifungal 
compound from the white mulberry Morus alba, which is thought to be formed by an 
enzyme-mediated Diels-Alder reaction between dieme ii and morachalcone A iii. Diene 
ii has never been isolated, but an analogue of ii, moracin C i has been isolated from M. 
alba and is thought to be a biological precursor to diiene ii.
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We have developed the most efficient synthesis of moracin C i to date (10 
steps, 12.3% overall), involving a ’one-pot' ester formation/intramolecular Wiltig 
reaction, regioselective ortho-lithiation, and an unexpected but advantageous acid- 
induced acyl migration. Our route provides a general method for the synthesis of 
polyphenolic benzofurans.
We have synthesised a sample of diene ii using a route similar to that of 
moracin C (12 steps). This synthesis included a regioselective carboxylation and an E-
selective modified Julia olefination. The small sample of ii obtained was not fully 
characterised, due to instability during chromatography, but the structure was 
unequivocally confirmed by *11 NMR spectroscopy.
We have prepared a series of protected morachalcone A iii precursors. These 
are easily prepared (3 steps), and while suitable deprotection conditions have not yet 
been found, this route can provide suitable intermediates for a biomimetic or total 
synthesis of chalcomoracin.
Structural modifications were made to moracin C (see below), and in an attempt 
to probe the substrate specificity of the Diels-Alderase enzyme, two potential 
substrates v and vi, were fed to suspensions of M. alba cells. Initial analysis suggested 
that one of these compounds (v) was incorporated.
Remove benzofuran
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The Enzymatic Diels-Alder Reaction
1
1.1 The Diels-Alder Reaction: A Brief History
In 1928, Otto Diels and Kurt Alder made a discovery which was to become one 
of the great milestones in the history of organic chemistry. 1 This discovery, which 
earned them a Nobel prize in 1950, was the [4+2] cycloaddition, or Diels-Alder 
reaction as it was later known. This proved to be one of the most useful carbon-carbon 
bond-forming reactions ever discovered.
The Diels-Alder reaction is the formation of a new 6 -membered ring through 
reaction of a 1,3-diene 1 with an olefin (or dienophile) 2. In a single step, 2 new 
carbon-carbon bonds and up to 4 chiral centres are formed in a controlled manner 
(Scheme 1).
1 2
Scheme 1
Bond formation arises through overlap of the molecular orbitals on one face of 
the diene component with the molecular orbitals on one face of the dienophile. The 
main interaction is between the Highest Occupied Molecular Orbital (HOMO) of the 
diene with the Lowest Unoccupied Molecular Orbital (LUMO) of the dienophile 
(Figure 1).
LUMO
HOMO
Figure 1
Decreasing the energy difference between the HOMO and LUMO improves 
the efficiency of the Diels-Alder reaction. This can be done by varying the substituents
1
on the two reactants. Electron-donating groups (e.g. aromatics) raise the HOMO of the 
diene. Electron-withdrawing groups (e.g. C=0, CN, CO2 R, etc.) remove electron- 
density from the dienophile, thus lowering the LUMO.
1.2 Control in the Diels-Alder Reaction
The Diels-Alder reaction mechanism is concerted (i.e. bonds break at the same 
time as new bonds form), and as a result, the reaction is stereospecific with respect to 
the diene and the dienophile geometries. The reaction may also exhibit endo-exo 
diastereoselectivity, regioselectivity and face-selectivity. These types of control will be 
dealt with in turn.
1.2.1 Geometry of the Diene2
The first, and most important feature of the diene is that is must be able to 
adopt the s-cis (cisoid) conformation 3 (Scheme 2). Cycloaddition is not possible in 
the s-trans (transoid) form 4.
No Reaction
s-trans
4
Scheme 2
The geometry of each of the double bonds in the diene has a bearing on the 
reaction product. Feasibly, there are 4 types of diene geometry: E-E, E-Z, Z-E and Z-Z.
Cycloadditions involving E-E dienes 5 always give rise stereospecifically to 
products 6  with a syn-R/R' relationship. Conversely, E-Z dienes 7 give products 8  with 
anti-R/R' stereochemistry (Scheme 3). In each case, reaction of the dienophile on the 
opposite face of the diene gives the opposite enantiomer.
2
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O
R
E-E
5
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6
R'
R R
8E-Z7
[Note: in all diagrams, denotes where a mewcr-bond will form]
Scheme 3
Note that, with the exception of cyclic dienes e.g. 10„ reactions of Z-Z dienes 9 are 
often disfavoured due to steric crowding of the substituients, but when they do occur, 
they give syn products. (Scheme 4).
1.2.2 Geometry of the Dienophile2
An alkene can have either a Z- or ^-geometry. AkS with the diene, this geometry 
influences the outcome of the reaction, and is retained ini the product.
E-Dienophiles
As shown in Scheme 5, the reaction of Zs-alkenes* 11 always results in a 1,2-anti 
relationship in the cyclohexene 14 and ent-14. There are two modes of reaction: the R- 
endo mode 12, where R lies 'underneath' the diene (endo\ Greek 'within'), and the R- 
exo mode 13, where the diene does not 'cover' R (exo\ Greek 'outside'). For each mode 
of reaction, the diene could approach the dienophile tfrom the opposite face to that 
illustrated. This would form the opposite enantiomer in each case.
BUT
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Scheme 4
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Scheme 5
Z-Dienophiles
Reaction of Z-dienophiles 15 also gives rise to exo- and erafo-products 18 and 
ent-18, that have their substitutents R and R' in a syn relationship (,Scheme 6).
16- endo
OR
17- exo
■R'
18
0»R'
""R
ent-18
Scheme 6
1.2.3 Endo-Exo Diastereoselectivity2*3
As discussed, the Diels-Alder reaction proceeds with retention of diene and 
dienophile geometry. We have also seen how the two reaction modes {endo and exo) 
can alter the stereochemistry of the product.
In the simple examples used above, the endo and exo products were 
enantiomeric. Normally however, the endo and exo modes of addition give 
diastereomeric products.
4
In general, ewdo-products tend to be favoured, due to the secondary orbital 
overlap between the HOMO of the diene and the LUMO of the dienophile. This effect 
is greatest in the reactions of cyclic dienes (e.g. cyclopentadiene 1 0 ) with cyclic 
dienophiles (e.g. maleic anhydride 19) {Scheme 7).
\ //
10
0  o
19
HOMO
secondary Q 
overlap LUMO
Scheme 7
100% conversion 
single product
Consider the reaction between cyclopentadiene 10 and methyl crotonate 20 
{Scheme S ) 4  At 30 °C, we see formation of both products with a very low preference 
for the endo product 21 {Table 1, entry 1) Again, this slight preference can be 
attributed to the secondary orbital overlap between 10 and 20 {Figure 2a). An ideal 
reaction would produce exclusively the endo or exo product, so how do we influence 
the outcome of the reaction? When 0.9 equivalents of AICI3 was added, the ratio of 
products changed drastically {Table 1, entry 2). Not only was there a massive 
selectivity for the endo-product 21 {endo-exo, 94:6), but the reaction was complete in 
30 minutes {cf. 24 hours for the uncatalysed reaction). What was causing this?
MeO
O
10 CC^MeMe
C0 2 Me 
21 - endo 22 - exo
Scheme 8
Reaction conditions %endo % exo
1 PhH, 30 °C, 24 h 54 46
2 PhH, 30 °C, 30 min, 0.9 mol eq AICI3 94 6
Table 1
5
The Lewis acid has an effect on the rate of the reaction, and on the endo-exo 
selectivity.
(i) Rate Enhancement
With methyl crotonate 20 , 5 the Lewis acid coordinates with the carbonyl 
resulting in an metal-acid complex 23 {Figure 2b). The allylic cation quality of this 
complex lowers the energy of the LUMO of the dienophile. This brings the HOMO 
and LUMO closer together, resulting in an increased rate.
(ii) Endo-exo selectivity
Complexation results in the carbonyl carbon having a greater LUMO 
coefficient. This makes the secondary orbital overlap greater, and hence favours 
formation of the endo product 21 {Figure 2b).
secondary 
overlap
Me
better
overlap
HOMO
LUMO
23
(a) non-catalysed (b) catalysed
Figure 2
In addition, use of Lewis acids enables the reaction to be carried out at a much 
lower temperature. This decreases the extent of retro-Diels-Alder reaction which can 
occur at higher temperatures.
1.2.4 Regioselectivity2’3
Up to now, all the examples we have covered have involved simple symmetrical 
dienes. The next aspect of Diels-Alder control we must consider is when both diene 
and dienophile are unsymmetrical {Scheme 9). What control do we have over the 
product now?
X X
'y or
Scheme 9
6
The regioselectivity depends on the nature of any substitutents, and their 
position on the diene. Electron-donating groups (EDG) at C-l of the diene 24 favour 
'ortho' products 25 over 'meta' products 26 {Scheme 10). If the EDG is at C-2 of the 
diene 28 however, the 'para' product 29 is preferred {Scheme 11).
EDG
J X 0 2 Mer if -
24
EDG EDG
CO2M6
C0 2 Me
25 Major 
Scheme 10
27 Minor
EDG\ ^  / C 0 2Me EDG
'CC^Me 
29 Major
Scheme 11
This ortho-para preference is beneficial to 1,3-substituted dienes 30, where the 
two 'directing effects' favour a single product {Scheme 12). In many substituted dienes 
however, there can be some ambiguity over which product is preferred. In cases such 
as this, the nature of the substituent, and its position on the diene are most important in 
determining the outcome of the reaction.
only product 
Y is both ortho and para
Scheme 12
Consider the reaction between £-l,3-pentadiene 31 with methyl acrylate 32 
{Scheme 13)} There are potentially four products (and their enantiomers). Products 33 
and 35 are the endo-products and products 34 and 36 are the exo-products. When the 
two components were heated together at 120 °C, all 4 possible products were isolated 
with very poor selectivity {Table 2, entry 1).
7
This result demonstrates two points:
Endo-pxodxxcis, 33 and 35 predominate, but they are by no means exclusive (the 
approximate endo-exo ratio is 56:44).
'Ort/io'-products 33 and 34 are favoured over 'raeta'-products 35 and 36 (ortho- 
meta, 84:16).
CO2 M6
^CC^M© .CC^Me
34
31 32
Scheme 13
33 34 35 36
1 120 °C, 6  h 45 39 1 1 5
2 10-20 °C, AICI3 , 3 h 93 5 2 0
Table 2
When 0.15 equivalents of AICI3 was added (Table 2, entry 2), the reaction 
could be carried out at room temperature rather than at reflux in benzene. Furthermore, 
the endo-exo  selectivity increased from 56:44 to 95:5 and the ortho-m eta  
regioselectivity improved from 84:16 to 98:2.
Another method of improving the reactivity and selectivity of the Diels-Alder 
reaction is to carry out the reaction in water. The hydrophobicity of the organic 
reagents cause them to be 'driven together' thus forcing the reaction. During the study 
of the quassinoids,6  Grieco et al used this 'hydrophobic effect' to enhance the outcome 
of a poorly-selective reaction (Scheme 14). Simply by changing the diene from an ester 
to a carboxylate salt 38 (R=Na, Table 5), and running the reaction in water, the ratio of 
desired product was improved by a factor of 3.5, and the reaction time was reduced 
from 12 days to a mere 5 hours. As well as regioselectivity and exo-endo selectivity, 
this reaction shows face-selectivity due to blocking of the upper face by the axial 
methyl group of the ring function in 37.
8
OMe
.CO2 R
CHO
OMe
OHO 39 endo
OMe
O
OHO
40 exo
Scheme 14
R Solvent Time (h) Yield (%) endo-exo
Et PhH 288 52 0.85:1
Na h 2o 5 1 0 0 3:1
Table 3
1.2.5 Face-selectivity
The final element of control required in the Diels-Alder reaction is the control 
of absolute stereochemistry. How do we achieve an enantioselective reaction? Not only 
do we have to control endo-exo selectivity, we also have to differentiate between faces 
of the diene or dienophile. We need to have the reaction take place solely on one face 
of either component. This can be done in two ways:
• Covalently-bound chiral auxiliaries;
• Chiral (Lewis Acid) Catalysts.
1.2.5.1 Covalently-Bound Chiral Auxiliary
Chiral auxiliaries work by blocking one face of the dienophile (Figure 3a) or 
diene (Figure 3b), thereby restricting reaction to the opposite face.
9
R
Figure 3
Auxiliaries bound to the dienophile (Figure 3a):
• Camphorsultam 41 (Scheme 15) - used by Smith III et al in the synthesis of acid 
42, an intermediate in the synthesis of immunosuppressant FK-506.7
EtAICI2
LiOH41
42
86%, 93% ee
Scheme 15
• a,P-unsaturated hydroxyketones 43 {Scheme 16) - used in the synthesis of 
optically active shikimic acid 44.8
10
OAc O
OH AcO
BF3.Et20
72%
OAc►
OAc
Scheme 16
HO,,
HO"
C 0 2H
OH
44
Menthyl ester (Scheme 17) - Yamamoto and co-workers have shown that the di- 
menthyl ester of fumaric acid 45 can undergo Diels-Alder reactions with 
remarkable diastereoselctivity.9
O
R*0
45
OFT
O
R* =
Scheme 17
100% conversion 
99%de
Chiral auxiliaries bound to the diene (Figure 3b):
These are less common, but examples include l-(0-methylmandeloxy)dienes 46,10 
and dienylglucopyranosides 47 . 11
46 47
11
1.2.5.2 Chiral (Lewis Acid) Catalysts
Since Lewis Acids have proved to be most effective at catalysing and 
controlling Diels-Alder reactions, the logical step was to use a enantiopure Lewis acid 
to induce enantioselectivity. Recently, Yamamoto and co-workers12 have developed a 
Br0 nsted acid-assisted chiral Lewis acid catalyst 48, combining intramolecular 
hydrogen-bonding with attractive n-n donor-acceptor interactions. This catalyses the 
Diels-Alder reaction of a variety of a,P-unsaturated aldehydes with cyclopentadiene 
with excellent yield and enantioselectivity (Scheme 18). (Bromoacrolein 49 gives the 
exo-product 50, whereas a-unsubstituted aldehydes give predominately ewdo-products, 
but with less selectivity.)
Br
a CHO
49
48 (10 mol%) 
cyclopentadiene
CH2CI2
50
Scheme 18
48
99%,
CHO exo .endo, 99:1 
I %ee exo, >99%
Br
Two recent examples of chiral ligands used in Lewis acid catalysts are 5113 
and 52.14 Copper complexes of these ligands catalyse the Diels-Alder reaction of 
cyclopentadiene and two point-binding dienophiles 53 (so called due to the presence of 
two Lewis acid binding sites, e.g. C=0). All give high diastereo- and enantioselectivity 
(Scheme 19).
10 mol% Cu(CIQt)2-6H20 10 mol% Cu(OTf)?
12
AV J
53 R=H, Me
Cyclopentadiene, 
catalyst 
 ►
catalyst: 51: 87% yield
endo-exo, >99:1, 98% ee  
52: >99% yield 
endo-exo, >98:2, >99% ee
Scheme 19
1.3 Further Examples in Target-Orientated Synthesis
As we have seen, the Diels-Alder reaction is 'one of the most common and 
powerful transforms' 15 in organic synthesis. The importance of this reaction in modem 
organic chemistry is evident from its involvement in many complicated and stylish 
syntheses. These include the synthesis of (-)-shikimic acid 58 by Evans et al {Scheme 
20 ) . 16 This used an enantiomerically pure ligand complex 54. The cycloaddition 
between oxazolidinone 55 and furan 56 in the presence of 54 gave adduct 57 with high 
endo-exo selectivity and excellent enantioselectivity. This was also used by Evans in 
the synthesis of ^ -tetrahydrocannabinol. 17
>AA oVJ  ^
55 56
54 (5 mol%)
-7 8  °C, 42 h
'Cii
Scheme 20
97% conversion, 
endo-exo, 80:20, 
endo ee, 97%
II
HO,
XT
c o 2h
OH
58
13
The menthyl chiral auxiliary developed by Yamamoto and co-workers9 has also 
been of great use in the field of natural product synthesis. Corey et al used the 
dimenthyl fumarate 45 to great effect in the synthesis of bilobalide 59, a tetracyclic 
macrolide isolated from the ginkgo tree Ginkgo biloba {Scheme 21) . 18
Finally, in one of the most famous total syntheses in organic chemistry, the 
total synthesis of Taxol®, Nicolaou et al19 used phenylboronic acid to achieve total 
selectivity for one diastereomer in the reaction of allylic alcohol 60 with lactone 61 to 
give adduct 63. In the absence of the boronic acid, the wrong regiochemistry resulted. 
However, complete regiocontrol can be induced by tethering the dienophile 60 to the 
diene 61 as a boronate ester 62. The resulting intramolecular Diels-Alder reaction 
proceeds with complete endo selectivity {Scheme 22).
XX^Menth
Menth^
Menth
'C02Menth
O
Scheme 21
PhB(OH)2
60 61 62
63
79% from 60
E t02
OH x )
OH
Scheme 22
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1.4 Why Do We Need a Diels-Alderase Enzyme?
Despite being such a common reaction, the Diels-Alder reaction has several 
major disadvantages. The main drawbacks to this reaction are that it often requires 
harsh conditions - namely high temperature and pressure, and the use of 
environmentally-unfriendly reagents such as chlorinated solvents and transition metal- 
based Lewis-acids.
Enzymes are exceptionally good catalysts that can be used in very low 
stoichiometric amounts, and can perform in very mild conditions (neutral pH, room 
temperature, aqueous solution, etc . ) . 2 0  They can increase the rate of a reaction by a 
magnitude of 106 -1014. In addition, an enzyme can control the outcome of the reaction 
it catalyses. Use of a chemo- and regioselective enzyme may eliminate the need for any 
protecting groups within the substrate. A Diels-Alderase enzyme could influence the 
diastereoselectivity of the Diels-Alder reaction, thus giving control over the endo’.exo 
ratio. Finally, as with all enzymes, a Diels-Alderase would perform its function to give 
an enantiomerically enriched/pure product.
In these days of environmental-friendliness, the 'cleaning-up' of chemistry is 
always an issue, and enzymes have proved themselves to be leaders in the field of clean 
technology. Enzymes can be produced very efficiently in water using only 
biodegradable materials (e.g. by over-expression in bacteria), and the enzymes 
themselves, being proteins, are also biodegradable. Many biological molecules are only 
soluble in water, therefore a catalyst that would survive (and excel!) in an aqueous 
system would be of great synthetic benefit. Also, from a chemists point of view, 
understanding enzyme mechanisms can allow us to design better chemical catalysts.21
There are examples of antibodies being used to catalyse the Diels-Alder 
reaction, 2 2  but no natural Diels-Alderase enzyme has ever been isolated (as a single 
band by SDS gel electrophoresis). Indeed, there has been only one unambiguous 
demonstration of the involvement of a Diels-Alderase in biosynthesis23 and this 
enzyme, in this case, catalysed the intramolecular Diels-Alder reaction (See section 
1.8.1). An enzyme that catalyses an intermolecular Diels-Alder reaction is potentially 
much more useful to synthetic organic chemists.
15
1.4.1 Choice of Biological System24
Many natural products are claimed to be formed by enzymatic Diels-Alder 
reactions. 2 4  However, when selecting a biological system from which to isolate a 
Diels-Alderase enzyme there are several types of evidence for the existence of this 
enzyme that should be considered.
(i) Evidence from the structure of the natural product
The product of the putative enzymatic Diels-Alder reaction must contain a 
cyclohexene ring, and have stereochemistry consistent with a concerted [4+2] 
cycloaddition. The natural product must also be enantiomerically enriched/pure. 
Several possible Diels-Alder natural products have been isolated as racemates (e.g. 
endiandric acid C 6425 and brombins II 6526). This indicates a non-enzymatic 
biosynthesis.
H
H02i
Ph
64 Endiandric acid C 65 Brombins II
from Endiandra ir>trosa(Laurace$ from Brombya platynema
Enantiomeric purity is not sufficient evidence of an enzymatic reaction, 
however. We have seen how using water as a solvent can improve Diels-Alder 
reactions, as shown by Breslow and Rizzo, who demonstrated a 70-fold increase in 
reaction rate when using water over isooctane. 2 7  An enantiomerically pure/enriched 
Diels-Alder adduct could arise by spontaneous cycloaddition if the diene and/or 
dienophile were themselves enantiomerically pure [e.g. Plagiospirolide A 67 derived 
from diplophyllolide 6 6  (Scheme 23) \ . 28
enzymatic or 
O spontaneous?
66 Diplophyllolide 
[a]D -10 8 ° (MeOH)
67 Plagiospirolide A 
[a]D-173.6° (CHCfe)
Scheme 23
16
Therefore, the proposed diene and dienophile must both be achiral, and the 
natural product must be optically active.
(ii) Evidence of biosynthesis
It must be possible to propose a reasonable biosynthesis for the natural 
product, involving the Diels-Alder reaction and precursors that have already been 
isolated from the same system. Feeding studies must primarily show incorporation of 
natural and unnatural substrates, but also the viability of the Diels-Alder biosynthesis 
(i.e. the substrates fed should be dienes or dienophiles).
(iii) Chemical evidence
A biomimetic synthesis would confirm that a Diels-Alder reaction is possible 
between the proposed precursors.
1.4.2 What about Biocatalysis?
Is it possible that natural, enantioselective Diels-Alder reactions are being 
catalysed, but not by a specific enzyme? Kakulapati et al29  have shown that Bakers 
yeast acts as an efficient biocatalyst in the Diels-Alder reaction between a range of 
oxo-arylpyridazines 6 8  and azodicarboxylates such as 69 (Scheme 24). No 
cycloaddition occurred in the absence of yeast, or in the presence of boiled yeast. 
Likewise, experiments to resolve racemic 70 using yeast were unsuccessful.
C 0 2Et
Bakers Yeast 
----------------
70
72-82%, 
%ee, 9-63%R=H, Me, OMe, Cl
Scheme 24
Common proteins have also been used as biocatalysts. Colonna et al30 used 
Bovine Serum Albumin (BSA) in the reaction of naphthoquinone 71 with 
cyclohexadiene 72 {Scheme 25). Enantiomeric enrichment of cycloadduct 73 was very 
low (<38% ee) and the reaction was very slow.
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OH O
5 mol% BSA 
--------------
H20 , 18 h
OH O OMe
73
29%, 38% ee
OH O OMe
25% 
Scheme 25
OMe
OH O
12%
OMe
OH O
15%
These studies indicate that biocatalysis without a specific Diels-Alderase 
enzyme may have a role in the biosynthesis of Diels-Alder adducts. However, low 
enantiomeric enrichment and (especially in the case of the BSA-catalysed reactions) 
poor product selectivity suggest that enantiomerically pure Diels-Alder adducts must 
be produced by something more specific, i.e. an enzyme.
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1.5 The Intramolecular Enzymatic Diels-Alder Reaction
As mentioned, there are several natural products which are claimed to be 
formed by an enzymatic Diels-Alder reaction. In this section we shall discuss only 
those examples with the strongest evidence.
1.5.1 The Solanapyrone A System
All previous work into the enzymatic Diels-Alder reaction have focused on the 
intramolecular reaction. For several years Oikawa et al31’32 has been studying the 
biosynthesis of (-)-solanapyrone A 74, a phytoalexin from the pathogenic fungus 
Altemaria solani.
OH' OMe
74
(-)-Solanapyrone A is biosynthesised by an exo Diels-Alder reaction from 
prosolanapyrone III 77 which, in turn is produced by sequential oxidation from 
prosolanapyrones I I 76 and 175 (Scheme 26).
OH' OMeOMeOMe
Prosolanapyrone III 
77
Prosolanapyrone IIProsolanapyrone I
Scheme 26
The most conclusive experiments used cell-free extracts . 3 2  When 
prosolanapyrone III 77 was incubated in enzyme-free aqueous solution under standard 
conditions (30 °C, 10 min), 10% was converted into Diels-Alder adducts, 
solanapyrones A 74 and D 78, the product of the endo Diels-Alder (Scheme 27, Table 
4, entry 1). The ratio of exo-endo was 3:97. When carried out in cell-free extract, 25%
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of 77 was consumed giving 74 and 78 in a ratio of 53:47 (entry 2). By comparison of 
these results, Oikawa concluded that the consumption of 77 by the enzyme was 15%, 
giving products with an overall exo selectivity of 87:13 (entry 3). The enantiomeric 
purity of 74 was 92±8% [determined by CD absorption compared to natural (-) 
solanapyrone A].
OB OMe
OH' OMe OH' OMe
30 °C, 10 min q
74
Solanpyrone A
78
Solanpyrone D77
(exo product) (endo product)
Scheme 27
Conditions Conversion %Exo %Endo
1 . Control Aqueous 1 0 % 3 97
2 . Test Cell-free extract 25% 53 47
3. Difference Enzyme 15% 87 13
Table 4
The cell-free extract experiment was repeated with prosolanapyrone I I 76 as the 
fed substrate. Under an inert atmosphere, no cyclisation took place. When the 
experiment was carried out in air, three products of note were isolated: 
prosolanapyrone III 77, and solanapyrones A 74 and D 78. Once again, there was a 
noted exo selectivity (83:17) and a very high enantioselectivity (%ee exo, 99±4% ee).
The following points were noted from the first set of experiments:
• Solanapyrone A was produced in optically active form from an achiral precursor.
• There was a difference in diastereoselectivity between spontaneous cyclisation and 
cyclisation in a cell-free extract. Solanapyrone D 78 is produced by spontaneous 
cyclisation in water (and in chemical synthesis) , 33 but levels of solanapyrone A 74 
rise markedly in the cell-free extract experiments.
• A small rate-enhancement was observed. When four times the concentration of 
extract was used, the reaction proceeded 4.1 times faster than the control.
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The prosolanapyrone II-feeding experiment showed that:
• Under no circumstances do unoxidised cycloadducts form (i.e. cycloadducts of 77 
and 76).
• No cycloaddition occurs without oxygen.
• Prosolanapyrone in 77 is formed in the presence of oxygen.
• Diastereo- and enantioselectivities were better when prosolanapyrone II 76 was the 
fed substrate.
From these results, Oikawa concluded that the Diels-Alder reaction is enzyme 
controlled. The enzyme's main function is as an oxidase, but it does have a small 
catalytic influence on the diene cyclisation, and a substantial effect on the exo-endo 
ratio. Recently, Oikawa et al managed to partially purify the Diels-Alderase from A. 
solaniP  but they have yet to obtain a sample of the enzyme that is a single band by 
SDS gel electrophoresis.34
1.5.2 The Manzamine System
The other major contributors to the investigation of intramolecular enzymatic 
Diels-Alder reactions have been Baldwin and Whitehead in their study of the 
biosynthesis of manzamine alkaloids.
Manzamine A 79 was first isolated in 1986 by Higa and co-workers from the 
sponge Haliclona sp.35 This was closely followed by the isolation of manzamines B 
80 and C 81 from the same sponge.36 Their complicated structural formulae led Higa 
to state that "there appears no obvious biogenetic pathway."
In 1992, Baldwin and Whitehead proposed a common biosynthetic path to 
these compounds.37 Manzamine C 81 could be traced to three precursors, tryptophan,
79 80 81
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acrolein and a symmetrical Cio dialdehyde 82 (Scheme 28). Reductive coupling with 
ammonia would give 81.
NH2
c o 2h
n h 3
< ^ C H O
OHC CHO
82
81
Scheme 28
Baldwin and Whitehead then proposed an analogous biosynthetic pathway for 
the more complicated manzamines A 79 and B 80 (Scheme 29). Two molecules each 
of ammonia, acrolein and 82 could be coupled to give hydropyridinium 83. This 
undergoes an endo Diels-Alder reaction to give adduct 84 (in redox equilibrium with 
85). Ring-opening, incorporation of tryptophan and oxidation would then give 
manzamine B 80. Minor changes after tryptophan incorporation would give 
manzamine A 79 by the same path.
2 x
Diels-Alder
80
85
Scheme 29
84
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The only evidence to suggest the involvement of a Diels-Alderase was the 
proposal that optically active manzamines were derived from an achiral precursor. In 
1994, Kobayashi et al isolated keramaphidin B 8 6  from the marine sponge 
Amphimedon sp. . 38 Keramaphidin B is a pentacyclic alkaloid, and is a reduced form of 
iminium 84 in Baldwin and Whiteheads' proposed biosynthesis.
86
The discovery of a compound similar to a proposed intermediate should be 
further evidence of a Diels-Alderase. However Kobayashi discovered that crystals of 
natural keramaphidin B 8 6 , which has 4 chiral centres, were racemic. If a Diels- 
Alderase were involved, keramaphidin B 8 6  should have been isolated in an optically 
active form. Kobayashi then looked at the isolated sample of 8 6  in more detail.3 9  
Chiral HPLC analysis of both crystals and mother liquors showed that the ratio of 
(+):(-) enantiomers was 1:1 and 20:1, respectively. Keramiphidin B was being 
produced enantiomerically enriched, but was crystallising as a racemate. This 
observation proved crucial to the acceptance of Baldwin and Whiteheads' biosynthesis. 
In order to provide more evidence of a Diels-Alderase, a biomimetic synthesis of 
keramaphidin B 8 6  was attempted (Scheme 30).40 In a methanol-water solution 
buffered at pH 7.3, pyridinium ion 83 underwent an endo cycloaddition giving an 
adduct which was immediately reduced. Exhaustive chromatography gave a sample of 
pure 8 6  in low yield.
1-1 MeOH- 
aq. TRIS, pH 7.3
0.2-0.3%
83
Scheme 30
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The following points can be made about this study:
• The structure of the manzamines A and B, 79 and 80 is consistent with a biological 
Diels-Alder reaction as proposed by Baldwin and Whitehead.
• Biomimetic synthesis has shown that keramaphidin B 8 6  can be formed by an 
intramolecular cycloaddition.
• Keramaphidin B is produced in optically active form, however the putative 
precursor is achiral.
Baldwin concluded that the involvement of a Diels-Alderase enzyme in this 
system was very likely.
1.5.3 Other Natural Products from this Intramolecular Enzymatic 
Diels-Alder Reaction
Several natural products, mainly derived from keramaphidin B 8 6 , can also be 
described as being 'Diels-Alderase' adducts. Two of these are the ircinals A 87 and B 
8 8 . 41 Both have been isolated from the sponge Ircinia sp.. These have the same 
keramaphidin-derived skeleton as the manzamines A and B and may be converted into 
the latter by condensation with tryptophan as proposed by Baldwin and Whitehead.
CHO CHO
,....OH
HN.
OH
87 88
As well as the (+)-ircinals 87 and 8 8 , 4 1  (-)-halicyclamine A 89,42 and 
haliclonacyclamine A 90,43 (from Haliclona sp.) are thought to be formed by a retro- 
aza-aldol opening of keramaphidin B-precursor 84 {Scheme 31).44
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25
1.6 The Intermolecular Enzymatic Diels-Alder Reaction
Many polyphenolic compounds isolated from moraceous plants show evidence 
of Diels-Alderase involvement. These all have the same basic skeleton {Figure 4) and 
include chalcomoracin 91,45 kuwanon G 92,4 6  dorstenone 93 47  and artonin 194 48
^ — Ar2
Ar1 = a flavone, flavonoid, chalcone or biaryl 
^  Ar2 = a phenol 
Ar3 = a phenol
Figure 4
HO
OH HO
OH
OH
OH
HO
Chalcomoracin 91 
[oc]d +194° (acetone) 
from Morus alba
OH HO
^ O H
OH HO
OH
OH
Dorstenone 93 
[a]D -371° (CHCfe)
OH
Kuwanon G 92 
[a]D -534° (MeOH) 
from Morus alba
OH H
/y OH
from Dorstenia barteri
Artonin 194 
[a]o +95° (acetone) 
from Artcarpus heterophyllus
Evidence for Diels-Alderase Involvement:
• All of these compounds are optically active and are derived from achiral diene and 
dienophiles.
• The 4,5-relationship in the cyclohexene ring is consistent with a Diels-Alder 
reaction on an Zs-chalcone.
• In cases where the absolute stereochemistry has been determined (by X-ray 
crystallography and CD spectroscopy), it is always 4R, 5S.
• There are examples of both endo and exo adducts, but in all cases addition occurs 
on the same face of the diene.
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1.6.1 The Chalcomoracin System
Of all the Diels-Alder adducts produced, the chalcomoracin system was of 
most interest to us.
In 1980, Takasugi et al isolated and elucidated the structure of chalcomoracin 
91.45 Chalcomoracin is a naturally-occurring antifungal compound found in the 
diseased shoots of the white mulberry Morus alba. It consists of several polyphenolic 
aromatic moieties and a methylcyclohexene ring, which has stereochemistry consistent 
with an endo Diels-Alder reaction of an E-dienophile. It was proposed that 
chalcomoracin was derived from dienophile morachalcone A 95 and diene 96 (Scheme 
32 ).49)50 The production of an optically active adduct from achiral precursors 
suggested the involvement of an enzyme.
OH OH
OH
HO
OHOH
PH
HQ
HO
HO OH96OH
Scheme 32
Of the two precursors, only morachalcone A 95 has ever been isolated from M. 
alba. Although the existence of the diene 96 has never been proven, the antifungal 
compound moracin C 97 has been found in M. alba. It has been proposed that 
moracin C is a biological precursor to 96 which, once formed, undergoes cycloaddition 
with morachalcone A 95.
OH
HO
OH97
Much of the biosynthetic work in this area has been carried out by Nomura 
and co-workers, 5 0  investigating Diels-Alderase activity in moraceous plants. They
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performed a series of feeding experiments with M. alba, using 13C-labelled acetates; 
modified substrates; and unnatural substrates.
1.6.1.113C-Labelled Substrates
Sodium [1-13C]-, [2-13C]- and [1,2-13C2 ]-acetates were fed to M. alba cells 
and the suspensions shaken for 7 days at room temperature.5 0  After work-up, it was 
found that, in all 3 experiments incorporation of the labelled acetates had occurred 
{Figure 5).
OH
•  [1-13C] acetate
O [2-13C] acetate
•  Q [1,2-13C2 ] acetate
Figure 5
The labelling pattern from the experiments with [1-13C]- and [2-13C]-acetate 
indicate several things:
• If chalcomoracin is formed by the suggested Diels-Alder reaction, then the 
chalcone is derived from a cinnamoyl polyketide skeleton 98. This is shown, both 
by the incorporation of [2-13C]-acetate into positions 2, 4 and 6  of ring B, and the 
lack of labelling in ring C.
• Ring A has a labelling pattern similar to ring B, while no labels were incorporated 
into ring D. This suggests that the arylbenzofuran is also derived from polyketide 
98.
HO
OH
HO,
HO
[1-13C]-Acetate incorporation into the arylbenzofuran was only noted in positions 
3'-and 5'- of ring A, suggesting cyclisation occurs between carbons 3 and 8  of the 
polyketide, followed by decarboxylation (Scheme 33). On the other hand, [1-13C]- 
acetate incorporation into ring B suggests cyclisation between C-4 and C-9 of 98 
(Scheme 34).
EnzS. .OH
OH
O O
EnzS.
HO.
OH
C 0 2O OH
Scheme 33
EnzS. .OH
Enz
OH
OH
OH O
Scheme 34
Examination of the labelled products showed that there were differing levels of 
isotope incorporation. The aromatic sections showed 17% uptake, while the prenyl 
groups had only a 0.4% incorporation. This difference in labelling suggests that these 
portions are biosynthesised in a different way. The cyclohexene ring has a labelling 
pattern consistent with a diene formed by elimination of H2  from the methylene and 
the ds-methyl groups of the prenyl group of moracin C 97. The prenyl group in 
moracin C is labelled in a similar manner to the prenyl group in the chalcone (Scheme 
35).
A r^ M
-s-r
Scheme 35
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1.6.1.2 Modified Substrates
In a later study by Nomura and co-workers, 51 4-O-methylmorachalcone 99 
was fed to a suspension of M. alba cells. After 7 days, standard extractive work-up 
gave a 41% yield of optically active Diels-Alder adducts {Scheme 37 and Table 5).
HO
“OMe
M. alba suspension 
Tween 80 
7 days 
25°C
41%
OH
OHOH
HQOH
MeO OHOH
100-102 103
Scheme 36
Isolated Yield RtyR2/R 3 [ccId
100
(methylkuwanon J)
1.9% Ri=Me, R2=H, 
R3=OH
+26 (0.16, EtOH)
101
(methylkuwanon Q)
2 .6 % R ^M e, R2=R3=H +133(0.075, EtOH)
102
(dimethylkuwanon J)
27.7% Ri=R2=Me,
R3=OH
+28 (0.085, EtOH)
103 8.7% — +152(0.088, EtOH)
Table 5
All adducts were isolated in optically active form. Three of the four adducts 
(1 0 0 , 1 0 1  and 1 0 2 ) were of the kuwanon family and are believed to be formed by
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cycloaddition between the double bond of the chalcone and a morachalcone-derived 
diene. The other adduct was 18"-0-methylchalcomoracin 103.
The results of these feeding studies prove that chalcomoracin and the members 
of the kuwanon family are synthesised from morachalcone A 95 in a manner 
consistent with an enzymatic Diels-Alder reaction.
1.6.1.3 Unnatural Substrates
Labelled moracin C has never been fed to cell cultures to confirm that it is the 
natural precursor to chalcomoracin. However, studies on artonin I 94 support this 
hypothesis. Artonin I 94 is an optically active natural product isolated from the 
Indonesian moraceous plant Artocarpus heterophyllus (Figure (5) . 4 8  Examination of 
its structure shows that it too is a plausible Diels-Alderase adduct. Artocarpesin 104 is 
a natural flavone also from A. heterophyllus, and is presumed to be the precursor to the 
diene required in artonin I biosynthesis. While prevalent in A. heterophyllus, neither 
compound has ever been isolated from M. alba.
OH
HO
OH
HOOH
OH104
HO
HO
[cc]d  +95 (0.05, acetone) 
from A. heterophyllus
Figure 6
The obvious structural similarities between 104 and the prenylated compounds 
from M. alba led Nomura and co-workers to believe that it may be a suitable unnatural 
substrate to use in their feeding studies. Artocarpesin was fed to M. alba cell cultures 
under standard conditions 4 8  After work-up, several naturally-occurring Diels-Alder 
adducts were isolated including a significant amount (8 %) of artonin 194. The artonin
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I from these experiments was of comparable optical purity to the naturally-occurring 
compound {[oc]d +91 (0.0075, acetone) from M. alba).
1.6.2 Will the Diene Really Exist?
As mentioned, although moracin C 95 is known, diene 96 has never been 
isolated {Scheme 33, p27). Possibly the diene moiety is not stable in water and cyclises 
onto one of the neighbouring hydroxyls. Such a cyclisation would form another 
member of the moracin family, moracin D 105. This natural chromene has been 
isolated from M. alba.52 However, moracin D may also be a precursor to diene 96. 
The chromene ring in moracin D 105 is in the same oxidation state as the diene group, 
and it is possible that the chromene ring is 'opened* by the Diels-Alderase (or another) 
enzyme to give diene 96 {Scheme 37). To date, no investigation of this has been made.
HO
OH
Diels-Alder
adducts
OH
105 96
Scheme 37
Several phenolic dienes have been isolated from natural sources {Figure 7), and 
so diene 96 is a plausible intermediate.
OH O 
From Tephrosia fulvinervii3
OH
From Groundnut kernel#4
From Ormosia monosperma'5 
Figure 7
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1.7 Primary Aims
We have chosen the chalcomoracin system for the following reasons:
• The stereochemistry of the cyclohexene ring in chalcomoracin is consistent with a 
concerted [4+2] cycloaddition on an F-chalcone.
• Chalcomoracin is optically active and derived from achiral precursors. These 
precursors (or derivatives of them) have been found in the same organism.
• The Diels-Alder reaction is intermolecular.
• Chalcomoracin is an endo Diels-Alder adduct. The corresponding exo-product has 
never been isolated from M. alba, indicating that the reaction is diastereoselective.
• There have been a range of Diels-Alder adducts found in M. alba. This, together 
with the incorporation of an unnatural substrate, suggests that the enzyme has a 
reasonably broad substrate-specificity.
The aim of this project is to develop an assay for the Diels-Alderase enzyme. 
This assay will be based on the biosynthesis of chalcomoracin proposed by Nomura 
and co-workers.4 0  For this assay we require to synthesise both dienophile 95 and 
diene 96. These can be used in a biomimetic study to establish the involvement of a 
Diels-Alder reaction. The synthesis of 95 and 96 will also provide relevant 
intermediates for the total synthesis of chalcomoracin. Our initial efforts will be 
directed towards the total synthesis of moracin C 97. Due to the obvious structural 
similarities, we hope that a synthesis of 97 will provide a straightforward route to diene 
96.
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Benzofuran Synthesis
2
2.1 Previous Syntheses of Moracin C
2.1.1 What is moracin C?
As well as being a powerful antifungal compound, 5 6  moracin C 97 is also an 
oviposition stimulant for the lesser mulberry pyralid moth Glyphodes pyloalis.51 To 
show this, Nakamura and co-workers inoculated mulberry leaves with samples of 
natural and synthetic moracin C in concentrations as low as 0.01 gram leaf equivalents 
(18pg per leaf), and found that egg-laying on those leaves was greatly stimulated.
These interesting biological properties, as well as moracin C's involvement in 
chalcomoracin biosynthesis have made it a popular synthetic target.
2.1.2 Mann and Widdowson's Synthesis
The first of the two previous syntheses of moracin C was by Mann and 
Widdowson in 1991.58 The primary disconnection in their route involved 
regioselective prenylation of an aromatic ring, and a Stille coupling to form the 
arylbenzofuran nucleus 106 {Scheme 38).59 This required the establishment of a 1,3,5- 
substitution pattern in the aryl iodide 108 - a notoriously difficult relationship to set 
up.
OH OR
>
106
>
HO' RO
OH OR97
ORt
RO
107 108 OR
Scheme 38
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The starting material for the synthesis was resorcinol 109. The iodine could be 
introduced by remote lithiation of an aryl-chromium complex using a method already 
pioneered by Masters and Widdowson.5 9 >6 0  Scheme 39 outlines the initial preparation 
of the chromium complex 1 1 1  from resorcinol.
TIPSCI
imidazole
DMF
99%
109
(TIPS
o t ip s
110
OTIPS
Cr(CO)6
THF
OTIPS
111
Scheme 39
In a previous study5 9  Masters and Widdowson had used the bulky 
triisopropylsilyl group to direct to the m eta  position. Treatment of (r |6- 
triisopropylsilyloxybenzene)tricarbonylchromium(O) 1 1 2  with tert-butyllithium and 
quenching with methyl iodide gave two monomethylated products 113 and 114 in a 
combined total of 78% yield (Scheme 40). These were the meta- and para- derivatives, 
respectively and were isolated in a ratio of 10:1 (by lH NMR spectroscopy). There 
was also a small amount (3%) of o-triisopropylsilyl phenol 115, a result of ortho- 
lithiation followed by silicon migration.
OTIPS
Cr(CO)3
112
i) f-BuLi, THF
ii) Mel
78%
OTIPS
Cr(CO)3
OTIPS
Cr(CO)3
113
10 1
Scheme 40
Cr(CO)3
TIPS
115
There are two possible explanations for this regioselectivity. The first concerns 
the conformation of the chromium complex. The normal arrangement of an 
arenetricarbonylchromium(O) complex is where the substituent is eclipsed by one of 
the carbonyl groups. This has been shown to be the most stable conformation (Figure 
S) , 61 and causes an electron-deficiency at the eclipsed carbons, making them more 
susceptible to either nucleophilic attack or deprotonation.
36
o0
10TIPSmost
acidic
O
Figure 8
The second explanation concerns a property common to aromatic rings 
substituted with electronegative groups. Ortho-Lithiation is a method of aromatic 
substitution which involves initial chelation of an alkyllithium to a heteroatom, followed 
by deprotonation in the or^o-position. Addition of an electrophile leads to highly 
regioselective substitution of the aromatic ring {Scheme 41).62
The most common groups ortho to which lithiation is possible are O-alkyl 
(methyl and benzyl especially), A-alkyl, and 5-alkyl, although other groups may also 
direct lithiation (e.g. Se, F, -CONHR', -CN, and oxazolines) . 6 2  In complex 111 
however, it is possible that the bulkiness of the triisopropylsilyl groups makes the 
ortho proton inaccessible (Figure 9).
Treatment of complex 111 with n-butyllithium followed by quenching with 
iodine resulted in isolation of a single regioisomer 116 in moderate yield {Scheme 42).
E
Scheme 41
(OC)3Cf
Bu—Li
Figure 9
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OTIPS
OTIPS
Cr(CO)3
i) /7-BuLi, THF
ii) l2,THF
57%
111 116
Scheme 42
OTIPS
C r C 0 3
The prenyl unit in moracin C was to be inserted by o-lithiation later in the 
synthesis, and this required a change in the protecting group. Of all the functionality 
that directs lithiation, the methoxy group is one of the most efficient. It is a very strong 
orr/iodirector, and its relatively small size means that it does not sterically hinder the 
reaction process. The protecting groups on complex 116 were changed using a 
convenient 'one-pot' sequence of desilylation with tetrabutylammonium fluoride 
(TBAF) and methylation. This gave dimethoxy complex 117 in good yield (Scheme 
43), and completed the first fragment for the Stille coupling.
OTIPS
/  ^  OTIPS 
Cr(CO)3
116
TBAF, NaH, 
Me2S 0 4) THF
70%
Scheme 43
/ v  OMe 
Cr(CO)3
117
The desired stannane fragment was to be constructed by lithiation at C-2 of a 
benzofuran having an oxygen substitutent at C-6 . Previously however, Mann and 
Widdowson had discovered that lithiation of 6 -methoxybenzofuran 118 gave a 4:1 
mixture of benzofurans 119 and 120, substituted in the 2- and 7- positions, 
respectively (Scheme 44) . {63 The side-product 120 arises as a result of co-ordination of 
the lithium atom to the oxygen atom of the methoxy group and the benzofuran (Figure 
10).
MeO
118
i) n-BuLi, THF
ii) TMSCI, THF
70%
119:120 = 4:1
MeO
119: R1=TMS, R2=H 
120: R1=H, R2=TMS
Scheme 44
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Figure 10
When the protecting group was changed from methyl to the tert- 
butyldiphenylsilyl group (which is relatively bulky and does not direct lithiation) 
alkylation occurred solely in the 2-position. This finished the synthesis of stannane 
122, the second fragment for the Stille coupling reaction (Scheme 45).
MeO
118
>
i) EtSH, NaH, DMF
ii) TBDPSCI, 
imidazole, DMF
54% (2 steps) TBDPSO
TBDPSO
Scheme 45
\
121
i) n-BuLi, THF
ii) SnMesC! 
70%
f r V s ^  
122
Coupling of the two fragments under standard Stille conditions gave the aryl 
benzofuran complex 123 in moderate yield {Scheme 46).
OMe
OMe
[Cr]
117
OMe
-►
TBDPSO'54%
[Cr] OMe
123
Scheme 46
Prenylation of the aromatic ring of 123 to give complex 124, proceeded cleanly 
via regioselective lithiation, transmetallation to copper and alkylation with prenyl 
bromide (Scheme 47). Decomplexation with iodine, followed by demethylation 
(Ph2 PLi) and desilylation (TBAF) gave moracin C in 12 steps (longest linear sequence 
= 9 steps from resorcinol, overall yield = 4.9%).
i) n-BuLi, THF 
|i) CuBr.M^S
iii) prenyl bromide
60%
OMe
124 OMe
excess fe, 
CH2CI2 
85%
OMe
TBDPSO'
OMe125
i) n-BuLi, PPh2H, THF
ii) TBAF.THF 
50%
Moracin C97  
Scheme 47
2.1.3 Nakamura and co-worker's Synthesis
The second synthesis of moracin C was also in 1991, by Nakamura and co­
workers.57 Like Mann and Widdowson, they opted to form the 2-arylbenzofuran 
nucleus by a Stille coupling and to install the prenyl group by ort/io-lithiation.
Once again, the starting material for the aryl iodide fragment was resorcinol. 
This time however, the prenyl group was installed early in the synthesis. Resorcinol 
109 was converted into the fos-tetrahydropyranyl (THP) ether 126, as the THP group 
is a good ortho-director, and is easier to remove than a methyl group. Ether 126 was 
treated with rc-butyllithium and prenyl bromide to afford alkylation in the desired 
position. The THP groups were then removed under weakly acidic conditions to give 
prenylated resorcinol 127 (Scheme 48).
i) n-BuLi, Et20 
prenyl bromide
ii) (C 02H)2i MeOH
QP 64% (2 steps)
OH
OH
127DHP, H+
R=H ---------------►R=THP
109 86% 126
Scheme 48
Iodination of the inaccessible 5-position of the ring was done using Masters 
and Widdowson's protocol of remote lithiation of an arenetricarbonylchromium(O) 
com plex.59’60 This required protection of the free hydroxyls in 127 as bulky 
triisopropylsilyl ethers and complexation to chromium (Scheme 49). Remote lithiation 
and iodination of complex 128 followed by decomplexation gave aryl iodide 129, the 
first fragment of moracin C, in very poor yield (Scheme 49).
41
OH
OH
127
i) TIPSCI, imid. 
DMF
ii)Cr(CO)6
42% (2 steps)
OTIPS
OTI PS
129
i) n-BuLi, l2, THF
ii) excess I2 , hv 
17% (2 steps)
OTIPS
129
Scheme 49
The stannylated benzofuran 122 was prepared from 6-hydroxybenzofuran, by 
the same method as Widdowson and Mann (Scheme 45).63 The two fragments were 
then coupled together in the presence of palladium and desilylated to give moracin C 
97 (Scheme 50).
OTIPS
TBDPSO'TBDPSO'
OTIPS122
TBAF, THF 
14% (2 steps)
Moracin C97
Scheme 50
Unfortunately, the Stille coupling and deprotection were again very low 
yielding. This meant that, although the synthesis was the same length as Mann and 
Widdowson's (12 steps with 9 steps in the longest linear sequence from resorcinol), 
the overall yield was substantially lower (<1% overall).
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2.2 Synthetic Approaches to Benzofurans
Over the years, chemists have used a vast number of methods to synthesise 2- 
arylbenzofiirans. This chapter shall highlight specific examples of the various ways of 
constructing these often biologically important compounds. As well as the cross­
coupling methods used by Widdowson and Nakamura, routes to these compounds fall 
into 3 major categories:
• rearrangements;
• alkyne cyclisations; and
• non-alkyne cyclisations.
2.2.1 Rearrangements
The first of the three categories concerns the rearrangement of a precursor 
(sometimes cyclic, often acyclic) into the desired benzofuran. Whilst exploring the 
biosynthesis of 2-arylbenzofurans derived from isoflavonoids, Kinoshita discovered 
an acid-induced ring contraction that conveniently converted a 2-hydroxy-isoflav-3-ene 
130 into a benzofuran 133 in 78% yield.64 Treatment of 130 with acid gave an 
intermediate tertiary cation 131, which spontaneously underwent ring contraction to the 
dihydrobenzofuran 132. Loss of formaldehyde gave the fully aromatic system. This 
was used in the synthesis of vignafuran 133 (Ar=4-hydroxy-2-methoxyphenyl), a 
potent antimicrobial phytoalexin isolated from cowpea leaves infected with the 
microorganism Vigna unguiculata (Scheme 51).
In contrast to the above acid-induced reaction, Barbier demonstrated the 
synthesis of 2-phenylbenzofurans by base-catalysed rearrangement.65 Treatment of
MeO .OH MeO Cow
Ar
HCHO133
78% from 130 132
Scheme 51
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marginalin 134, a natural benzofuranone from the water beetle Dytiscus marginalis 
(Coleoptera), with sodium methoxide in methanol gave moderate rearrangement to 
benzofuran 138 {Scheme 52).
HO,
OH
o_
— lOMe135
HQ
HO.
134
HO.
O OMe
136
OMe
OHHO.
H+
C 0 2H
HO.
OH
138
40% from 134
Scheme 52
Barbier proposed that this proceeded via conjugate addition of methoxide onto 
a p-quinomethide 135 formed in situ. Ring-opening of addition product 136 gave 
phenoxide 137. Intramolecular Michael addition followed by treatment with acid gave 
the arylbenzofiiran 138.
Both of these above examples have involved the rearrangement of cyclic 
intermediates. There are however, several cases where an acyclic precursor has 
undergone rearrangement prior to cyclisation. Ledoussal et al,66 found that treatment 
of an ortho-O-Sicyl benzylic bromide 139 with chromium(H) chloride gave a a-bonded 
chromium complex 140. This complex underwent a 1,5-acyl migration yielding
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benzylic ketone 141. Treatment of this ketone with a Lewis-acid resulted in benzofuran 
142 formation (Scheme 53).
Phmigration
CrCI2
Ph Ph
140139 141
80%
Ph
142
Scheme 53
A somewhat unusual approach was taken by Sato and co-workers,67 who 
utilised a [2,3]-sigmatropic rearrangement of phenoxysulfonium ylides to give a range 
of 2-substituted benzofiirans. The reaction of dialkyl sulfide 143 with sulfuryl chloride 
gave cation intermediate 144. This reacts with a phenol such as 145 giving sulfonium 
ylide 146 (Scheme 54).
,OAc
S
143 Ph
OH
145
Et0^
W V
OAc 
Ph
Et02( T ^ s .
Ac
Ph
146
Scheme 54
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[2,3]-Sigmatropic rearrangement of ylide 146 followed by tautomerism and 
acetate removal gave o-alkylated phenol 148 {Scheme 55).
OAc
E t02<
Ph
146
AcO, Ph
[2,3]
AcO, Ph
E t02*
OH
147
HO. Ph
OH
148
Scheme 55
Treatment of phenol 148 with acid resulted in formation of episulfide 
intermediate 149 which immediately underwent cyclisation to dihydrobenzofuran 150. 
Loss of thiol gave the 2-phenylbenzofuran 151 {Scheme 56).
PhE t02<
Ph
E t02i
148
OHOH
149
O
MeO,
E t02<
Ph
Ph
HO OMe
150
67% from 148
Scheme 56
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2.2.2 Alkyne Cyclisations
One of the commonest, and easiest ways of forming substituted benzofurans is 
through reaction of a phenol with an alkyne.
In the synthesis of an A1-selective adenosine antagonist 155 (isolated from 
Salvia miltorrhizia Bunge),68 Wong and co-workers constructed the central 
benzofuran nucleus through coupling of cuprous acetylide 152 with bromophenol 153, 
using the method of Castro and Stephens (Scheme 57).69
.OBn
OMe
pyridine152Ci
65%OMe
OH
153
OR
OMeOMe
154 R1= Bn, R2= H,
R?= CH=CHC02Me
155 R1= H, R2= CHO,
R?= (CH2) 3OH
Scheme 57
Palladium-catalysed cyclisations onto alkynes are also common. Arcadi et al 
demonstrated the synthesis of 2-substituted benzofurans with complete regiocontrol.70 
A palladium/copper iodide mixture was used under Sonogashira coupling conditions 
(Scheme 58). This resulted in isolation of a single regioisomer 158.
OH Pd(PPh3 )2 (OAc) 2 / ^ s ^ O v
. ~  —
156 157 158
Scheme 58
Controlling the regioselectivity of these Pd-mediated reactions can sometimes 
be problematic. This was demonstrated by Larock et al who investigated the 
palladium-catalysed annulation of alkynes.71 Coupling of iodophenol 156 with alkyne 
159 in the presence of palladium diacetate gave a 3:2 mixture of 2,3-disubstituted 
benzofurans 160 and 161 (Scheme 59).
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Ph- -C 02Et
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Pd(OAcfc>, 
K2CCb, LiCI
160:161 =3:2
combined 69%
160
Scheme 59 
2.2.3 Non-Alkyne Cyclisations
The final, and largest, category concerns the formation of benzofurans by either 
inter- or intramolecular cyclisation. Once again, this approach has been used in the 
synthesis of several natural products.
The first example demonstrates a Lewis acid-promoted cycloaddition of 
styrene 162 to quinone monoimide 163, and was the approach taken by Engler et al 
{Scheme 60).72 The resulting dihydrobenzofuran 164 was oxidised to give the target 
system. This method was used in the synthesis of eupomatenoids-1 165 and -12 166, 
which are natural neolignan compounds with potent antibacterial and 
immunosuppressant properties.
FrO.
R O'
162
^ \ ^ . N S 0 2Ph
OMe
163
BF3 .Et20
86-88%
NHS02Ph
FVO
1 6 4  OMe
i. Oxidation 73%
ii. Stille 97-98%
R'O
OMe
Eupomatenoid-1 165 
R1/R2 =CH2  
Eupomatenoid-12 166 
R1=R2=CH3
Scheme 60
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In the synthesis of the phytoalexin vignafuran 169, and another member of the 
moracin family, moracin M 170, Watanabe et al used a convenient cyclisation of 
deoxybenzoin derivatives to make the benzofuran core.73 Lithiation of 
phosphoramidate 167 with seobutyllithium followed by quenching with a variety of 
methyl benzoate esters gave the deoxybenzoin derivatives 168. Immediate treatment 
with formic acid resulted in cyclisation {Scheme 61).
A more unusual approach was taken by Grubbs and co-workers in the 
synthesis of a phytoalexin 174 isolated from Sophora tomentosa L.74 A combination 
of olefination followed by ring-closing metathesis gave a short, easy route to this 
target. Olefination of ester 171 (using the procedure developed by Takai and co­
workers)75 gave the acyclic enol ether 172. Ring-closing metathesis catalysed by 
molybdenum complex 17376 gave the natural product in high yield {Scheme 62).
i) s-BuLi
ii) ArC0 2 Me
A r
OPO(NMe2 )2
TBSO' “OPO(NMe2 )2
167 168
h c o 2h
Vignafuran 169 R1=OMe, F?=R4 =H,
R3=OH, R5=Me (22.5%)
R1 R2
Moracin M 170 R1=R3=R5=H,
R2=R4=OH (7%)
Scheme 61
Ar CH3 CHBr2, TiCI4,
Zn, TMEDA, PbCfe (cat.)
72%
Ar
Ar=2,4 ,-(OBnhC6H3
R O  Me
OR
173 R=CMe(CF3)2
i) 173 85%
ii) deprotect 96%
174
Scheme 62
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Pandey et al effectively demonstrated the use of photochemistry in their 
approach.77 Irradiation of a range of substituted acetone derivatives such as 175, in the 
presence of 1,4-dicyanonaphthalene (DCN), caused single electron transfer (SET) and 
formation of an intermediate arene radical cation 176. Intramolecular cyclisation 
yielded the benzofuran 177 {Scheme 63).
hv, DCN 
ph pH 10
MeO v  MeO ^
175 176
MeO'
177
50-60% from 175
Scheme 63
A more traditional approach to benzofurans is cyclodehydration, as adopted by 
Kavinde et al.7S Unexpectedly, reaction of o -hydroxyketone 178 with diethyl 
bromomalonate in the presence of potassium carbonate did not give the corresponding 
diester 179. Instead, benzofuranone 180 was isolated. Subsequent reduction and 
elimination gave the 2-arylbenzofuran 181 {Scheme 64). It was proposed that the 
diethyl bromomalonate brominated the activated methylene group of ketone 178.
181
80% from 178
.OH
Ph
178
Ph
O179
Scheme 64
The final examples represent the type of cyclisation which was of most interest 
to us. Hercouet and Le Corre had shown that it was possible to form benzofurans by a
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'one-pot, two-stage' process.79 Reaction of o-hydroxybenzyltriphenylphosphonium 
bromide 182 with an acid chloride in the presence of triethylamine resulted in 
formation of an intermediate ester. This ester cyclised by an intermolecular Wittig 
reaction to give benzofuran 183 (Scheme 65).
McKittrick and Stevenson used an adaptation of this procedure in their 
synthesis of the benzofuran 185, which is an oxidant in yeast.80 Esterification of the 
free hydroxyl of phosphonium salt 182 with carboxylic acid 184 was done using 
standard DCC-coupling conditions. The intramolecular Wittig reaction was done as 
before to give the natural product 185 (Scheme 66).
PPh3Br
© nnL o 0
z182 183
Scheme 65
PPh3Br
i) DCC, DMAP
ii) Et3N
OAc MeO
185
184
Scheme 66
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The Synthesis of Moracin C
3
3.1 Initial Strategy
Our retrosynthesis of moracin C 97 featured two main disconnections. The 
prenyl group was to be installed by a regioselective orf/io-lithiation, in a manner similar 
to that used by Mann and Widdowson.58 We planned to construct the arylbenzofuran 
nucleus using the intramolecular Wittig reaction used by Hercouet and Le Corre 
(Scheme 67).79 This would require synthesis of a suitably protected phosphonium salt
186, which would be coupled with commercially available 3,5-dimethoxybenzoic acid
187. Our approach avoids having to set up the difficult T,3',5' relationship in the C-ring 
of moracin C
PH
H 0‘
97 OH
OMe
PGO
OMe
© 0
OMe
PGO OH
OMe
186
Scheme 67
Hercouet and Le Corre had demonstrated that benzylic phosphonium salts 
could easily be prepared from the corresponding benzylic alcohols, simply by reaction 
with triphenylphosphine hydrobromide.79 The phenol 186 that we require should be 
accessible from 2,4-dihydroxybenzaldehyde 188 (Scheme 68).
5 2
186
OH OHO
HO OH
188OHPGO
Scheme 68
Reduction of 2,4-dihydroxybenzaldehyde 188 to the corresponding alcohol 
proved difficult. Standard reduction methods (sodium borohydride, lithium aluminium 
hydride) were unsuccessful. However, catalytic hydrogenation resulted in a near 
quantitative yield of 4-methylresorcinol 189 (Scheme 69).
f Y CH0 
188
Since the alcohol was not accessible, we decided to brominate in the benzylic 
position. Treatment of the benzylic bromide with triphenylphosphine would then give 
the salt we required (Scheme 70). This required the protection of the 4-hydroxyl of 
189. We decided to protect this hydroxyl as a terf-butyldimethylsilyl (TBS) ether 
which would be stable throughout the bromination, but would be easy to remove.
OHTBSO'
TBSO‘ OHTBSO' OH
Scheme 70
However, attempts to silylate selectively in the 4-position of 189 were 
unsuccessful, giving a complex mixture of products. We felt that since the TBS group 
would be stable to hydrogenation, selective protection of 2,4-dihydroxybenzaldehyde 
188 would be easier. The internal chelation between the carbonyl and the 2-hydroxyl 
should make the 4-hydroxyl slightly more reactive, enabling selective protection 
(Figure 11).
Figure 11
5 3
H2,
Pd/C
MeOH
95% HO OH
189
Scheme 69
By adapting the conditions described by Ronald et al,81 we were able to protect 
the 4-hydroxyl as the TBS ether: 1.2 equivalents each of imidazole and tert- 
butyldimethylsilyl chloride in DMF at room temperature gave a 72% yield of mono- 
TBS ether 190 (plus approximately 15% bis-TBS product) (Scheme 71).
1.2 6C| TBSGI,
1 .2  eq imidazole 
 ►
DMF, RT 
72% TBSO
188 190
Scheme 71
Catalytic hydrogenation of aldehyde 190 went as expected in high yield to give 
phenol 191 (Scheme 72). Hercouet and Le Corre has described a method of benzylic 
bromination using bromine in CCI4 , seemingly avoiding aromatic substitution.79 This 
method, and one by Zhang et al using NBS/AIBN82 were both tried with 191, but 
resulted in complex mixtures of products (Scheme 72).
TBSO
CHO H2Pd/C
OH
190
MeOH
95%
B^ /CCLj.
or
TBSO'
191
Scheme 72
OH NBS/ 
AIBN
TBSO
Br
OH
This lack of selectivity may be because the aromatic ring is too electron-rich. 
The presence of an electron-withdrawing group may deactivate the ring sufficiently to 
favour aliphatic bromination. Consequently, we decided to esterify phenol 191 with 
3,5-diacetoxybenzoic acid 192 under DCC conditions to give ester 193 (Scheme 73). It 
was hoped that the two acetoxy groups would further deactivate the system. 
Bromination of ester 193, under several conditions, gave a complex mixture of 
products. In view of this, a different method was sought.
5 4
192, DCC, DMAP 
 ►
CH2CI2 
84%
.OAc
TBSO'TBSO' OH
191
193
Br2/CCI4  OAc 
or
NBS/AIBNOAcH02<
192
OAc
OAc
TBSO'
OAc
Scheme 73
3.2 Second Approach
For our alternative approach, we considered the question of protecting group 
selectivity. Did we need to differentiate between the two hydroxyls of the starting 
material? As shown in Scheme 67, the first step in benzofuran formation is the 
coupling of salt 186 with 3,5-dimethoxybenzoic acid 187. What if this was done at the 
start of the synthesis? Esterification of both hydroxyl groups of aldehyde 188 would 
avoid the problem of of differentiating between them, and the extra ester could be 
hydrolysed after benzofuran formation. To investigate this, aldehyde 194 was prepared 
under standard DCC conditions (Scheme 74).
^V=H0 « 7 , o  fr v 'CH8
| I DCC, DMAP I  I I I
ch  c| *
188 5 7 % 2 194
Scheme 74
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Reduction of aldehyde 194 in the presence of two esters was not considered a 
problem. Use of a mild reducing agent should furnish the alcohol leaving the esters 
untouched. However, on treatment with sodium borohydride, *H NMR spectroscopy 
of the product showed that, not only had the carbonyl been 'over-reduced' to the methyl 
group, but one of the esters had hydrolysed {Scheme 75). At this stage it was not clear 
which ester had been cleaved, so the product was characterised as 195 or 196.
Further attempts at reduction were made, this time using sodium 
cyanoborohydride. It was found that, although no reaction took place at pH 7, 
reduction occurred at pH 3 to give the benzylic alcohol 197 in quantitative yield 
{Scheme 76).
NaBH4l THF
OR
195
194
196
Scheme 75
Ar quant. Ar
NaBH3CN, 
THF-H20 , pH3
Ar
94 197
PPh3.HBr 95/o  
MeCN ©  ©
' r PPh3  Br
199
198
200
Scheme 76
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When alcohol 197 was heated with triphenylphosphine hydrobromide {Scheme 
76), instead of isolating salt 198 as anticipated, we once again saw selective hydrolysis 
of one of the esters. As before it was not clear which ester had cleaved, although 
and 31P NMR spectroscopy confirmed the presence of a single product, salt 199 or 
200. In order to determine the structure of the product, a series of trial reactions were 
performed.
(i) The salt 199 or 200 was heated in toluene with triethylamine {Scheme 77).
Result: no benzofuran 201 was produced.
PhMe, EfcN o
199/200  y
reflux A r / ^ 0
OMe
V M
2 0 1 OMe
Scheme 77
(ii) The salt 199 or 200 was esterified with acid 187, and was then heated in 
toluene with triethylamine {Scheme 78).
Result: benzofuran 201 was isolated. Treatment with potassium hydroxide 
hydrolysed the ester group and gave benzofuran 202, which is the synthetic precursor 
of moracin C.
199/200
i. 187, DCC, DMAP,
CH2CI2
ii. PhMe, EfcN, reflux o
75% (2 steps)
OMe
201 OMe
KOH,
MeOH
92% OMe
HO'
OMe202
Scheme 78
(iii) The salt 199 or 200 was esterified with benzoic acid, and was then heated 
in toluene with triethylamine {Scheme 79).
Result', benzofuran 203 was the only benzofuran product isolated.
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. PhCCfcH, DCC, DMAP, 
CH2CI2
i. PhMe, EfcN, reflux 
 
ii. KOH, MeOH 
2 0 % (2  steps)
Scheme 79
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These tests confirm that the ester group in the 2-position of alcohol 197 is 
hydrolysing and salt 200 is being produced.
Why is there Regioselective Hydrolysis?
We believe we are witnessing an intramolecular acyl migration, an example of 
neighbouring-group participation. Scheme 80 outlines a possible mechanism. 
Protonation of the ester at C-2 of alcohol 197 results in intramolecular attack from the 
neighbouring hydroxyl. This gives cyclic intermediate 205 which, after a series of 
proton transfers, collapses to give protonated benzylic ester 207. From here, salt 200 is 
produced by either SnI or Sn2 reaction with triphenylphosphine.
207 200
Scheme 80
Migration occurs because benzylic ester 208 {Figure 12) is thermodynamically 
favoured over benzylic alcohol 197: the lone pairs on the benzylic oxygen are 
conjugated with a carbonyl group in the benzylic ester 208 but are isolated in benzylic 
alcohol 197 {Figure 12). This more than compensates for the loss of conjugation when
5 8
the cross-conjugated ester group of aryl ester 197 is converted into a phenol. Put 
another way, a phenol is a better leaving group than an alcohol, so intermediate 206 is 
converted into phenol 207 more readily than intermediate 205 is converted into alcohol 
204.
isolated
O O
A  A
Ar' 'O '  ^  jp  Ar A r ^ O
197
cross-conjugated
Figure 12
O
208
Further evidence of this mechanism arose during a routine cyanoborohydride 
reduction of aldehyde 194. The reaction was left for longer than usual, and migration 
occurred under low pH conditions to give phenol 208 in 90% yield.
We can assume that in the sodium borohydride reduction of aldehyde 194 as 
discussed above, we see a related base-induced migration resulting in phenol 196 being 
formed (Scheme 81).
194
NaBH4
Sfg1 or S|nj2
OH
196
Scheme 81
There have been other examples of migrations from phenolic to benzylic 
hydroxyls which support our proposed mechanism.83
Having proved the structure of salt 200, and having shown that the benzofuran 
201 can be constructed from it, we turned our attention to the efficiency of the 
synthesis. Neither of the ester groups in alcohol 197 are retained in benzofuran 201. 
The ester in the 2-position is lost during the migration, and that at the 4-position 
(essentially a protecting group) is removed by hydrolysis after cyclisation. We decided 
to investigate whether this migration/selective hydrolysis occurred with simple esters. 
If successful, this would not only make our synthesis more efficient, but would also 
provide a general route to 2-arylbenzofurans. 2,4-Diacetoxybenzaldehyde 209 was 
prepared in high yield by modifying the procedure of Malkin and Nierenstein (Scheme
5 9
52).84 Reduction of aldehyde 209, at pH 3 led to acyl migration and the formation of 
phenol 210. This was then converted into phosphonium salt 211 without difficulty
(iScheme 82).
HO
CHO Ac20 , K2CO3  
Et20  
 ►►
OH 91% AcO
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CHO
OAc
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NaBH3CN,
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98%AcO‘ OH AcO OH
211 210
Scheme 82
After forming benzofuran 212 (Scheme 83), we needed to change the 
protecting group at the 6-position. As discussed in Section 2.1.2, a bulky protecting 
group is required to prevent lithiation at C-7 of the benzofuran. We opted for the TBS 
group. The acetate in 212 was removed, and the free hydroxyl of 202 silylated to give 
benzofuran 213 in good overall yield (Scheme 83).
AcO
© ©
PPh3 Br j 187, DCC, DMAP
c h 2 c i2
ii. PhMe, EfcN
76% AcO
OMe
212
KOH,
MeOH
90%
OMe
OMe
TBSCI,
imidazole
DMF
93%
202 R=H
213 R=TBS
OMe
Scheme 83
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For the prenylation of 213, we originally followed Mann and Widdowson's 
method,58 involving lithiation, transmetallation using copper(II) bromide-dimethyl 
sulfide complex, then alkylation (Scheme 84). Although successful, this was low 
yielding (maximum 51%). In an attempt to improve the yield, we used the lithium 
thienylcyanocuprate reagent.85 After lithiation, transmetallation to this reagent forms an 
organocopper species which should be more reactive towards electrophiles. This 
proved successful with prenylation taking place in 69% yield {Scheme 84).
OMe
TBSO'
213 OMe
. BuLi.THF
i. CuBr.SM^
ii. prenyl bromide 
<51%
TBSO
OR 
i. BuLi.THF
l Q ~ Cu(CN)Li
iii. prenyl bromide 
69%
O
214 OMe
Scheme 84
All that remained now was to deprotect 214. Demethylation often requires very 
harsh conditions. The presence of the prenyl group increases the problem, as it is 
prone to cyclisation when ortho to free hydroxyls. Mann and Widdowson used 
lithium diphenylphosphide (prepared in situ from diphenylphosphine and 
butyllithium) to demethylate,58 and we followed this protocol. Treatment of 214 with 
an excess of this reagent followed by immediate desilylation with TBAF gave the 
target, albeit in a low yield {Scheme 85).
OH
i. BuLi, PPh2 H, THF
ii. TBAF, THF,
214
34% HO
OH
Scheme 85
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This concluded our total synthesis of moracin C.86 Although a completely 
linear synthesis, our route is by far the most efficient to date (10 steps, 12.3% overall 
yield).
6 2
Diene Synthesis
4
We required diene 96 for our assay of Diels-Alder activity. We wanted to use a 
similar retrosynthetic strategy to that used in the synthesis of moracin C 97, namely 
intramolecular Wittig reaction, form the benzofuran and orf/zo-lithiation to install the 
diene side-chain (Scheme 86). The major question was how to make the E-diene?
OH
HO'
OH
PGO
OP
OP
II
As with Moracin C
Scheme 86
4.1 Preliminary Studies
There were two important aspects of this synthesis that had to be considered: 
(i) How do we ortho-lithiate to give an E-diene? (ii) How can we deprotect to give the 
free hydroxyl, without causing cyclisation?
For our initial experiments, we used a series of protected resorcinols 215 as a 
model system. We planned to ortho-lithiate then quench with 3-methylbutenal 216. 
Dehydration of intermediate alcohol 217 using conditions outlined by Runk et a/87 
would give a diene (hopefully with the requisite E-geometry), which could then be 
deprotected (Scheme 87). The most important aspect of this route was the choice of 
protecting group. How resilient would the diene be to the deprotection conditions?
63
OR
215 217 |----- 218 R=protecting group
1—^ 2 1 9  R=H
Scheme 87
We planned to use three different protecting groups, all with orf/zo-lithiating 
ability. The most simple was the methyl group, and we also studied the THP group (as 
well as being ortho-directing, it is relatively simple to removal),48 and the 
(trimethylsilyl)ethoxymethyl (SEM) group since it can be removed in acid-free 
conditions.88
We first tried commercially available 1,3-dimethoxybenzene 220. This was 
easily lithiated at low temperature {Scheme 88). Quenching with aldehyde 216 gave us 
intermediate alcohol 221. We found that it was easier to proceed with the dehydration 
rather than purify and characterise at this stage. Dehydration using phosphorus 
oxychloride and pyridine went smoothly giving diene 222 in high yield. *H NMR 
spectroscopy showed that only the E-isomer had been produced (^Ha-Hb 16.5 Hz). 
Problems arose however, when deprotection was attempted. Lithium 
diphenylphosphide, used in the synthesis of moracin C, was unsuccessful, as were 
more traditional methods of demethylating using boron tribromide or trimethylsilyl 
iodide.89
OR OHOR
i. BuLi.THF
ii. 216, reflux
OR OR
217220 R=Me
223 R=
POCI3, 
pyridine 
 >
90%
( 2  steps)
OR Ha
222 R=Me 90% (2 steps) 
224 R=SEM 60% (2 steps)
t
OH
OH
219
Scheme 88
Use of the THP group in diene formation was unsuccessful. It was assumed 
that lithiation proceeded cleanly, but there was not enough spectroscopic evidence to 
prove the formation of any diene product. The bis-SEM ether 223 was more 
successful, with isolation of diene 224 at the end of the sequence (Scheme 88). Once 
again however, deprotection was difficult. Treatment with TB AF at room temperature, 
or with TBAF and A,A-dimethyl propyleneurea (DMPU) at reflux both proved 
unsuccessful.
4.2 Synthesis of a Protected Diene
As well as requiring diene 96 for our Diels-Alderase assay, we also wanted to 
synthesise chalcomoracin to prove that it can be made by a Diels-Alder reaction. Due 
to the problems encountered when trying to deprotect our model dienes, we decided to 
postpone deprotection until after the Diels-Alder reaction. The model studies had 
shown that the methyl protecting group would be too difficult to remove. We hoped 
that the methoxymethyl (MOM) group would have the same ortho-directing ability, 
but would be much more labile. Methyl 3,5-dihydroxybenzoate 225 was protected to 
give ester 226. Hydrolysis then gave free acid 227 in moderate overall yield (Scheme 
89).
OH MOMCI, R 0 2 CX^  ^,OMOM 
EtNPr2
CH2 CI2
OH 62% OMOM
225 R=Me
 226 R=Me
KOH,
EtOH
70% |_ ^ 2 2 7  R=H
Scheme 89
Carboxylic acid 227 and phosphonium salt 211 were coupled under the same 
conditions used in the synthesis of moracin C, to give benzofuran 228 (Scheme 90). 
The acetate was removed and replaced with the bulky TBS group.
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Initial attempts to lithiate 230 were unsuccessful. Only starting material was 
recovered, even after forcing conditions (4 hours at reflux). In order to make sure that 
lithiation was taking place, we performed a labelling experiment, lithiating as normal, 
then quenching with D2 O (Scheme 91) to give benzofuran 231. *11 and 13C NMR 
spectroscopy showed that incorporation of the deuterium label to give benzofuran 231 
was complete, confirming that lithiation had occurred.
OMOM
TBSO'
230 OMOM
i. BuLi, THF
ii. D20  
82%
OMOM
TBSO'
OMOM231
Scheme 91
Although easily formed, the organolithium intermediate is clearly not reactive 
towards the electrophilic aldehyde. It is possible that the two MOM groups are 
completely blocking access to the nucleophilic carbon atom (Figure 13), or that 
aggregates between molecules of lithiated species are formed.
66
too sterically 
hindered
Figure 13
The problem we faced was how to 'expose' the organolithium to the aldehyde. 
We required a reagent which would compete for co-ordination to the lithium, making it 
more easily accessible. Lithiation was carried out as before, but this time two 
equivalents of DMPU were added prior to the aldehyde (Scheme 92). The resulting 
alcohol was immediately dehydrated to give the diene 232 in moderate yield over two 
steps. 1H NMR spectroscopy of diene 232 confirmed the double bond geometry as 
exclusively E (J 16.5 Hz).
It is thought that the addition of DMPU would have two main effects.
• Co-ordination of DMPU to the lithium 'pushes' the MOM groups away, and so 
exposes the carbanion (Figure 14).
OMOM
OMOM
i. BuLi, THF
ii. 2 eq DMPU
iii. Me2C=CHCHO
iv. POCfe, pyridine 
60%
OMOM
232
Scheme 92
OMOM
O—  more exposed
Figure 14
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Co-ordination to lithium makes the carbon-lithium bond longer and hence 
reactive (Figure 15).
MeN— \0=OMeN— '
longer bond, 
so  more reactive
Figure 15
4.3 Synthesis of Phenolic Dienes
Synthetic routes to phenolic dienes are rare. These routes have many 
disadvantages, including low yield and selectivity. Typical examples include:
• Base-induced elimination of HC1 or HBr from allylic halides.90 Although E- 
selective, these are usually low yielding (<10%).
• Grignard opening of coumarins.91 Once again, these are low yielding (20-25%), 
but do give exclusively Z-products.
• Irradiative opening of chromenes.92 Reactions of this type are often poorly 
selective.
• Acid-induced dehydration of complex naturally-occurring alcohols 93
A more general, connective method of synthesising compounds such as these is 
by an alkenation reaction. Reactions of this sort have been used to make dienes of 
protected phenols, and in one case, a free phenol. Alkenation reactions fall into three 
classes:
• Phosphorus-based (Wittig, Homer-Wittig, Homer-Wadsworth-Emmons);
• Silicon-based (Peterson); and
• Sulfur-based reactions (Julia).
4.3.1 Phosphorus-based Reactions
The olefination reaction most commonly used to make dienes is the Wittig 
reaction. The main disadvantage with this reaction is the lack of geometrical control.
In a continuing study on mulberry phytoalexins,94 Takasugi and co-workers 
attempted a Wittig reaction between 2,6-dimethoxybenzaldehyde 233 and the ylide 
234, derived from methallyltriphenylphosphonium chloride {Scheme 93). Diene 222 
was produced but with very low selectivity (E/Z, 3:2).
OMe
CHO
OMe OMe
233 234 222
E/Z, 3:2
Scheme 93
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In a later study,95 Tamura et al investigated the geometrical effect of changing 
the group on phosphorus. Treatment of phosphonium nitrite 235 with butyllithium 
followed by benzaldehyde gave diene 236 in moderate yield (63%) but with poor 
selectivity (Scheme 94). However, when the reaction was repeated using the 
tributylphosphonium salt 237, not only was the yield higher (82%), but the selectivity 
was dramatically increased (E >95%).
An example which was of particular interest to us was the synthesis of a
the synthesis of dienes 243-245 by Wittig reaction between phosphonium salts 239- 
241 and the sodium salt of salicylaldehyde 242 {Scheme 95). All dienes were isolated 
in good yield, with !H NMR spectroscopy showing that only E-isomers were formed.
A common variant of the Wittig reaction is the Homer-Wadsworth-Emmons 
reaction.97 This uses anions derived from dialkylphosphonates 246.
The main advantages are that the anions are generally more nucleophilic than 
standard Wittig-type ylides, and by changing the phosphonate ester size, greater 
selectivity can be achieved. The Homer-Wads worth-Emmons reaction is of particular
Ph
i. BuLi
ii. PhCHO
235 R=Ph 
237 R=T3u
236 R=Ph, 63%, E/Z, 45:55 
238 R=nBu,82%, E/Z, >95%
Scheme 94
phenolic diene, produced without protection of the hydroxyl96 Minami et al reported
© ©
239 n= 1
240 n=2
241 n=3
242 243 n=1, 64%
244 n=2, 54%
245 n=3, 72%
Scheme 95
O
R'
246
R=Et, iPr
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use in the synthesis of a,p- or a,P,y,5-unsaturated carbonyl compounds (often esters). 
This was demonstrated in the synthesis of the C9 -C2 3  fragment of streptogramin 
antibiotics, by Helquist et al {Scheme 96).98 Good selectivity was achieved in the 
reaction of phosphonate 247 with N-protected glycinal 248.
i. BuLi
O ii. BocNHCH2CHO 248
II  ^
( E t O k P v ^ ^ /C O g E t  BocHN
247
Scheme 96
C 0 2Et
249
68% 
E/Z, 10:1
The final example of phosphorus-based olefination is the Homer-Wittig 
reaction." This involves deprotonation of a phosphine oxide 250, followed by reaction 
with a carbonyl compound to give alkene 252 {Scheme 97). If a lithium base is used, 
the reaction can be 'stopped' at the a-hydroxyphosphine oxide intermediate 253 and it 
is this property that was exploited by Warren and Davidson in a stereocontrolled 
synthesis of dienes.100
250
Base 
R
Ph2P  M 
251
M=Li
R'CHO
.OH
r - ^ R'
252
Ph2l
253
Scheme 97
Warren and Davidson prepared ally lie phosphine oxide 257 by acid-induced 
dehydration of a tertiary alcohol 254, and by rearrangement/dehydration of a
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secondary alcohol 255 via cation 256 (Scheme 98). The overall yields of 257 were 
comparable in each case.
(a) Ph2
O
(b)
H
\ ^ P P h 2
IBuLiMeCHO
ptsa
80%
256
255
257
BuLi 
cyclohexanone^f
TFA
86%
Ph2l
HO
254
Scheme 98
Further treatment of 257 with butyllithium and either acetaldehyde or 
benzaldehyde, gave diastereomeric alcohols 258a and 258b (Scheme 99). These were 
easily separated and, upon reaction with sodium hydride were converted 
stereospecifically into dienes Z-259 and E-259.
257
BuLi
RCHO
Ph-
H 0‘
258a
R=Me, 50% 
R=Ph, 12%
258b
R=Me, 29% 
R=Ph, 35%
Scheme 99
NaH
£-259
R=Me, 80% 
R=Ph, 80%
NaH
Z-259
R=Me, 80% 
R=Ph, 70%
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4.3.2 Silicon-based Reactions
The use of silicon in olefination reactions is best demonstrated in the Peterson 
reac tio n .101 This involves either acid or base-catalysed elimination of (3- 
hydroxysilanes. The geometrical outcome of the elimination depends on both the 
configuration of the silane, and the reaction conditions used. The most common 
method of preparing P-hydroxysilanes is by addition of an a-silyl anion (e.g. 
Grignard 260) to a carbonyl compound {Scheme 100), producing two diastereomers, 
anti 261 and syn 262. At this stage, both geometrical isomers are accessible from either 
diastereomer. Treatment of the syn isomer with base gives the Z-alkene, while the anti 
gives rise to the £-alkene. Conversely, acid-catalysed elimination results in syn 
producing E- and anti producing Z-alkenes.
R2 R1
r-  y  /
SiMe 3 RCHO^ anf/261 acid
R1^ M g X  0H  ^  R
260
syn 262 R R
Scheme 100
OH
[2 ^ Y R1
b a s e ^
SiMe3 
anti 261 acid ^ V
9 b a s e ^
SiMe3 acidA<
A similar method can be employed in the synthesis of dienes. In a recent 
report,102 Fleming et al investigated the stereochemical control that can be achieved in 
the vinylogous Peterson reaction {Scheme 101).
? H ? 'Ra Base ^  R 2
Scheme 101
The substrates for this reaction were prepared by addition of the anions of 
propargylsilanes to aldehydes, followed by hydrogenation of the triple bonds to the Z- 
double bonds. Base-catalysed elimination of the syrc-hydroxysilane 263 gave an 
exclusively E-E diene 264. Similarly, the anti-isomer 265 gave the Z-E diene 266 
{Scheme 102).
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OH SiPhMe2
SiPhMe2
KH
80% 
Scheme 102
4.3.3 Sulfur-based Reactions
The most famous example of a sulfur-based olefination is the Julia coupling 
(Scheme 103).103 This involves addition of metallated sulfone 267 to a carbonyl 
compound. The P-hydroxysulfone 268 is then functionalised (usually as an ester, 
mesylate or tosylate), and reductive elimination with sodium amalgam gives the alkene 
270.
?°2Ph Dl _ 3
SO?Ph . 0 S 0 2Ph T R1 R
C  r,^ oh — Ri V R- ^  HR,' T R : R 2  7\  ■"* . r 2  r 4
M r 3 r 4 R3  R4  R R
267 268 269 270
R=Ac, COPh, Ms, Ts
Scheme 103
The Julia reaction has been widely used in the synthesis of complex natural 
products, and has proved to be a very selective method of forming £,£-dienes.104 The 
main disadvantages are that it is a two-step process, and harsh conditions are required 
for reductive elimination.
In 1991, S. A. Julia (brother of M. Julia who discovered the original reaction) 
and co-workers reported the direct olefination from carbonyl compounds and lithiated 
sulfones.105 This 'one-pot Julia reaction' uses a lithiated alkyl (or alkenyl-benzyl-, etc.) 
sulfonyl benzothiazole 271 (Scheme 104). Reaction with a carbonyl compound gives a 
p-alkoxy sulfone 272 which immediately forms a spirocyclic intermediate 273. The 
benzothiazole moiety is then transferred from sulfur to oxygen giving 274. Finally, 
elimination of sulfur dioxide and lithiated benzothiazolone 275 yields the alkene 276.
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s o 2
L
V H
K *
276 N
LiO—v
S
275
O ^ f oS R2
R , / ^ 0  H 
S ^ N
274
Scheme 104
The main question concerned the geometry of the products. In an extensive 
study of the reaction,106 Julia and co-workers noted that use of aromatic, alkenyl or 
alkynyl carbonyl compounds gave predominately E-alkenes, while alkyl carbonyls 
gave predominately Z-alkenes (but with less selectivity). In an attempt to rationalise 
these results, Julia proposed the following process (Scheme 105). Upon reaction of a 
lithiated sulfone with an aldehyde, two diastereomeric intermediates 277 and 278 are 
formed. Both have a chair-like conformation, where the lithium is chelated to the 
neighbouring nitrogen of the benzothiazole and one of the oxygens of the sulfone. 
These alkoxides add to the C=N of the benzothiazole to give spirocyclic intermediates 
279 and 280. After transfer of the benzothiazole from S to O, giving 281 and 282, 
rotation positions the benzothiazole antiperiplanar to the sulfonyl group, enabling anti 
elimination of 283 and 284 to give the appropriate alkenes.
«AAAAAAA/» 
/ \ J W W V A A /'
277 syn
*wwwv*
Vv
9 s ° 2
rh^ r2
279
Li
*
O' •BT
RM 'Y S02Li
l-P v^ R 2
H
281
*
1 r2R1v k rs °2Li
B T -O  t  H 
H
283
R1 * R2w
285
H
282
I
- H
Rlv h ' S° 2Li
B H )  t  R2  
H
284
R1 T
286 R‘
Scheme 105
The anti isomer 278 (which becomes the Zs-alkene), would be expected to be 
disfavoured due to the proximity of the R1 and R2 groups, leading to an overall 
preference for Z-alkene 285 by this route. The Z-isomer does indeed predominate 
when R1 is alkyl, but an alternative pathway has to be used to explain the preferential 
formation of the £-alkene when R2 is aromatic, alkenyl or alkynyl {Scheme 106). 
Fragmentation of spirocycle 280 to give zwitterion 287 would be encouraged by 
stabilisation of the carbocation by conjugation with aromatic or other electron-rich R2- 
groups. Rotation to relieve steric congestion would give zwitterion 288, then 
elimination of sulfur dioxide would give the E-alkene 286. More importantly, it is also
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possible to form zwitterion 288 from the syrc-alkoxide 277, either by fragmentation of 
spirocycle 279, or by loss of lithiated benzothaizolone from sulfmate 281.
The modified Julia reaction provides some of the best selectivity in the 
synthesis of conjugated E-olefins. In most cases, the required sulfone is easily 
prepared, and the coupling step is quick (2-4 hours) and gives products that can easily 
purified.
Julia prepared several dienes from the range of sulfones below. In each case, 
the diene was isolated in good-excellent yield (40-93%) and high selectivity (E/Z, 
66:34-95:5).
JVNAA/WV*
Fragment1
Fragment1
H
281 288
*
E-alkene286 
Scheme 106
289 290
4.4 Synthesis of Diene 96
We required the fully deprotected diene 96 for our assay. We were not able to 
deprotect diene 232 (see page 66) without destroying the diene side-chain, so we 
considered the alternative retrosynthesis outlined below (Scheme 107).
OPGPH
olefination
CHO
HO PGO
294 OPGOH
OMeOMe
formylation
CHO
PGO PGO
OMeOMe296 295
Scheme 107
Compounds like benzofuran 296 are intermediates in our synthesis of moracin 
C, so their synthesis has already been well developed. Regiospecific introduction of a 
formyl group might be achieved by ortho-lithiation, or alternatively under Vilsmeier- 
Haack conditions. The aldehyde should be stable to demethylation conditions, so the 
two methyl groups could be removed and replaced with a more labile protecting group 
(e.g. silyl ether) that could be removed after olefination without affecting the acid- 
sensitive diene functionality. Wittig reaction followed by deprotection would give 96.
4.3.1 Vilsmeier-Haack Route
We first attempted aldehyde formation by Vilsmeier-Haack formylation of 
benzofuran 212. Using the method of Godfrey and Sargent,107 we treated 212 with 
phosphorus oxychloride in hot DMF (Scheme 108). After 1 hour, it was found that the 
aldehyde isolated was not the desired 4'-formylated product, but a regioisomer 297 
where the aldehyde had been introduced in the 2'-position.
OMe OH PM e
POCI3  
 ^
DMF, 100 °C AcO‘ 
56%
AcO‘
212 297OMe OMe
Scheme 108
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4.4.2 Orf/fo-Lithiation Route
The introduction of a formyl group by reaction of an organolithium with DMF 
(or equivalent formamide) has been well documented in the literature.108 Using the 
lithiation procedure already established, we attempted the synthesis of aldehyde 298 
from benzofuran 213 (Scheme 109). All efforts were unsuccessful, with mainly 
starting material recovered (plus a small amount of desilylated compound). A range of 
conditions were tried, as outlined in Table 6. As well as using DMF as an aldehyde 
equivalent, we also used boronate ester 299 unsuccessfully.109 The use of similar 
boronate esters had been reported by Rathke et al.n0
OMe OMe
i. BuLi
ii. DMF
CHO
TBSO'TBSO'
OMe OMe298213
Scheme 109
Aldehyde Equivalent Temperature
DMF -78 °C
DMF -35 °C
DMF 0°C
(  /B -C H B r2 
0/ 299
-35 °C
Table 6
Our next approach proved more successful. Since it was problematic to get the 
organolithium to react with DMF, we decided to prepare an ester from which the 
aldehyde would be easily accessible. We changed the silyl protecting group from the 
te/t-butyldimethylsilyl (TBS) to the tert-butyldiphenylsilyl (TBDPS) group (Scheme 
110), as we hoped that the increased bulk would provide more stability and so avoid 
desilylation.
MepM e TBDPSC)
imidazole, 
\  DMF, 60 °C
TBDPSO'48%HO
300202 OMeOMe
Scheme 110
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Lithiation of 300 proceeded cleanly and, after reaction with methyl 
chloroformate, gave ester 301 in good yield {Scheme 111). Our original plan was to 
reduce this directly to the aldehyde with DIBAL-H, but this resulted in a complex 
mixture of compounds, including 'over-reduced' alcohol. More success was found by 
treating with an excess of lithium aluminium hydride, followed by oxidation using 
either Dess-Martin periodinane,111 or pyridinium dichromate. Both methods gave 
aldehyde 302 in moderate yield over two steps.
pM e
i. BuLi.THF
ii. CICOpMe
^  / /
TBDPSO 75% TBDPSO
300 OMe 301 R=C02Me OMe
Method A
i. LiAIH*, Et20
ii. periodinane, 
CH2 CI2  
42%
Method B
i. UAIH4 , Et20
ii. PDC, CH2CI2  
41%
302 R=CHO
Scheme 111
At this stage, we expected demethylation to be straightforward, but when 
aldehyde 302 was treated with an excess of boron tribromide it was converted to the 
monomethylated aldehyde 303, albeit in high yield {Scheme 112). It was found that a 
greater excess of boron tribromide, or a longer reaction time only resulted in 
decomposition of 303.
OMe OMe
CHOCHO
303 0H
Scheme 112
Since the demethylation of 302 with boron tribromide was not successful, we 
tried a different method. Wagner et al reported the complete demethylation of 2,6- 
dimethoxybenzaldehyde using aluminium tribromide in a mixture of carbon disulfide 
and dibromomethane.112 We tried this procedure with aldehyde 302, and isolated two 
products {Scheme 113). Both products were aldehydes and *11 NMR spectroscopy 
showed no trace of methoxyl groups, but both seemed to be lacking a complete 
TBDPS group. Structural analysis eventually showed them to be aldehydes 304
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(where one phenyl group had been replaced with a hydroxyl), and 305 (where both had 
been replaced).
OMe
CHO
TDBPSO
302 OMe
O
.S i\
R j R' 
feu
AIBr3  
C S 2 -C H 2 B r2  (1 11)
OH
CHO
OH
304 R=Ph, R'=OH (38%)
305 R=R'=OH (57%)
Scheme 113
A possible explanation for the formation of silanols 304 and 305 is outlined in 
Scheme 114. The presence of residual water in the system, either from the Lewis acid 
or from the solvents, could produce HBr in solution. Protonation of a phenyl ring 
would generate cation 306, which would be stabilised due to its position (3- to the 
silicon. Attack in a Sn2 fashion by bromide followed by water during the work-up, 
would eliminate benzene giving the silanol 304. Repetition of this procedure would 
result in the loss of the second phenyl group, giving 305.
302
rBu
PhH
H20
' Ph 304
feu Br Ph
Scheme 114
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As well as the unforeseen reaction with aluminium tribromide, demethylation 
occurred cleanly. We felt however, that the presence of free hydroxyls, (both ortho- to 
the aldehyde and on the silicon), would prevent olefination, so we removed the 
hydroxysilyl groups from 304 and 305, and reprotected the hydroxyls to give the tris- 
TBS ether 307 (Scheme 115).
304 + 305
CHO
i. TBAF, THF
ii. TBSCI, imidazole, DMF
53%
OTBS
TBSO'
307 OTBS
Scheme 115
At this stage, we were dealing with very low quantities of substrate, and since 
the chromatographic stability of these compounds was in question, they were carried 
through subsequent steps without full characterisation (although JH NMR 
spectroscopy confirmed the structures as those shown).
We had originally planned to construct the diene by a Wittig reaction. As 
mentioned earlier, it had been shown by Tamura et al95 that tributylphosphonium salts 
provided better geometrical selectivity in reactions of allylic ylides, so we prepared 
phosphonium salt 309 for our olefination reaction (Scheme 116). Although easy to 
prepare, the salt 309 was hygroscopic and difficult to handle, and the Wittig reaction 
was unsuccessful.
308
Given the excellent results shown by Julia and co-workers in the synthesis of 
£-dienes from allylic sulfones,106 we opted for the modified Julia reaction to construct 
our diene. The required sulfone 290 was easily prepared by reaction of 2- 
mercaptobenzothiazole 310 and methallyl chloride 308, followed by oxidation of 
sulfide 311 (Scheme 117).
PBu3, PhMe ©  ©
--------------------►  /P B u 3 Cl
50%
309
Scheme 116
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acetone
96%
310 311
H2 O2 .
(N H 4)6Mo7 0 2 4 .4 H 20
EtOH-H20
290
Scheme 117
Julia reaction between aldehyde 307 and sulfone 290 was carried out using the 
method outlined by Julia and co-workers,106 and gave diene 312 in good yield 
(Scheme 118). As with the starting aldehyde 307, diene 312 was not completely 
characterised, but !H NMR spectroscopy confirmed exclusive formation of the E- 
diene ( 7 h i "-H2" 16.4 Hz). Immediate desilylation with TBAF gave diene 96 in low yield 
after repeated attempts at chromatography.
OTBS
CHO
TBSO'
OTBS307
LDA, 290, THF 
71%
OTBS
TBSO'
OTBS312
TBAF, THF 
<1%
OH
2" 31
HO
OH
Scheme 118
Purification (specifically the removal of excess TBAF) was difficult due to the 
instability of the diene 96 on both silica and deactivated, neutral alumina gels. However, 
!H NMR spectroscopy showed that only the £-isomer was present (Figure 16).
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Section of 400 MHz tH NMR of diene 96
OH
2" 3’
HO
OH96
s
Figure 16
The *H NMR spectrum shows that only one benzofuran product is present. A 
singlet for H-3 is present at 57.39, while H-4, H-5 and H-7 are identified by signals at 
57.16 {ortho-coupled doublet, J  8.4 Hz), 56.80 {ortho-and meta-coupled double­
doublet, J  8.4 and 2.0 Hz), and 56.72 {meta-coupled doublet, J  2.0 Hz), respectively. 
The E- geometry is confirmed by the presence of two doublets at 57.52 and 6.96 with 
coupling constants of 16.4 Hz. The 2H singlet at 57.47 shows that the aryl ring is 
completely symmetrical, i.e. no cyclisation has taken place. This is also confirmed by 
the presence of both a terminal methylene group, which can be seen as two broad 
singlets at 54.82 and 4.76, and the hydroxyl signals at 511.18 and 11.03 in the ratio of 
2:1 {Figure 17).
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Section of 400 MHz *H NMR of diene 96
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r
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Figure 17
Although successful in our synthesis of diene 96, we felt that the route could be 
improved. One of the main flaws was the reaction of the TBDPS group with 
aluminium tribromide, leading to a rather uneconomical deprotect-reprotect sequence 
(Scheme 115).
The synthesis of moracin C by Nakamura and co-workers had shown the 
ortho-directing ability of the THP group.48 We felt that the use of this protecting 
group instead of methyl might be advantageous, since it should be much easier to 
remove under mild conditions.
M e02 C l ^ T ) H  DHP, R 0 2O ^ ^ . O T H P  KQH
H+ T  T BOH
--------------►  313 R=MeV 84%
OH
225
314 R=H
81%
OTHP
Scheme 119
We prepared the fully THP-protected acid 314 by protection of methyl 3,5- 
dihydroxybenzoate 225, followed by hydrolysis of ester 313 (Scheme 119). Acid 314 
was coupled with phosphonium salt 211 under standard cyclisation conditions, giving 
benzofuran 315 (Scheme 120). Once again, the acetate was removed and replaced with 
the bulky TBDPS group.
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I i. 314, DCC, DMAP
CH2 CI2 
ii. PhMe, EfcN
AcO ^  OH 
211
67%
AcO
TBDPSCI,
imidazole
DMF
317 R=TBDPS ^ -
77%
KOH, 
MeOH 
90°/
316 R=H
Scheme 120
OTHP
OTHP
OTHP
OTHP
Lithiation of benzofuran 317 to give ester 318 proceeded cleanly, although 
more forcing conditions were required (Scheme 121). Reduction and oxidation of ester 
318 proved difficult, with no aldehyde recovered after a number of attempts.
OTHP
TBDPSO'
317 OTHP
BuLi, THF 
C02Me, A
OTHP
TBDPSO'
318 OTHP
Scheme 121
In the hope that the TBS group would be more stable to the reduction/oxidation 
conditions, the THP groups were replaced at this stage (Scheme 122). The procedure 
outlined by Nakamura and co-workers using methanol and aqueous oxalic acid48 gave 
ester 319 in good yield. Ester 319 was then reprotected as the bis-TBS ether 320.
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OTHP
(C 0 2 H)2  
MeOH-H20
C 0 2 Mg -----------------►
75%
OH
319 'OH
TBSCI,
imidazole,
DMF
86%
OTBS
^  ^ — C 0 2Me 
320 OTBS
Scheme 122
Reduction and oxidation of ester 320 was more successful although, despite 
using manganese dioxide as a milder oxidant, one of the TBS groups was lost during 
the reaction (Scheme 123). This was attributed to the strong internal chelation between 
the carbonyl and the hydroxyl of aldehyde 321. This aldehyde was resilylated but a 
more reactive silylating agent was required. We were now dealing with such low 
quantities that the structure of aldehyde 322 was confirmed by !H NMR spectroscopy 
and mass spectrometry alone.
OTBS
i. LiAIH4, Et20
ii. Mn02l CH2 CI2  
C 0 2Me -----------------►
50%
320 OTBS
Scheme 123
0 —H
TBSOTf,NEt3,
CH2 CI2
70%
TBS
CHO
322 OTBS
We attempted the Julia reaction between aldehyde 322 and sulfone 290, with 
immediate desilylation of the product. However, we encountered difficulties with 
removal of excess TBAF and te/t-butyldiphenylsilanol and the material was destroyed 
during several attempts at preparative thin layer chromatography. We believe the first 
route to be superior.
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In summary, we synthesised and characterised by 2H NMR spectroscopy, a 
small quantity of the desired diene 96. However, a more satisfactory method of 
purifying the final product is required.
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4.5 Studies Towards the Synthesis of Moracin D
The natural occurence of diene 96 in M. alba has never been confirmed (See 
Section 1.9.2). We had already developed a synthesis of one of its proposed 
biosynthetic precursors, moracin C 97, so we decided to devote some attention to the 
other possible precursor, moracin D 105.
Scheme 124 shows our retrosynthetic strategy. Benzofuran 323 would be 
formed in a manner similar to that used in the synthesis of moracin C and diene 96. 
We aimed to make the chromene ring by the reaction of benzofuran 323 with 2- 
methylbutenal 216. Lopes and co-workers had shown that the condensation of phenols 
with unsaturated aldehydes, including 216, in the presence of phenylboronic acid gave 
chromenes in good-excellent yield.113
OH
PGO
OH323>
HO
105 OH
216
Scheme 124
We first tried the phenylboronic acid cyclisation on a model system (Scheme 
125). Reaction of resorcinol 109 with 2-methylbutenal 216 did not give phenol 324, 
but instead produced chromene 325 (the result of double cyclisation), in low yield. 
Although the regiochemistry of the cyclisation was wrong in this example, we decided 
to attempt the reaction on an arylbenzofuran 323.
OH
' '  216,
PhB(OH)2
PhMe/AcOH
324
None isolated
OH
109
325
12%
Scheme 125
89
A suitable arylbenzofuran for the phenylboronic acid cyclisation would need 
the hydroxyl in the 6-position protected. Treatment of benzofuran 212, an intermediate 
in the synthesis of moracin C 97, with boron tribromide resulted in efficient 
demethylation, but the acetate protecting group was also hydrolysed. The product 
another member of the moracin family of natural products, moracin M 326.
OHOMe
AcO‘
326 OH212 OMe
Scheme 126
We needed a more robust protecting group. Our synthesis of diene 97 had 
shown that the TBDPS group was stable to certain demethylation conditions. 
Benzofuran 300, an intermediate in the synthesis of diene 232, was treated with boron 
tribromide (Scheme 127). Demethylation occurred cleanly, but more importantly the 
TBDPS group remained intact. Unfortunately, reaction of benzofuran 327 with 2- 
methylbutenal 216 resulted in a mixture of products which were inseparable by 
chromatography.
OHOMe
70% JBDPSOTBDPSO
327 OHOMe300
216,
PhB(OH)2
PhMe/AcOH
Inseparable mixture
Scheme 127
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Approaches to the Synthesis of Morachalcone A
5.1 Aldol Approach
To complete our enzyme assay, we required the dienophile morachalcone A 95. 
The easiest disconnection is in the a,|3-unsaturated section of the molecule {Scheme 
128). Ketone 328 and aldehyde 329 are readily prepared from commercial starting 
materials, and can be coupled together in an aldol condensation to form the chalcone.
OH
HO'
OH
OPG O
CHO
PGO PGO OPG
329328
OHO
HO OHHO
330 188
Scheme 128
Jain et al outlined a procedure for the preparation of ketone 331 involving 
reaction of 2,4-dihydroxyacetophenone 330 with prenyl bromide and potassium 
hydroxide {Scheme 129).114 Although low yielding, this route had the advantage that it 
could be done on a large scale and, by slight adaptation of the work-up outlined by 
Jain, pure ketone 331 could be isolated without the need for chromatography.
Br
KOH,
MeOH
13% HO 331
Scheme 129
HO
330
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The main consideration when planning the aldol condensation was the choice 
of protecting group. We first looked at the most simple, the methyl group. Following 
the method of Wattanasin and Murphy,115 we prepared chalcone 334 in good yield by 
simple condensation of 2,4-dim ethoxybenzaldehyde 332 with 2,4- 
dimethoxyacetophenone 333 (Scheme 130). Demethylation with boron tribromide gave 
chalcone 335.
OMe
.CHO
ORMeO NaOH,
332
R 0‘MeOH
62%Me O
OR
334 R=Me
MeO' 335 R=H
333
Scheme 130
These aldol conditions were then repeated using the prenylated ketone 331, 
protected as the bis-methyl ether 336. Once again, condensation with aldehyde 332 
proceeded in good yield with NMR spectroscopy of the chalcone 337 showing 
exclusively ^-double bond geometry (J 15.9 Hz) (Scheme 131). Unfortunately, 
treatment with boron tribromide gave only a complicated mixture of products, with no 
trace of the desired product.
OH O
M6 2 SO4
K2 C 0 3
acetone
Me O
332,
NaOH OMe
MeOH
62%
MeO'
337 “OMe
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One of the main problems encountered when dealing with chalcones such as 
338, having a free hydroxyl in the 2-position, is the potential for cyclisation in acid 
conditions, forming the isoflavanone 339 {Scheme 132). It is possible however, to open 
isoflavanones and reform the chalcone in basic conditions.116
338
R'
339
R'
Scheme 132
Our next attempt at the synthesis of morachalcone A 95 used the MOM 
protecting group. We expected that this would be easy to remove under mildly acidic 
conditions, and if cyclisation were to occur, we would be able to generate morachalcone 
A by treatment with base. Scheme 133 shows the synthesis of chalcone 342. Again, 
protection of aldehyde 188 and ketone 331 followed by condensation, using the 
procedure of Wattanasin and Murphy115 gave the Zs-chalcone.
Once again we encountered difficulties when trying to deprotect (Scheme 133). 
Treatment with dilute HC1 gave only recovered starting material, while more forcing 
conditions (conc. HC1, reflux) only resulted in degradation of the substrate.
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Other Protecting Groups Tried:
We also used the THP group in the hope that it would be even easier to remove 
than the MOM group (Scheme 134). We were only able to protect the hydroxyl at C-4 
of ketone 331, presumably due to steric crowding of the hydroxyl at C-2. 
Deprotonation of the free phenolic hydroxyl in ketone 343 will inhibit enolisation of 
the ketone and so prevent aldol condensation. The ^  NMR spectrum of the crude 
mixture from the aldol condensation showed no sign of chalcone formation.
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In a move away from carbon-based protecting groups, we tried the TBS group. 
In the presence of a strong base, reaction of aldehyde 345 and ketone 346 would give 
intermediate 347. The lability of the silyl group may result in silicon migration onto the 
adjacent oxygen giving phenol 348. Loss of silanol followed by desilylation would 
give morachalcone A 95 (Scheme 135).
OTBSO
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346
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345
CHO
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^  TBSO'
346
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95
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Scheme 135
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We tested the silyl protecting group using non-prenylated ketone 330, since 
prenylation was very low yielding. After silylation of aldehyde 188 and ketone 330 , 
we attempted the coupling step using potassium hexamethyldisilazide as base (Scheme 
136). Thin layer chromatography and NMR spectroscopy of the crude reaction 
showed a complex mixture, including starting aldehyde and ketone and some 
desilylated starting material. This route was not pursued further.
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Monache et al report the synthesis of phenolic chalcones where the benzyl 
group was used to protect free hydroxyls.117 Here debenzylation was carried out using 
boron trichloride. We felt that, while the use of boron trichloride would be 
unsuccessful given our results with boron tribromide, it might be possible to 
debenzylate using other methods. To this end, we prepared chalcone 353, by protection 
of aldehyde 188 and ketone 331, then condensation of 351 and 352 (Scheme 137).
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OBn
Jung et al reported that transfer hydrogenation using 1,4-cyclohexadiene with a 
palladium on charcoal catalyst allowed debenzylation of secondary alcohols in the 
presence of a trisubstituted double bond. 118 When we tried this method with chalcone 
353 (Scheme 138) we found that, although NMR spectroscopy showed some 
debenzylation, thin layer chromatography showed the presence of several products as 
well as starting material.
OBn O
OBn
BnO'
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5.2 Wittig Approach
An alternative approach to morachalcone A 95 would be to form the chalcone 
by a Wittig reaction between ylide 354 and aldehyde 188 (Scheme 139). Ylide 354 can 
be formed by deprotonation of phosphonium salt 355, which is easily prepared from 
ketone 331 by protection, a-brom ination and bromide displacement by 
triphenylphosphine.
OH
HO'
OH
OPG O
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HO OHPGO
354 188
OPG O
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355
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331
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Hercouet and Le Corre119 and later Le Floc'h and Lefeuvre120 reported the 
synthesis of ylides similar to 354 as part of the synthesis of chromenones 359 
(iScheme 140). Bromination of ketones 356, followed by displacement of the bromide 
by triphenylphosphine gave salt 357. Ester hydrolysis then deprotonation gave ylide 
358 in good yield.
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We decided to follow this protocol. Again, our initial attempts were carried out 
using the non-prenylated ketone 330. We protected the free hydroxyls as acetates 
using the method of Malkin and Nierenstein (Scheme 141 ) 8 4  to give ketone 360 in 
good yield.
HO OH
330
86%
AcO' OAc
360
Scheme 141
Several methods of a-bromination were tried (Scheme 142, Table 8), including 
the method mentioned by Le Floc'h and Lefeuvre using bromine and carbon 
tetrachloride. 120 The best results came from addition of 0.5 equivalents of ethereal 
bromine to an open solution of ketone 360 in ether-dioxane exposed to air (Table 8, 
entry 5). Bromoketone 361 was isolated in good yield, with !H NMR spectroscopy 
showing no signs of over-bromination. Reaction of bromoketone 361 with 
triphenylphosphine in toluene gave salt 362.
Reaction Conditions Result
1 Br2 /CHC13 Starting Material
2 Br2 /CCl4 /reflux Complex Mixture
3 Br2 /CHCl3/AlCl3 Starting Material
4 Br2/AcOH Starting Material
5 Br2 /Et2 0/dioxane Bromoketone 361
Table 8
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The next step was to deacetylate 362 prior to ylide formation. Le Floc'h and 
Lefeuvre had achieved this by heating the ester at reflux with conc. HBr. 120 This, and 
other methods of deprotection (Scheme 143, Table 9) were unsuccessful, resulting in 
substrate degradation, with no characterisable material isolated.
AcO' 'OAc
362
© ©
PPh3 Br Deprotection method
(see Table 9) 
Scheme 143
H 0‘ OH
363
Reaction Conditions Temperature Result
1 HBr Reflux Complex Mixture
2 HBr/EtOH Reflux Complex Mixture
3 HBr/EtOH RT Complex Mixture
4 MeOH/HCl RT Complex Mixture
5 Zn/MeOH RT Complex Mixture
6 K2 C 0 3 /Me0H RT Cyclisation?
Table 9
Direct treatment of salt 362 with potassium carbonate in methanol (Table 9, 
entry 6 ) gave, amongst other compounds, a highly UV active product. It is possible that 
this was chromenone 364, the result of an intramolecular Wittig reaction with the 
acetate in the 2-position of 362.
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HO
364
An alternative approach was to deacetylate bromoketone 361 prior to bromide 
displacement by triphenylphosphine. Deacetylation was carried out using potassium 
carbonate in methanol (Scheme 144) giving bromoketone 365 in low yield. Further 
reaction of this compound was difficult due to its low solubility in even very polar 
organic solvents. All attempts to increase solubility (e.g. by silylation), or to form the 
chalcone by 'one-pot' bromide displacement-Wittig reaction were unsuccessful.
31%
H 0‘ OH
365
OAcAcO'
361
Scheme 144
To summarise, we have completed the synthesis of protected morachalcone A. 
These protected precursors may be useful in a synthesis of chalcomoracin. Of all the 
protecting groups tried, the benzyl group looks most promising, although exact 
conditions for complete debenzylation have yet to be found.
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Substrate Specificity and Feeding Studies________
6.1 Substrate Specificity
It has not yet been conclusively proven that chalcomoracin 91 is produced by 
an enzymatic Diels-Alder reaction (see Section 1.9.1). Although all existing evidence 
suggests that this is the case, there has been no demonstration of a diene being 
incorporated into chalcomoracin. We wished to prove that a diene is involved in 
chalcomoracin biosynthesis (this shall be discussed later), and to develop an assay for 
enzyme activity. We also wanted to probe the specificity of the enzyme. At present, the 
synthesis of diene 96 is long and low yielding. If the enzyme were able to accept a 
simpler substrate, this would make the development of the assay much easier.
We looked at the synthesis of moracin C 97 to see if we could synthesise 
simpler structures that would be accepted by the enzyme. The two main simplifications 
are shown in Scheme 145. These simplifications led us to two target compounds for 
study, 2-prenylresorcinol 366, and 6 -deoxymoracin C 367.
2-Prenylresorcinol 366 is the simplest possible moracin C analogue. 
Incorporation of 366 into a Diels-Alder adduct would show that the benzofuran moiety 
was not needed in enzyme binding, and this would mean that simple substrates for the 
enzyme could be made very easily.
If 6 -deoxymoracin C 367 was converted into a Diels-Alder adduct in cell 
culture, it would show that the 6 -hydroxyl was not required for binding to the enzyme. 
This would be valuable information for three reasons:
i. Synthesis of 6 -deoxymoracin C and related substrates would be much quicker.
ii. Any Diels-Alder adducts would be easily distinguishable from natural adducts.
iii. When trying to isolate the enzyme, the 6 -hydroxyl could be used to 'tether' diene 
96 to an affinity column.
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2-Prenylresorcinol 366
We prepared 2-prenylresorcinol 366 following the method of Nakamura and 
co-workers (Scheme 146).51 ortho-Lithiation of THP-protected resorcinol 368, 
followed by immediate deprotection gave the target compound 366 in moderate overall 
yield.
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6 -Deoxymoracin C 367
OTHP . BuLi
i. prenyl bromide
ii. (C 02 H)2, MeOH
60%
OTHP
368 366
Scheme 146
6 -Deoxymoracin C 367 can be made in the same way as moracin C (Scheme 
147), except that we start from commercially available phosphonium salt 369, thus 
shortening the synthesis considerably.
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The synthesis of 6 -deoxymoracin C is outlined in Scheme 148. Benzofuran 
370, made by standard coupling of phosphonium salt 369 with 3,5-dimethoxybenzoic 
acid 187, was demethylated and the product, benzofuran 371, reprotected with the THP 
group to give benzofuran 372.
Demethylation after introducing the prenyl group would require lithium 
diphenylphosphide. Although such demethylation was successful in our synthesis of 
moracin C, it was low yielding and required a large excess of the lithium reagent. 
Removal of THP is generally more efficient.
We later prepared benzofuran 372 by direct coupling of salt 369 and acid 314 
(prepared by the THP protection of methyl 3,5-dihydroxybenzoate 225, followed by 
alkaline hydrolysis), thus reducing the number of steps. The synthesis was completed 
by ortho-lithiation and prenylation, followed by deprotection. This gave 6 - 
deoxymoracin C in low to moderate yield (9% from acid 187,42% from acid 314).
104
PPho Br '■ 187« DCC, DMAP 
1 d CH2 CI2
ii. Et3 N, PhMe
65%
369
h o 2 c .1V
OR
187 R=Me
314 R=THP
PPta Br i. 314, DCC, DMAP 
' CH2CI2
ii. Et3 N, PhMe
 ►
66%
369
Scheme 148
OMe
\\ /
370 OMe
BBr3  
CH2 CI2  
65°/
DHP
H+
35%
OTHP
\\ /
372 OTHP
. BuLi
i. prenyl bromide
ii. (C 0 2 H)2, MeOH 
62%
366 OH
105
6.2 Feeding Experiments
We now had the modified substrates we required to probe the specificity of the 
Diels-Alderase enzyme, and we had a substantial amount of M. alba cell cultures 
(grown by Dr Chris Brett of the University of Glasgow, and Mrs Jyoti Vithlani of 
GlaxoWellcome). We devised a series of feeding experiments using 2- 
prenylresorcinol 366 and 6 -deoxymoracin C 367. These substrates were fed to 
suspensions of M. alba cells (approximately 5 mg of substrate per 30 cm3 of cell 
suspension) under the conditions outlined in Table 11. There were six experiments in 
all, 3 experiments per substrate. Sampling of the experiments was carried out after 2, 6  
and 9 days (see Chapter 10). Analysis was carried out by LCMS by scanning for 
specific molecular ions [(M+H)+ and (M-H)+] of the desired adducts, 373 and 374.
Suspension Solvent Substrate Addition Solvent
Control h 2o No Substrate Added
1. h 2o DMSO
2. H2 0/MS4 Growth Medium DMSO
3. h 2o Aqueous Tween 80
Table 11
OH HO
OH
OH
HO
OH H
OH
374
(M+H)+ 633 
(M-Hf 631
OH
HO
The experiments with 2-prenylresorcinol 366 showed little success. This was 
attributed to the 'over-simplicity' of 366 as a substrate.
The most conclusive results came from two of the 6 -deoxymoracin C 
experiments. After nine days, the experiments using Tween 80 showed the presence of 
only natural chalcomoracin (by comparison with a substrate-free control experiment), 
however the other experiments showed the presence of two compounds with the 
desired molecular ion for deoxychalcomoracin 374. The LCMS spectrum is shown in 
Figure 18.
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Section of the LCMS of Deoxymoracin C Feeding Expt.
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Dr Andrew Knaggs of GlaxoWellcome isolated chalcomoracin from our cell 
cultures, using ^  NMR spectroscopy and mass spectromtery for confirmation. We 
used his results to identify natural chalcomoracin (the main peaks at 18.94-19.03 
minutes) in our cell extracts. The peaks at 17.56-17.61 minutes and 21.11-21.34 
minutes however, are for species with molecular ions of 633 (M+H) and 631 (M-H), 
i.e. deoxychalcomoracin. We found that the control experiment contained the peak at 
17.56-17.61 minutes, indicating that this particluar species must be a natural 
compound similar to chalcomoracin. The peak at 21.11-21.34 minutes is not present in 
the control, however. This suggests that it arises as a result of the fed substrate. The 
experiments were stopped after 9 days, and the crude extract purified by preparative
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HPLC. Figure 19 shows the HPLC trace of the final crude extract. The peak at 5.08 
minutes is natural chalcomoracin, while the band at 7.54 minutes corresponds to the 
compound we believe to be deoxychalcomoracin 374. We are awaiting further results 
to confirm this.
Section of the HPLC of Deoxymoracin C Feeding Expt.
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6.3 Conclusions and Outlook
6.3.1 Conclusions
The following has been achieved in this project:
• We have developed the most efficient synthesis of moracin C 97 to date, exploiting 
an acid-induced acyl migration, which we believe provides a general route to 
polyphenolic benzofiirans.
• We have synthesised, both in protected and fully deprotected forms, the proposed 
diene 96 involved in the biosynthesis of chalcomoracin.
• Several protected forms of the dienophile, morachalcone A 95 have been made.
• Feeding studies have shown us that 6 -deoxymoracin C 367 is a suitable modified 
substrate; it is easily incorporated into the biosynthesis of Diels-Alder adducts.
6.3.2 Future Aims of the Project
Further development of this work falls into two main areas:
• Continuation of the feeding studies - with the successful incorporation of 
deoxymoracin C, the next step is to feed the analogous diene to M. alba. As we 
have seen, the synthesis of deoxymoracin C is considerably shorter than that of 
moracin C, so the corresponding diene should be easy to prepare on a large scale.
• Synthesis of chalcomoracin - in order to confirm that chalcomoracin is a genuine 
Diels-Alder adduct, a biomimetic synthesis involving Diels-Alder reaction between 
diene 96 and morachalcone A 95 must be performed. If too difficult, an alternative 
route would be to couple protected diene 232 with one of the protected 
morachalcone A compounds (337,342, or 353) and then deprotect.
• At the moment, chalcomoracin extracted from M. alba has been purified by 
crystallisation. This may have increased the enantiopurity of the compound. The 
exact optical purity of natural chalcomoracin must be determined in order to prove 
that an enantiomerically pure/enriched adduct is being formed prior to purification.
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• Assay - the assay for this Diels-Alderase enzyme will be based on morachalcone A 
95 and diene 96. Cell-free extracts will be used, and the Diels-Alder reaction 
between 95 and 96 followed, either by analytical HPLC or by UV spectroscopy 
(the Diels-Alder reaction would break the conjugation of the chalcone). A parallel 
experiment using denatured enzyme suspension will show the rate of spontaneous 
cycloaddition. Chiral HPLC will be used to distinguish between spontaneous 
(racemic) and enzymatic chalcomoracin. Comparison of these experiments should 
show rate acceleration, enantioselectivity, and confirm incorporation of diene 96 
into chalcomoracin.
• Isolation of enzyme - this may be done by affinity chromatography using 
precursors attached on solid support. Morachalcone A 95 can be attached by the
2,4 or 2"- hydroxyls. Diene 96 can be attached by the 6 -hydroxyl which we have 
shown is not necessary for enzyme binding. If necessary, purification could be 
attempted using ion-exchange or size-exclusion chromatography.
Stereospecificity of enzyme - to confirm the stereospecificity of the enzyme with 
respect to diene 96, we can feed deuterium-labelled dienes (such as 375) to cell 
cultures {Scheme 149). We would expect the sole product to be the endo-adduct as 
the exo- has never been isolated, but by examining the 3,6 relative stereochemistry 
of the product, we can confirm on which face of the diene the Diels-Alder reaction 
occurs.
Diels-Alder D
morachalcone A 
95
“Ar2
D
Scheme 149
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Experimental for Chapter 3
7
General details
Reagents were purchased from Aldrich Chemical Company (Gillingham, 
UK) or Lancaster Synthesis (UK) and were used without further purification. 
Organic solvents were obtained from Rhone-Poulenc-Rorer and were dried, where 
necessary, using the procedures described by Leonard, Lygo and Procter. Melting 
points were recorded in open capillaries using a Gallenkamp apparatus and are 
uncorrected. *H and 13C NMR spectra were recorded for solutions in CDCI3 with 
tetramethylsilane as an internal standard on a Bruker AM-200 spectrometer 
operating at 200 and 50 MHz respectively or on a Bruker DPX/400 spectrometer 
operating at 400 and 100 MHz respectively, unless otherwise stated. 13C NMR 
spectra were assigned with the aid of Distortionless Enhancement by Polarisation 
Transfer (DEPT)-edited spectra. All coupling constants are measured in Hz. Thin 
layer chromatography was performed using Merck aluminium-backed silica plates of 
0.25 mm thickness. Chromatograms were visualised using UV conditions at 254 nm, 
staining with iodine or using a variety of common stains prepared by the methods 
described in Leonard, Lygo and Procter. Column chromatography was carried out on 
silica gel (particle size 70-230 mesh) or deactivated neutral alumina gel (standard 
grade, ca. 150 mesh). Mass spectra (MS) were recorded on AEI MS 12 or MS902 
spectrometers using the electron-impact ionisation (El) mode or, if stated, chemical 
ionisation (Cl) or fast atom bombardment (FAB) modes. Infra-red (IR) spectra were 
recorded on Nicolet Impact 410 or Jasco FT-IR spectrometer. Combustion analysis 
was carried out on a Carlo-Erba 1106 elemental analyser.
I l l
4-Methyl resorcinol 189
2,4-Dihydroxybenzaldehyde 188 (2.000 g, 14.49 mmol) was dissolved in methanol 
( 2 0  cm3) and 1 0 % palladium on carbon added (0 . 2 0  g, 1 0 % by mass of catalyst : 
aldehyde). This mixture was stirred under a hydrogen atmosphere at RT for 15 hours. 
After this time, the catalyst was removed by filtering twice through Celite®. The 
methanol was then removed under reduced pressure to leave a grey solid. This was 
recrystallised from 1:1 toluenerpet. ether to leave 189 as cubes (1.707 g, 13.77 mmol, 
95%). m.p.: 100-103 °C (Lit. 121 105 °C. 5h(200MHz; CD3 OD): 3.43 (3H, s, -Me), 
7.55 (1H, dd, J  2.4 and 8.1, 5-H), 7.63 (1H, d, J  2.4, 3-H), and 8.18 (1H, d, 8.0, 6 -H). 
The 13C , IR and mass spectra were identical to those reported. 121
2-Hydroxy-4-f-butyldimethylsilyloxybenzaIdehyde 190
2,4-Dihydroxybenzaldehyde 188 (3.0 g, 21.74 mmol), f-butyldimethylsilyl chloride 
(3.913 g, 26.09 mmol, 1.2 eq) and imidazole (1.768 g, 26.09 mmol, 1.2 eq) were 
dissolved in dry DMF (100 cm3) and stirred under nitrogen at room temperature 
overnight. The reaction was poured into H2 O (50 cm3) then extracted into Et2 0  (3 x 
50 cm3). The combined extracts were washed with water (50 cm3) and brine (2 x 50 
cm3), dried (MgSC>4 ) and concentrated in vacuo. Flash chromatography in silica 
(hexane-Et2 0 , 1:1) gave the aldehyde 190 (4.934 g, 19.58 mmol, 72%) as a 
colourless oil; /?p[hexane-Et2 0  (1:1)] 0.58; \)max(soln)/cm_1: 3256 (OH), 2932 (C-H), 
1702 (C=0), 1595 (Ar), 1570 (Ar), 1256 and 841 (Si-C), and 1118 (Si-O); 
5h(200MHz; CDCI3 ): 0.28 (6 H, s, -SiMe2), 0.99 (9H, s, *Bu), 6.32 (1H, d, 7 2.2, 3- 
H), 6.48 (1H, dd, J  2.2 and 8.5, 5-H), 7.41 (1H, d, 8.5, 6 -H), 9.73 (1H, s, -CHO), and
11.35 (1H, br s, -OH); 5c(50MHz; CDCI3 ): -3.95 (CH3), 18.72 (C), 26.02 (CH3), 
108.02 (CH), 113.46 (CH), 116.22 (C), 135.82 (CH), 164.17 (C), 164.48 (C), and
194.87 (CH); m/z (Cl) 253 [(M+H)+, 45%]; (Found: M, 253.1260. C i3 H2 i 0 3Si 
requires 253.1266).
2-Hydroxy-4-f-butyIdimethylsiIyIoxytoluene 191
2-Hydroxy-4-f-butyldimethylsilyloxybenzaldehyde 190 (0.500 g, 1.98 mmol) was 
dissolved in methanol (20 cm3) and 10% palladium on carbon (50 mg, 10% by mass) 
added. This was stirred under a hydrogen atmosphere for 20 hours. The catalyst was
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removed by filtering through Celite®, then the solvent was removed under reduced 
pressure to leave a brown oil. This was purified by column chromatography eluting 
with 1:1 diethyl ether:hexane to give the phenol 191 (0.449 g, 1.88 mmol, 95%) as a 
colourless oil; Rp[hexane-Et20  (1:1)] 0.63; umax (soln)/cm_1: 3602 (-OH), 1590 (Ar), 
1571 (Ar), 1256 and 842 (Si-C), and 1106 (Si-O); 5h(200MHz; CDC13): 0.26 (6 H, s, 
-SiMe2), 1.10 (9H, s, *Bu), 2.28 (3H, s, -Me), 5.01 (1H, br s, -OH), 6.47 (2H, m, 3 
and 5-H), 7.06 (1H, d, J  8.0Hz, 6 -H); 5c(50MHz; CDC13): -4.48 (CH3), 15.05 (CH3),
16.18 (C), 25.67 (CH3), 107.27 (CH), 112.30 (CH), 116.60 (C), 131.04 (CH), 154.26 
(C), and 154.61 (C); m/z (El): 238 (M+, 30%), 181 (100), and 75 (5); (Found: M+, 
238.1389. C i3 H2 2 0 2Si requires Af, 238.1390).
2-(3,,5’-Diacetoxybenzoyloxy)-4-fbutyldimethyIsilyloxy toluene 193
,OAc
TBSO-
OAc
3,5-Diacetoxybenzoic acid 192 (0.5 g, 2.18 mmol) was dissolved in dry CH2 C12  (35 
cm3) and to this was added, sequentially, dimethylaminopyridine (0.043 g, 0.35 
mmol, 0.16 eq), 2-hydroxy-4-f-butyldimethylsilyloxytoluene 191 (0.702 g, 2.950 
mmol, 1.35 eq), and dicyclohexylcarbodiimide (0.567 g, 2.75 mmol, 1.26 eq) in 
CH2 C12  (5 cm3). This was stirred at RT under nitrogen for 24 hours. After this time, 
the white precipitate was filtered off and the organic solution washed well with water 
and brine (2 x 50 cm3 each), and then dried (Na2 S 0 4). Filtration through a short 
silica plug to remove baseline material followed by removal of the solvent in vacuo 
left the ester 193 (0.520 g, 1.14 mmol, 57%) as a pale yellow oil; Rp[hexane-Et20  
(1:2)] 0.40; o max (film ycnr1: 1742 (C=0), 1617 (Ar), 1594 (Ar), 1560 (Ar), 1262 
and 841 (Si-C), and 1107 (Si-O); 5h(200MHz; CDC13): 0.21 (6 H, s, -SiMe2), 0.98 
(9H, s, ^Bu), 2.14 (3H, s, -Me), 2.29 (6 H, s, -OAc), 6.64 (1H, d, J  2.3, 3-H), 6.70 
(1H, dd, J  2.4 and 8.5, 5-H), 7.10 (1H, d, J  8.3, 6 -H), 7.23 (1H, t. J  2.1, 4’-H), and
7.85 (2H, d, 72.1, 2' and 6 '-H); 5c(50MHz; CDC13): -4.53 (CH3), 15.50 (CH3), 18.13 
(C), 20.98 (CH3), 25.80 (CH3), 113.62 (CH), 118.02 (CH), 120.77 (CH), 120.78 
(CH), 122.60 (C), 131.21 (CH), 131.58 (C), 149.39 (C), 151.05 (C), 154.36 (C),
162.89 (C), and 168.76 (C); m/z (Cl): 459 [(M+H)+, 20%], 401 (35), 352 (20), 281 
(20), 238 (42), 181 (97), and 124 (100); [Found: (M+H)+, 459.1812. C2 4 H3 i0 7Si 
requires M, 459.1839).
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2,4-Di(3' ,5' -dimethoxybenzoyloxy)benzaldehyde 194
MeO. .OMe
OMe OMe
To a solution of 3,5-dimethoxybenzoic acid 187 (3.00 g, 16.5 mmol) in dry CH2 CI2  
(80 cm3) under nitrogen was added sequentially: 4-dimethylaminopyridine (0.29 g,
2.4 mmol), 2,4-dihydroxybenzaldehyde 188 (1.03 g, 7.5 mmol) and a solution of 
dicyclohexylcarbodiimide (3.92 g, 19.0 mmol) in dry CH2 CI2  (10 cm3). The mixture 
was stirred at RT for 24 h. After this time, dicyclohexylurea was filtered off, and the 
organic solution washed twice with water, then dried over MgSC>4 . The solvent was 
then removed under reduced pressure. Recrystallisation from ethyl acetate gave 
aldehyde 194 (2.910 g, 13.90 mmol, 84%) as needles; m.p. 145-148°C; Rp(Et2 0 ) 
0.45; vmax (KBr)/cm_1 1743 (ester C=0), 1695 (aldehyde C=0), and 1608 (Ar); 
8h (200 MHz, CDCI3 ) 3.86 (6 H, s, 2 x OMe), 3.87 (6 H, s, 2 x OMe), 6.74 (1H, t, J
2.4 , 4'-H), 6.75 (1H, t, J  2.4, 4"-H), 7.31-7.36 (6 H, m, Ar-H), 8.03 (1H, d, J  7.4, 6 - 
H), and 10.20 (1H, s, CHO); 5C(50 MHz, CDCI3 ) 55.61 (2 x CH3), 106.75 (CH),
106.87 (CH), 107.73 (CH), 107.81 (CH), 117.23 (CH), 120.00 (CH), 125.98 (C),
130.04 (C), 130.32 (C), 131.15 (CH), 153.05 (C), 155.85 (C), 160.79 (C), 160.85 
(C), 163.85 (C), 164.33 (C), and 187.20 (CH); m/z (El) 466 (M+, 23%), and 165 
(100); (Found: C, 64.6; H 4.8%; M+ 466.1253. C2 5 H2 2 O9  requires C 64.37; H 
4.75%; M, 466.1254).
2-Methyl-5-(3',5'-dimethoxybenzoyloxy)phenol 196
MeO.
OH
Aldehyde 194 (0.100 g, 0.22 mmol) was dissolved in THF (10 cm3) and cooled to 
0°C. To this was added sodium borohydride (0.008 g, 0.22 mmol, 1 eq), and the 
reaction stirred at 0 °C for 0.5 h. After this time, the reaction mixture was poured into 
acetic acid (10 cm3) and extracted into EtOAc (3 x 10 cm3). The organic solution 
was washed with water and saturated sodium bicarbonate solution (2 x 1 0  cm3 each), 
dried (Na2 SC>4 ) and the solvent removed in vacuo to leave a colourless oil which 
crystallised under high vacuum to give phenol 196 (0.050 g, 0.19 mmol, 81%) as fine 
needles: m.p. 88-92 °C; \)max (KBrVcnr1: 3025 (-OH), 1733 (C=0), 1610 (Ar), and 
1597 (Ar); 5h(200MHz, CDCI3 ): 2.18 (s, 3H, -Me), 3.81, (6 H, s, 2 x -OMe), 6.47 (br 
s, 1H, -OH), 6.54 (d, 1H, J  2.2, 3-H), 6.61 (1H, dd, J  2.3 and 8.1, 5-H), 6.69 (1H, t, J
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2.3, 4'-H), 7.08 (1H, d, J 8.3, 6 -H), and 7.29 (2H, d, /  2.4, 2' and 6 '-H); 8c(50MHz, 
CDC13): 15.36 (CH3), 55.61 (CH3), 106.52 (CH), 107.67 (CH), 108.71 (CH), 113.03 
(CH), 122.18 (C), 131.77 (CH), 149.50 (C), 150.00 (C), 154.70 (C), 160.68 (C), and
165.90 (C); m/z (El) 288 (M+, 45%), 165 (100), 137 (35), and 122 (25); (Found: C, 
66.7; H 5.7%; M+, 288.0995. Ci6 H i6 0 5  requires C, 66.67; H, 5.56% ; M, 288.0998).
2,4-Di(3',5'-dimethoxybenzoyloxy)benzyl alcohol 197
OH
MeO. .OMe
OMe OMe
Sodium cyanoborohydride (0.352 g, 5.60 mmol) was added to a suspension of 
aldehyde 194 (2.610 g, 5.60 mmol) in THF/H2 O (19:1, 100 cm3). The solution was 
acidified to pH 3 with AcOH/THF/c.HCl (10:8:1) whereupon the slurry dissolved. 
The mixture was stirred at RT for 1 h, quenched with water, then extracted with 
CH2 CI2 . The organic layer was washed with saturated aqueous sodium bicarbonate 
and saturated brine, then dried over MgS0 4 . The solvent was removed in vacuo to 
give alcohol 197 (5.360 g, 5.54 mmol, 99%) as an amorphous solid under vacuum 
mp 38-40°C. RF(Et2 0 ) 0.30; Dmax (KBrVcnr1 3058 (OH), 1739 (C=0), 1609 (Ar), 
1596 (Ar), and 1500 (Ar); 8H(200 MHz, CDC13) 2.27 (1H, br s, OH), 3.81 (6 H, s, 2 x 
OMe), 3.82 (6 H, s, 2 x OMe), 4.62 (2H, s, CH2), 6.69 (2H, m, 2 x 4'-H), 7.14-7.18 
(2H, m, 3- H, 5-H), 7.29 (2H, d, /  2.3, 2'-H), 7.30 (2H, d, J  2.3, 2'-H), and 7.56 (1H, 
d, J  9.0, 6 -H); 8C(50 MHz, CDC13) 55.57 (2 x CH3), 59.71 (CH2), 106.50 (CH),
106.57 (CH) 107.62 (CH), 107.74 (CH), 116.09 (CH), 119.71 (CH), 129.64 (C), 
130.52 (CH), 130.89 (C), 130.96 (C), 148.67 (C), 150.59 (C), 160.72 (C), 160.77 
(C), 164.63 (C), and 164.81 (C); m/z (El) 468 (M+, 5%), 182 (75), 165 (100), and 
137 (20); (Found: M+, 468.1423. C2 5 H2 4 O9  requires M, 468.1420).
[4-(3,,5'-Dimethoxybenzoyloxy)-2-hydroxybenzyl]triphenylphosphonium
bromide 2 0 0
PPh3 Br
MeO. “OH
OMe
Alcohol 197 (4.670 g , 9.98 mmol) and triphenylphosphine hydrobromide (3.425 g, 
9.98 mmol), were heated under reflux in dry acetonitrile (100 cm3) under nitrogen 
for 3 h. The reaction was then allowed to cool to RT and stirred overnight. The
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acetonitrile was removed in vacuo, and the residue taken up in CH2 CI2  ( 1 0  cm3). 
Slow addition of diethyl ether gave a precipitate which was collected by filtration 
and recrystallised from ethanol to give phosphonium saltlWS (6.219 g, 9.48 mmol, 
95%) as plates; m.p. 187-190°C. o max (KBr)/cm-l 3443 (OH), 1736 (C=0), 1606 
(Ar), 1592 (Ar), 1511 (Ar), and 714 (C-P); 8H(400 MHz, CD3 OD) 3.74 (6 H, s, 2 x 
OMe), 4.69 (2H, br d, 7 14.0, CH2 -P), 6.45 (1H, s, 3-H), 6.48 (1H, dd, 7 1.7 and 8.3,
5-H), 6.69 (1H, t, 7 2.3, 4'-H), 6 . 8 8  (1H, dd, 7 2.7 and 8.3, 6 -H), 7.14 (2H, d, 7 2.3, 
2'-H), and 7.54-7.80 (15H, m, 3 x Ph); 8C(100 MHz, CD3 OD) 25.77 (d, 7 49.6, 
CH2 P), 56.56 (CH3), 107.38 (CH), 109.06 (CH), 110.67 (d, 7 2.7, CH), 113.52 (d, 7 
8 .8 , C), 114.67 (d, 7 3.1, CH), 129.96 (d, 7 85.7, C), 131.65 (d, 7 12.5, CH), 132.66 
(C), 133.60 (d, 7 5.0, CH), 135.76 (d, 7 9.7, CH), 136.71 (d, 7 2.5, CH), 154.16 (d, 7 
4.0, C), 158.79 (d, 7 5.0, C), 162.90 (C), and 166.46 (C); 8P(81 MHz, CDCI3 ) 21.3; 
(Found: C, 64.7; H, 4.75%. C3 4 H3 oBr0 5 P requires C, 64.86; H, 4.80).
6-(3M,5"-Dimethoxybenzoyloxy)-2-(3',5'-dimethoxyphenyl)benzo[7>]furan 201
OMe
MeO.
OMe
OMe
Dicyclohexylcarbodiimide (0.28 g, 1.35 mmol) in dry CH2 CI2  (15 cm3) was added to 
a solution of phosphonium salt 200 (0.91 g, 1.45 mmol), 4-dimethylaminopyridine 
(0.021 g, 0.17 mmol), and 3',5'-dimethoxybenzoic acid 187 (0.20 g, 1.07 mmol) in 
dry CH2 CI2  (50 cm3) under nitrogen, and the mixture was stirred overnight. The 
solution was concentrated and the residue dissolved in dioxane (50 cm3). 
Triethylamine (0.84 cm3, 6.03 mmol) was added and the mixture heated under reflux 
under nitrogen for 12 h. After cooling, the solution was filtered and the solvent 
removed in vacuo. Flash column chromatography (SiC>2 , CH2 CI2 ) of the residue gave 
benzofuran  201 (230 mg, 0.803 mmol, 75%) as needles; m.p. 110-113°C; 
/?f (CH2 C12) 0.25; \ ) m ax (soln)/cm-l 1752 (C=0), 1602 (Ar), 1573 (Ar), and 1519 
(Ar); 8h (200 MHz, CDCI3 ) 3.71 (6 H, s, 2 x OMe), 3.74 (6 H, s, 2 x OMe), 6.33 (1H, 
t, 7 2.2, 4'-H), 6.59 (1H, t, 7 2.3, 4"-H), 6.85 (1H, s, 3-H), 6 . 8 6  (2H, d, 7 2.2, 2'-H), 
6.96 (1H, dd, 7 2.0 and 8.4, 5-H), 7.24 (2H, d, 7 2.2, 2"-H), 7.29 (1H, d, 7 1.8, 7-H), 
and 7.42 ( 1 H, d, 7 8.4, 4-H); 8C(50 MHz, CDCI3 ) 55.39 (CH3), 55.59 (CH3), 101.00 
(CH), 101.61 (CH), 102.87 (CH), 105.24 (CH), 106.30 (CH), 107.65 (CH), 117.25 
(CH), 120.92 (CH), 127.05 (C), 131.28 (C), 131.88 (C), 148.21 (C), 154.60 (C), 
156.72 (C), 160.74 (C), 161.06 (C), and 165.16 (C); m/z (El) 434 (M+, 30%), 165 
(100), and 137 (22); (Found: C, 69.0; H 5.1%; M+, 434.1364. C2 5 H2 2 O7  requires C, 
69.10; H, 5.07% ; M, 434.1366).
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2-(3,,5,-Dimethoxyphenyl)-6-hydroxybenzo[£]furan 202
OMe
OMe
Benzofuran 201 (0.308 g, 0.71 mmol) and potassium hydroxide (0.100 g, 1.71 mmol) 
were dissolved in ethanol (5 cm3) and heated under reflux for 2 h. After cooling, the 
solution was diluted with aqueous NaOH (1 mol dm-3), acidified to pH 2 with 
aqueous HC1 (1 mol dm-3), and then extracted into CH2 CI2 . The organic solution 
was washed twice with water, then dried over M gS04. The solvent was removed in 
vacuo and the residue filtered through a short silica plug (eluting with CH2 CI2 ) to 
give benzofuran 202 (0.306 g, 0.65 mmol, 92%) as needles; m.p. 114-116°C (lit. 73  
112-115 °C); 7?f(CH2 C12) 0.2; Dmax(soln)/cm- 1 3448 (OH), 1624 (Ar), 1600 (Ar), 
1576 (Ar), and 1508 (Ar); 6H(200 MHz, CDCI3 ) 3.78 (6 H, s, 2 x OMe), 5.42 (1H, br 
s, OH), 6.37 (1H, t, J  2.2, 4'-H), 6.70 (1H, dd, J  2.2 and 8.4, 5-H), 6.84 (1H, s, 3-H), 
6 . 8 8  (2H, d, /  2.3, 2'-H), 6.94 (1H, /  1.9, d, 7-H), and 7.31 (1H, d, J  8.4, 4-H); 6C(50 
MHz, CDCI3 ) 55.48 (CH3), 98.24 (CH), 100.57 (CH), 101.73 (CH), 102.56 (CH),
112.18 (CH), 121.19 (CH), 122.56 (C), 132.36 (C), 153.93 (C), 154.85 (C), 155.89 
(C), and 160.95 (C); m/z (El) 270 (M+ ,100); (Found: C, 71.1; H 5.3% ; M+, 
270.0983; C i6 Hi4 0 4  requires C, 71.10; H 5.22%; M, 270.0982).
2-(3',5'-Dimethoxyphenyl)-6-hydroxybenzo[Z?]furan 202
In a similar way, a solution of acetate 212 (1.230 g, 3.94 mmol) and potassium 
hydroxide (0.530 g, 9.46 mmol, 2.4 eq) in ethanol-H2 0  (5:1, 20 ml) was heated 
under reflux for lh  and benzofuran 202 (0.958 g, 3.550 mmol, 90%) was then 
obtained following the same work-up procedure.
6-Hydroxy-2-phenyIbenzo[6]furan 203
II ^
HO" 'O
A solution of dicyclohexylcarbodiimide (0.34 g, 1.64 mmol) in dry CH2 CI2  (5 cm3) 
was added to a solution of phosphonium salt 200 (1.10 g, 1.75 mmol), 4- 
dimethylaminopyridine (0.030 g, 0.21 mmol), and benzoic acid (0.16 g, 1.30 mmol) 
in dry CH2 CI2  ( 2 0  cm3), under nitrogen, and the mixture stirred overnight. The 
solution was concentrated and the residue dissolved in dioxane ( 2 0  cm3). 
Triethylamine (1.02 cm3, 7.34 mmol) was added and the reaction heated under reflux 
under nitrogen for 12 h. After cooling, the solution was filtered and the solvent 
removed in vacuo. Flash column chromatography (SiC>2 , CH2 CI2 ) gave crude 6 - 
(3",5"-dimethoxybenzoyloxy)-2-phenylbenzo[&]furan (0.82 g). This crude material 
was dissolved in EtOH (20 cm3), KOH (0.12 g, 4.4 mmol) was added and the
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mixture was heated under reflux for 2 h. The reaction was quenched with aqueous 
NaOH (2.5 mol dm-3), acidified with aqueous HC1 (2 mol dm-3) and extracted into 
CH2 CI2 . The organic layer was extracted twice with aqueous NaOH (2.5 mol dm-3). 
The basic aqueous extracts were acidified as before and re-extracted into CH2 CI2 . 
The CH2 CI2  extract was dried over MgS0 4 , and concentrated in vacuo. The residue 
was filtered through a short silica column eluting with CH2 CI2 , the solvent was 
removed, and the residue was recrystallised from diethyl ether-hexane to give 
benzofuran 203 (0.90 g, 0.260 mmol, 20%) as pale yellow needles; m.p. 165-170 °C 
(lit. , 122 167 °C). 5h [200 MHz, (CD3 )2 CO] 6.83 (1H, dd, J  2.1 and 8.4, 4-H), 7.02 
(1H, d, J  1.9, 2’-H), 7.18 (1H, d, J  0.8, 3-H), 7.30-7.50 (4H, m, 5-H and 3 x Ph-H),
7.86 (2H, d, 77.1, 2 x Ph-H), and 8.55 (1H, s, OH); [lit. , 117 60 MHz, (CD3 )2 CO].
[4,-(3",5,,-Dimethoxybenzoyloxy)-2'-hydroxybenzyl]-3,5-dimethoxybenzoate
208
o
.OMe
OMeMeO. "OH
iMe
Sodium cyanoborohydride (0.205 g, 3.26 mmol) was added to a suspension of 
aldehyde 194 (1.520 g, 3.26 mmol) in THF/H2 O (19:1, 75 cm3). The solution was 
acidified to pH 3 with AcOH/THF/c.HCl (10:8:1) whereupon the slurry dissolved. 
The mixture was stirred at RT overnight, quenched with water, then extracted with 
CH2 CI2  (3 x 50 cm3). The organic layer was washed with saturated aqueous sodium 
bicarbonate and saturated brine (2 x 50 cm3 each), and dried (MgSC>4 ). The solvent 
was removed in vacuo to give phenol 208 (1.374 g, 2.94 mmol, 90%) as an oil which 
crystallised under vacuum; m.p. 124-126 °C; /?F(Et2 0 ) 0.26; \)max (KBr)/cm_1 3380 
(OH), 1724 (C=0), 1609 (Ar), 1535 (Ar), and 1467 (Ar); 5H(200 MHz, CDC13) 3.83 
(6 H, s, 2 x OMe), 3.85 (6 H, s, 2 x OMe), 5.36 (2H, s, CH2), 6.67 (1H, t, J  2.3, 4"-H 
or 4-H), 6.71 (1H, t, J  2.3, 4-H or 4"-H), 6.80 (1H, dd, J  2.3 and 8.2, 5'-H), 6.84 (1H, 
d, J  2.3, 3-H), 7.20 (2H, d, J  2.3, 276"-H or 2/6-H), 7.31 (2H, d, J  2.3, 2/6-H or 
276"-H), 7.41 (1H, d, /  8.2, 6 '-H), and 8.39 (1H, br s, OH); 8C(50 MHz, CDC13)
56.01 (CH3), 56.04 (CH3), 63.85 (CH2), 106.84 (CH), 106.99 (CH) 107.90 (CH), 
108.11 (CH), 111.88 (CH), 114.38 (CH), 119.86 (C), 131.25 (C), 131.57 (C), 133.58 
(CH), 153.49 (C), 157.32 (C), 161.08 (C), 161.16 (C), 165.03 (C), and 169.28 (C); 
m/z (FAB) 468 (M+, 15%), 451 (10), 307 (10), 287 (30), 219 (10), 165 (100), 154 
(50), 137 (45), 107 (25), and 73 (12); (Found: C, 64.0; H 5.0%; M+ 468.1416. 
C2 5 H2 4 O9  requires C 64.10; H 5.16%; A/+, 468.1420).
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2,4-Diacetoxybenzaldehyde 209
o
Following the procedure of Malkin and Nierenstein8 4  2,4-dihydroxybenzaldehyde 
188 (5.012 g, 36.32 mmol) gave, after recrystallisation from hexane, aldehyde z209 
(7.365 g, 33.05 mmol, 91%) as needles; m.p. 6 6 -6 8 °C (lit., 69-70 °C 84), our !H 
NMR data do not completely correspond to those previously reported ; 8 4  \)max 
(KBr)/cm_1 1767 (ester C=0), 1753 (ester C=0), 1690 (aldehyde C=0), 1606 (Ar), 
1585 (Ar) 1545 (Ar), and 1492 (Ar); 5H(200 MHz, CDC13) 2.33 (3H, s, OAc), 2.39 
(3H, s, OAc), 7.04 (1H, d, 72.2, 3-H), 7.17 (1H, dd, 72.2 and 8.5, 5-H), 7.95 (1H, d, 
7 8.5, 6 -H), and 10.07 (1H, s, CHO); 8C(50 MHz, CDCI3 ) 20.66 (CH3), 21.03 
(CH3), 116.97 (CH), 119.64 (CH), 125.54 (C), 132.06 (CH), 152.23 (C), 155.46 (C), 
168.20 (C), 168.78 (C), and 187.50 (CH); m/z (Cl) 240 [100%, (M+NH4 )4-]; m/z (El) 
222 (M+, 5%), 180 (35), 179 (15), 138 (100); (Found: C, 59.5; H, 4.6%. C 1 1H 1 0O5 
requires C, 59.46; H 4.54%).
4-Acetoxy-2-hydroxybenzyl acetate 210
OAc
Sodium cyanoborohydride (1.277 g, 20.28 mmol) was added to a stirred solution of 
aldehyde 209 (3.001 g, 13.52 mmol) in 19:1 THF/H2 O (60 cm3). The solution was 
acidified to pH 3 with AcOH-THF-c.HCl (10:8:1). After stirring at RT for 1 h, the 
mixture was diluted with water (100 cm3) and extracted into CH2 CI2  (3 x 100 cm3). 
The organic extract was washed with saturated bicarbonate solution (3 x 100 cm3) 
and brine (100 cm3), then dried (MgSC>4 ) and concentrated in vacuo to give phenol 
210 (2.670 g, 11.92 mmol, 8 8 %) as an oil. Rp[diethyl ether-hexane (2:1)] 0.43; \)max 
(film)/cm_1 3392 (OH), 1764 (C=0), 1736 (C=0), 1610 (Ar), 1516 (Ar), and 1501 
(Ar); 5h (200 MHz, CDCI3 ) 2.05 (3H, s, CH2 OAc), 2.23 (3H, s, ArOAc), 5.07 (2H, s, 
CH2), 6.57-6.62 (2H, m, 3-H and 5-H), 7.23 (1H, d, J  8.9, 6 -H), and 8.09 (1H, s, 
OH); 5C(50 MHz, CDCI3 ) 20.80 (CH3), 20.91 (CH3), 62.10 (CH2), 109.97 (CH), 
113.23 (CH), 119.78 (C), 131.90 (CH), 151.89 (C), 156.09 (C), 169.85 (C), and 
172.95 (C); m/z (El) 224 (M+, 30%), 182 (30), 164 (20), 122 (100), and 94 (30); 
(Found: M+, 224.0862. C 1 1H 1 2O5 requires M, 224.0865).
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(4-Acetoxy-2-hydroxybenzyl)triphenylphosphonium bromide 211
® PPh3 Br®
AcO OH
Triphenylphosphine hydrobromide (1.534 g, 4.47 mmol) was added to a solution of 
phenol 210 (1.002 g, 4.47 mmol) in dry acetonitrile (25 cm3) under nitrogen and the 
mixture heated under for 2 h. The solvent was removed in vacuo and the residue 
taken up in CH2 CI2  (10 cm3). Diethyl ether (100 cm3) was added and the resulting 
precipitate was filtered off and dried under suction to give the phosphonium salt 2 1 1  
as a white powder (2.231 g, 4.40 mmol, 98%); m.p. 204-206°C; 'Umax(filni)/ciir1 
3422 (OH), 1763 (C=0), 1603 (Ar), 1588 (Ar), 1511 (Ar), and 689 (C-P); 6H(400 
MHz, CD3 OD) 2.13 (3H, s, OAc), 4.66 (2H, d, J  13.9, -CH2 P), 6.33 (1H, s, 3-H),
6.35 (1H, dd, J  2.0 and 8.2, 5-H), 6.82 (1H, dd, J  2.8 and 8.2, 6 -H), and 7.51-7.79 
(15H, m, 3 x Ph); 5C(100 MHz, CD3 OD) 21.34 (CH3), 25.73 (d, J  49.6, CH2 P), 
110.62 (d, J  2.9, CH) 113.24 (d, J  8 .8 , C), 114.64 (d, J  3.0, CH), 119.96 (d, J  85.7, 
C), 131.64 (d, /  12.6, CH), 133.48 (d, 75.1, CH), 135.75 (d, J  9.8, CH), 136.69 (d, J  
2.7, CH), 154.04 (d, J  4.0, C), 158.66 (d, J  5.0, C), and 171.21 (C); 6P(81 MHz, 
CDCI3 ) 21.67; m/z (El) 262 (100%, Ph3 P°+), 183 (55), 108 (15); (Found: C, 64.0; 
H, 4.9; Br, 16.0%. C2 7 H2 4 Br0 3P requires C, 63.91; H, 4.73; Br, 15.80).
6-Acetoxy-2-(3’,5'-dimethoxyphenyl)benzo[^]furan 212
Me
AcO'
Me
Dicyclohexylcarbodiimide (5.398 g, 26.20 mmol) in dry CH2 CI2  (15 cm3) was 
added to a solution of phosphonium salt 211 (10.544 g, 20.80 mmol), 4- 
dimethylaminopyridine (0.406 g, 3.33 mmol), and 3,5-dimethoxybenzoic acid 187 
(3.823 g, 21.00 mmol) in dry CH2 CI2  (200 cm3) under nitrogen, and the mixture was 
stirred overnight. The solution was concentrated in vacuo and the residue dissolved 
in dry dioxane (100 cm3). Triethylamine (16.30 cm3, 117.71 mmol) was added and 
the mixture heated under reflux under nitrogen overnight. After cooling, the solution 
was filtered and the solvent removed in vacuo. Flash column chromatography [Si0 2 , 
hexane-diethyl ether (2 :1 )] of the residue gave benzofuran 2 1 2  as an amorphous 
solid (4.874 g, 15.96 mmol, 76%); m.p. 109-110°C; /?p[diethyl ether-hexane (1:2)] 
0.21; Dmax (filmVcm- 1 1753 (C=0), 1652 (Ar), 1602 (Ar), 1573 (Ar), and 1518 (Ar); 
6H(200 MHz, CDCI3 ) 2.35 (3H, s, OAc), 3.87 (6 H, s, 2 x OMe), 6.48 (1H, t, J  2.2, 
4’-H), 6.99-6.93 (4H, m, 2"-H, 3-H and 5-H), 7.30 (1H, s, 7-H), and 7.58 (1H, d, J
8.4, 4-H); 5C(50 MHz, CDCI3 ) 21.17 (CH3), 55.47 (CH3), 100.99 (CH), 101.54
120
(CH), 102.86 (CH), 105.05 (CH), 117.12 (CH), 120.91 (CH), 126.97 (C), 131.88 
(C), 147.90 (C), 154.54 (C), 156.67 (C), 161.04 (C), and 169.78 (C); m/z (El) 312 
(M+, 25%), 270 (100); (Found: M+, 312.0994. C i8 H i6 0 5  requires 312.0998).
6-(tert.-Butyldimethylsilyloxy)-2-(3,,5’-dimethoxyphenyl)benzo[7>]furan 213
Me
TBSO'
Me
A solution of benzofuran 202 (0.105 g, 0.40 mmol), imidazole (0.060 g, 0.80 mmol), 
and tert.-butyldimethylsilylchloride (0.12 g, 0.80 mmol) in dry DMF (5 cm3) was 
stirred under nitrogen at RT for 24 h. The mixture was poured into water and 
extracted into CH2 CI2 . The organic extract was washed with brine, then with water, 
dried (MgSCU), and the solvent removed in vacuo. The residue was filtered through a 
short silica column (eluting with CH2 CI2 ) to leave the benzofuran 213 (0.142 g, 
0.372 mmol, 93%) as an oil. Rp(CH2 Cl2 ) 0.80. Umax (soln)/cm_1 1600 (Ar), 1570 
(Ar), 1508 (Ar), and 1155 (Si-C). 5H(200 MHz, CDCI3 ) 0.15 (6 H, s, SiMe2), 0.93 
(9H, s, Me3 C), 3.77 (6 H, s, 2 x OMe), 6.36 (1H, t, J  2.2, 4'-H), 6.69 (2H, dd, J  2.1 
and 8.4, 5-H), 6.84 (1H, s, 3-H), 6 . 8 8  (2H, d, J  2.3, 2’-H), 6.92 (1H, d, J  1.6, 7-H), 
and 7.30 (1H, d, J  8.4, 4-H); 5C(50 MHz, CDCI3 ) -^.56 (CH3), 18.22 (C), 25.68 
(CH3), 55.44 (CH3), 100.57 (CH), 101.65 (CH), 102.51 (CH), 102.81 (CH), 116.74 
(C), 120.75 (C), 123.11 (CH), 132.40 (CH), 153.64 (C), 155.06 (C), 155.57 (C), and
161.01 (C); m/z (Cl) 385 [(M+H)+, 100%]; (Found: M +384.1752. C2 2 H2 8 0 4 Si 
requires M, 384.1752).
6-(te/?.-ButyIdimethylsilyIoxy)-2-[3',5'-dimethoxy-4,-(3"-methylbut-2M- 
enyl)phenyl]benzo[^]furan 214 
Using lithium 2-thienylcyanocuprate
OMe
TBSO'
OMe
n-Butyllithium (0.85 cm3, 1.42 mol dm- 3  solution in hexane, 1.20 mmol) was added 
over 1 h to a stirred solution of benzofuran 213 (0.307 g, 0.80 mmol) in dry THF (20 
cm3) under nitrogen at -78 °C. The solution was warmed to -30°C, stirred for a 
further 1 h, and then added via canula to a solution of lithium 2 -thienylcyanocuprate 
(4.8 cm3, 0.25 mol dm- 3  solution in THF, 1.20 mmol) under nitrogen at -30 °C. 
After 1 h prenyl bromide (0.14 cm3, 1.20 mmol, 1.5 eq) was added. The solution 
was stirred at -30 °C for 2 h, warmed to RT and stirred overnight. The reaction was 
poured into water and extracted into diethyl ether. The organic solution was washed
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twice with brine solution and twice with water, dried (MgS04), and the solvent 
removed in vacuo. Flash column chromatography [Si02, hexane-diethyl ether (4:1)] 
gave the benzofuran 214 (0.250 g, 0.553 mmol, 69%), as an amorphous solid; m.p. 
64-67°C. /?p[hexane-diethyl ether (4:1)] 0.50. i)max (soln)/cm_1 1618 (Ar), 1560 (Ar), 
1508 (Ar), 1165 (Si-C), and 972 (=C-H). 8H(200 MHz, CDC13) 0.30 (6 H, s, SiMe2 ), 
1.08 (9H, s, Me3 C), 1.74 (3H, s, =CMe), 1.85 (3H, s, =CMe), 3.43 (2H, d, J  7.0, 
CH2), 3.95 (6 H, s, 2 x OMe), 5.27 (1H, br t, J  7.1, CH=), 6.83 (1H, dd, J  2.1 and 8.4,
5-H), 6.95 (1H, s, 3-H), 7.05 (2H, s, 2'-H), 7.10 (1H, d, J  1.8, 7-H), and 7.42 (1H, d, 
J  8.4, 4-H); 8C(50 MHz, CDCI3 ) -4.48 (CH3), 17.69 (CH3), 18.16 (C), 22.29 (CH2), 
25.65 (CH3), 29.05 (CH3), 55.76 (CH3), 100.30 (CH), 100.69 (CH), 102.74 (CH),
116.57 (CH), 118.70 (C), 120.49 (CH), 122.52 (CH), 123.25 (C), 129.21 (C), 131.28 
(C), 153.46 (C), 155.45 (C), 155.52 (C), and 158.15 (C); m/z (El) 452 (M+, 100%), 
437 (117), 395 (12); (Found: M+, 452.2378. C2 7 H3 6 0 4Si requires 452.2382).
Using copper(ii) bromide-dimethyl sulfide complex
Benzofuran 213 (0.100 g, 0.26 mmol) was dissolved in dry THF (10 cm3) and cooled 
to -78 °C under nitrogen. n-Butyllithiun (1.06 mol dm-3  in hexane, 0.30 cm3, 0.26 
mmol, 1 eq) was added slowly, the solution warmed to -20 °C, then copper bromide- 
diemthyl sulfate complex (0.040 g, 0.26 mmol, 1 eq) added portionwise over 1 h. 
Prenyl bromide (0.05 cm3, 0.38 mmol, 1.45 eq) was added in one portion and the 
dark green solution stirred at RT overnight. The reaction was poured into water then 
extracted into Et20  (3 x 20 cm3). The combined extracts were washed with water (20 
cm3) and brine (2 x 20 cm3), dried (M gS04) and concentrated in vacuo. 
Chromatography on silica (4:1 hexane-Et2 0) gave benzofuran 214 (0.060 g, 0.14 
mmol, 51%) as an amorphous solid; All data matched those reported above.
Moracin C 97
OH
HO‘
OH
n-Butyllithium (2.83 cm3, 1.42 mol dm- 3  in hexane, 4.01 mmol) was added over 1 h 
to a stirred solution of diphenylphosphine (0.70 cm3, 4.01 mmol) in dry THF (5 cm3) 
at 0°C under nitrogen. Benzofuran 214 (0.302 g, 0.668 mmol) in dry THF (2.5 cm3) 
was added and the solution was allowed to warm to RT. The mixture was heated 
under reflux for 16 h and was then poured into aqueous NaOH (2.5 mol dm-3), 
acidified with aqueous HC1 (2.5 mol dm-3) and extracted into ethyl acetate. The 
organic extract was dried with Na2 S 0 4  and the solvent removed in vacuo. 
Tetrabutylammonium fluoride (4.1 cm3, 1 mol dm- 3  in THF, 4.10 mmol) was added
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and the resulting solution was stirred under nitrogen at RT overnight. Aqueous 
acetic acid (2 mol dm-3) was added and the mixture extracted into ethyl acetate. The 
organic layer was extracted with aqueous NaOH (2.5 mol dm~3). The basic aqueous 
solution was acidified with HC1 (2.5 mol dm-3) and extracted into ethyl acetate. The 
organic extract was washed with water, dried over Na2 S0 4  and the solvent was 
removed in vacuo. Flash column chromatography [Si0 2 , CH2 Cl2 -methanol (9:1)] of 
the residue gave moracin C 97 (71 mg, 0.227 mmol, 34%) as plates, m.p. 196-198°C. 
(lit. , 5 2 198-199°C); RF[CH2 Cl2-MeOH (9:1)] 0.30; 1W  (solnycnr1 3398 (OH), 
1624 (Ar), 1560 (Ar), 1508 (Ar), and 1117 (=C-H); 6H[200 MHz, (CD3 )2 CO] 1.57 
(3H, s, =CMe), 1.68 (3H, s, =CMe), 3.37 (2H, d, J  7.0, CH2), 5.15 (1H, br t, J  7.0, 
CH=), 6.79 (1H, dd, J  2.0 and 8.3, 5-H), 6.91 (2H, s, 2'-H), 6.95 (1H, s, 3-H), 6.97 
(1H, s, 7-H), and 7.22 (1H, d, J  8.3, 4-H); m/z (El) 310 (M+, 67%), 295 (26), 261 
(28), 255 (57), 183 (2 0 ), 152 (30); (Found: M, 310.1202. C i9 H i8 0 4  requires 
310.1205). *H NMR matched that reported. 58
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Experimental for Chapter 4
8
4-(2’,6,-Dimethoxyphenyl)-2-methylbuta-l,3-diene 222
1.3-Dimethyoxybenzene 220 (1.90 cm3, 14.50 mmol) was dissolved in dry THF (20 
cm3) and cooled to -35 °C under nitrogen. n-Butyllithium (1.60 mol dm-3  in hexane, 
10.0 cm3, 16.00 mmol, 1.1 eq) was added over 15 min, then the bright red solution 
stirred at -35 °C for 1 h. 3-Methylbut-2-enal 216 (0.92 cm3, 16.0 mmol, 1.1 eq) was 
added in one portion and the reaction was warmed to RT then heated at reflux for 4 
h. After cooling to RT, the reaction was quenched with water and extracted into Et2 0  
(3 x 20 cm3). The combined extracts were washed with water (20 cm3) and brine (2 
x 20 cm3), dried (MgSC>4 ) and concentrated in vacuo to afford a yellow oil. This oil 
was taken up in pyridine (14.00 cm3, 174.0 mmol, 12 eq) and cooled to 0 °C under 
nitrogen. Phosphorus oxychloride (1.60 cm3, 17.40 mmol, 1.2 eq) was added slowly 
and the yellow slurry stirred at RT overnight. Et2 0  (20 cm3) was added and this 
solution washed with dilute aqueous HC1 (1 mol dm-3, 20 cm3), water (20 cm3) and 
brine (2 x 20 cm3), then dried (MgSC>4 ). Concentration in vacuo followd by 
chromatography on silica (1:1 hexane/Et2 0 ) gave the diene 22294>87 (2.669 g, 13.08 
mmol, 90%) as a bright yellow oil; Rf [hexane-Et2 0  (1:1)] 0.72; t)max (film)/cm_1 
3009 (=C-H), 1592 (Ar), and 1493 (Ar); 5H(200 MHz, CDC13) 2.03 (3H, s, Me),
3.87 (6 H, s, 2  x OMe), 5.06 (1H, br s, =CHAHB), 5.10 (1H, br s, =CHACHB), 6.58 
(2H, d, J  8.4, 3'- and 5'-H), 6.89 (1H, d, J  16.5, 3-H), 7.15 (1H, t, J  8.4, 4'-H), and
7.36 (1H, d, J  16.5, 4-H); 8C(50 MHz, CDCI3 ) 18.40 (CH3), 55.71 (CH3), 103.92 
(CH), 106.13 (C), 116.30 (CH2), 119.85 (CH), 127.95 (CH), 135.48 (CH), 143.67 
(C), and 158.47 (C); m/z (El) 204 (M+, 70%), 189 (20), 173 (100), 158 (90), 91 (32), 
77 (30), and 43 (23); (Found: M+, 204.1151. C i3 H i6 0 2  requires M, 204.1150).
1.3-Zh's[(trimethylylsiIyl)ethoxymethoxy]benzene 223
0 ' ^ 0 " ^ siM e3
^ o ^ o ^ / SlM83
Resorcinol 109 (0.300 g, 2.70 mmol) was suspended in dry CH2 CI2  (5.0 cm3) under 
nitrogen. Ethyldiisopropylam ine (3.80 cm 3, 21.60 mmol, 8  eq) and 
(trimethylsilyl)ethoxymethyl chloride (2.40 cm3, 13.50 mmol, 5 eq) were added and
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the solution stirred at RT overnight. The reaction was quenched with water and 
extracted into Et2 0  (3 x 20 cm3). The combined extracts were washed with dilute 
aqueous HC1 (1 mol dm-3, 20 cm3) and brine (2 x 20 cm3), then dried (MgSC>4 ) and 
concentrated in vacuo. Chromatography on silica (5:1 hexane/Et2 0 ) gave the acetal 
223 (0.820 g, 2.21 mmol, 81%) as a colourless oil; Rp [hexane-Et2 0  (5:1)] 0.75; 
Umax (film)/cm* 1 1607 (Ar), 1593 (Ar), 1490 (Ar), 1249 and 836 (Si-C); 8H(400 
MHz, CDC13) 0.04 (18H, s, 2 x SiMe3), 1.00 (4H, t, J 12, 2 x CH2 Si), 3.75 (4H, t, J
7.2, 2 x OCH2), 5.20 (4H, s, 2 x OCH2 0), 6.69 (2H, dd, J  2.3 and 8.2, 4- and 6 -H),
6.74 (1H, d, J  2.3, 2-H), and 7.17 (1H, t, J  8.2, 4-H); 5c(100 MHz, CDCI3 ) 0.00 
(CH3), 19.47 (CH2), 67.59 (CH2), 94.34 (CH2), 106.38 (CH), 110.86 (CH), 131.21 
(CH), and 159.97 (C); m/z (El) 370 (M+, 5%), 269 (20), 254 (100), 239 (70), 147 
(10), 103 (13), and 73 (75); (Found: M+, 370.1994. C i8 H 3 4 0 4 Si2  requires M, 
370.1996).
4-[2f,6,-£w(trimethyIylsiIyl)ethoxymethoxy]-2-methylbuta-l,3-diene 224
OSEM
QSEM
Acetal 223 (0.568 g, 1.54 mmol) was dissolved in dry THF (10 cm3) and cooled to 
-35 °C under nitrogen. n-Butyllithium (1.38 mol dm -3  in hexane, 1.70 cm3, 2.30 
mmol, 1.5 eq) was added over 15 min, then the solution stirred at -35 °C for 30 min.
3-Methylbut-2-enal 216 (0.25 cm3, 2.30 mmol, 1.5 eq) was added and the reaction 
was warmed to RT then heated at reflux for 4 h. After cooling to RT, the reaction 
was quenched with water and extracted into Et2 0  (3 x 20 cm3). The combined 
extracts were washed with water (10 cm3) and brine (2 x 10 cm3), dried (MgS04) 
and concentrated in vacuo to afford a pale brown oil. This oil was taken up in 
pyridine (1.50 cm3, 18.42 mmol, 12 eq) and cooled to 0 °C under nitrogen. 
Phosphorus oxychloride (0.17 cm3, 1.84 mmol, 1.2 eq) was added slowly and the 
yellow slurry stirred at RT overnight. Et2 0  (20 cm3) was added and this solution 
washed with dilute aqueous HC1 (1 mol dm-3, 10 cm3), water (10 cm3) and brine (2 x 
10 cm3), then dried (MgS04). Concentration in vacuo followd by chromatography on 
silica (5:1 hexane/Et2 0 ) gave the diene 224 (0.403 g, 0.92 mmol, 60%) as a dark 
yellow oil; /?f [hexane-Et2 0  (5:1)] 0.60; 'Omax (soln)/cm_1 1587 (Ar), 1477 (Ar), 
1246 and 850 (Si-C); 5H(400 MHz, CDCI3 ) 0.02 (18H, s, 2 x SiMe3), 0.90 (4H, t, J
7.2, 2 x CH2 Si), 1.97 (3H, s, Me), 3.60 (4H, t, J  7.2, 2 x OCH2), 5.01 (1H, br s, 
=CHaCHb), 5.03 (1H, br s, =CHACHfi), 5.23 (4H, s, 2 x OCH2 0), 6.77 (2H, d, /  8.2,
4- and 6 -H), 6.79 (1H, d, J  16.5, 3-H), 7.05 (1H, t, J  8.2, 4-H), and 7.26 (1H, d, J 
16.5, 4-H); 5C(100 MHz, CDCI3 ) 0.00 (CH3), 19.53 (CH2), 19.78 (CH3), 66.34 
(CH2), 94.76 (CH2), 110.04 (CH), 117.83 (CH2), 118.47 (C), 121.37 (CH), 129.24
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(CH), 137.36 (CH), 144.91 (C), and 157.63 (C); m/z (El) 436 (M+ 2%), 370 (10), 
269 (15), 254 (97), 239 (60), 147 (15), 103 (17), and 73 (100); (Found: M+, 
436.2465. C2 3 H4 o0 4 Si2  requires M, 436.2466).
Methyl 3,5-fo‘s(methoxymethoxy)benzoate 226
MOMO C 0 2Me
Methyl 3,5-dihydroxybenzoate 225 (8.414 g, 50.08 mmol) and ethyl 
diisopropylamine (21.5 cm3, 0.123 mol, 2.46 eq) were dissolved in dry CH2 CI2  (60 
cm3) and cooled to 0 °C. Chloromethyl methyl ether (8.20 cm3, 0.108 mol, 2.16 eq) 
was added dropwise, then the reaction stirred for 1 hour at RT under nitrogen. The 
reaction was then poured into saturated sodium bicarbonate, and extracted into 
CH2 CI2  (3 x 100 cm3). The organic extract was washed with saturated brine (2 x 50 
cm3), dried (K2 CO 3 ), then poured through a short silica column eluting with 
dichloromethane. Concentration gave the ester 226 (7.950 g, 31.05 mmol, 62%) as a 
colourless oil; Rp(CH2 Cl2 ) 0.42; Dmax(film)/cm-1: 1724 (ester C=0), 1597 (Ar), and 
1545 (Ar); SH(200 MHz, CDCI3 ): 3.47 (6 H, s, 2 x OMe), 3.89 (3H, s, C 0 2 Me), 5.19 
(4H, s, 2 x OCH2 0), 6.92 (1H, t, J  2.3, 4-H), and 7.36 (2H, d, J  2.3, 2-H and 6 -H). 
8C(50 MHz, CDCI3 ): 52.06 (CH3), 55.94 (CH3), 94.22 (CH2), 109.41 (CH), 110.37 
(CH), 131.99 (C), 157.99 (C), and 166.34 (C); m/z (El) 256 (M+, 100%), and 225 
(30); (Found: M+, 256.0946. C 1 2H 1 6O6  requires M, 256.0946).
3,5-ft«(methoxymethoxy)benzoic acid 227
Ester 226 (7.950 g, 31.05 mmol) was dissolved in ethanol (70 cm3) and to this was 
added aqueous KOH (4 mol dm-3, 46.5 cm3). The reaction was left to stir at RT 
overnight. The reaction was diluted with water (100 cm3) and carefully acidified to 
pH 3 with dilute HC1 (1 mol dm-3). The white precipitate was filtered and dried 
under suction. Recrystallisation from ethanol/water gave the acid 227 (8.525 g, 35.23 
mmol, 70%) as needles, m.p. 106-108°C; Rp[hexane-Et2 0  (1:1)] 0.19; u max 
(KBr)/cm-1: 3422 (OH), 1697 (C=0), 1655 (Ar), 1637 (Ar), and 1596 (Ar); 8H(400 
MHz, CDCI3 ) 3.50 (6 H, s, 2 x OMe), 5.21 (4H, s, 2 x OCH2 0), 6.98 (1H, t, J  2.3, 4- 
H), and 7.44 (2H, d, J  2.3, 2-H and 6 -H). 8C(100 MHz, CDCI3 ) 56.98 (CH3), 94.88 
(CH2), 110.89 (CH), 111.65 (CH), 131.67 (C), 158.57 (C), and 171.78 (C); m/z (El) 
242 (M+, 100%), and 212 (10); (Found: C, 54.3; H 5.7%; M+, 242.0793. C n H i4 0 6  
requires C, 54.5; H, 5.8%; M, 242.0791).
MOMO
MOMO,
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6-Acetoxy-2-[3,,5'-fo‘s(methoxymethoxy)phenyl]benzo[£]furan 228
OMOM
AdD
OMOM
Dicyclohexylcarbodiimide (1.130 g, 5.49 mmol, 1.26 eq) in dry CH2 CI2  (10 cm3) 
was added to a solution of phosphonium salt 211 (2.959 g, 5.84 mmol, 1.34 eq), 4- 
dimethylaminopyridine (0.085 g, 0.697 mmol, 0.16 eq), and acid 227 (1.054 g, 4.36 
mmol, 1 eq) in dry CH2 CI2  (50 cm3) under nitrogen, and the mixture was stirred 
overnight. The solution was concentrated in vacuo and the residue dissolved in dry 
toluene (50 cm3). Triethylamine (3.40 cm3, 24.61 mmol, 5.65 eq) was added and the 
mixture heated under reflux under nitrogen overnight. After cooling, the solution 
was filtered and the solvent removed in vacuo. Rash column chromatography of the 
residue followed by recrystallisation from hexane/chloroform gave benzofuran 228 
(1.278 g, 3.44 mmol, 79%) as needles, m.p. 50-52°C; RF[hexane-CH2 Cl2  (1:1)] 
0.15; t)max (film)/cm_1 1761 (C=0), 1613 (Ar), 1594 (Ar), and 1568 (Ar); 6H(400 
MHz, CDCI3 ) 2.28 (3H, s, OAc), 3.48 (6 H, s, 2 x OMe), 5.19 (4H, s, 2 x OCH2 0), 
6.73 (1H, t, J  2.1, 4'-H), 6.93-6.98 (2H, m, 5-H and 7-H), 7.17 (2H, d, J  2.1, 2'-H and 
6 '-H), 7.28 (1H, s, 3-H), and 7.47 (1H, d, J  8.4, 4-H); 6C(100 MHz, CDCI3 ) 21.43 
(CH3), 56.48 (CH3), 94.87 (CH2), 102.19 (CH), 105.54 (CH), 105.63 (CH), 106.60 
(CH), 117.59 (CH), 121.30 (CH), 127.33 (C), 132.48 (C), 148.46 (C), 155.01 (C),
156.81 (C), 158.72 (C), and 170.05 (C); m/z (El) 372 (M+, 100%), 330 (90), and 225 
(15); (Found: C, 64.1; H 5.4%; M+, 372.1210. C2 0 H2 0 O7  requires C, 64.5; H, 5.4%; 
M, 372.1209).
6-Hydroxy-2-[3,,5'-Ws(methoxymethoxy)phenyl]benzo[£]furan 229
OMOM
OMOM
Benzofuran 228 (0.703 g, 1.89 mmol) and potassium hydroxide (0.254 g, 4.54 mmol,
2.4 eq) were dissolved in ethanolrwater (5:1, 10 cm3) and heated under reflux for 1 h. 
After cooling, the solution was diluted with water, then carefully acidified to pH 3 
with aqueous HC1 (1 mol dm-3), and then extracted into CH2 CI2  (2 x 50 cm3). The 
organic solution was washed with brine (2 x 50 cm3), then dried over Na2 SC>4 . The 
solvent was removed in vacuo and the residue filtered through a short silica plug 
(eluting with CH2 CI2 ). Recrystallisation from hexane-diethyl ether gave the 
benzofuran 229 (0.370 g, 1.12 mmol, 60%) as pale yellow needles; m.p. 94-96°C; 
/?f(CH2 C12) 0.16; Dmax (film)/cm_1 3398 (OH), 1614 (Ar), 1600 (Ar), and 1577 (Ar); 
5h (400 MHz, CDCI3 ) 3.48 (6 H, s, 2 x OMe), 5.25 (4H, s, 2 x OCH2 0), 6.40 (1H, br
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s, OH), 6.70 (1H, t, J  2.2, 4'-H), 6.79 (1H, dd, /  2.2 and 8.4, 5-H), 6.92 (1H, s, 3-H),
7.01 (1H, d, /  1.8, 7-H), 7.15 (2H, d, J  2.2, 2’-H), and 7.36 (1H, d, J  8.4, 4-H); 
5C(100 MHz, CDC13) 55.14 (CH3), 93.45 (CH2), 97.26 (CH), 100.92 (CH), 103.81 
(CH), 104.92 (CH), 111.12 (CH), 120.20 (CH), 121.59 (C), 131.57 (C), 152.89 (C),
153.60 (C), 154.72 (C), and 157.50 (C); m/z (El) 330 (M+, 100%), and 226 (10); 
(Found: C, 65.3; H 5.4%; M+, 330.1102. Ci8His06 requires C, 65.4; H, 5.4% ; M, 
330.1104).
6-(terf-Buty ldimethy lsily loxy )-2-[3' ,5' -bis (methoxy methoxy )pheny 1] 
benzo[&]furan 230
OMOM 
OMOM
A solution of benzofuran 229 (0.730 g, 2.21 mmol), imidazole (0.376 g, 5.53 mmol,
2.5 eq), and terf.-butyldimethylsilylchloride (0.832 g, 5.53 mmol, 2.5 eq) in dry DMF 
(40 cm3) was stirred under nitrogen at 60 °C for 24 h. The mixture was poured into 
water and extracted into Et20  (3 x 50 cm3), then the organic extract washed with 
brine (3 x 50 cm3), dried (MgSCU), and the solvent removed in vacuo. The residue 
was filtered through a short silica column (eluting with CH2 C12) to leave the 
benzofuran 230 (0.974 g, 2.19 mmol, 98%) as a colourless oil; 7?f(CH2C12) 0.56; 
Dmax (film)/cm ' 1 1613 (Ar), 1569 (Ar), and 1153 (Si-C); Sh(400 MHz, CDCI3 ) 0.14 
(6 H, s, SiMe2), 0.92 (9H, s, Me3 C), 3.40 (6 H, s, 2 x OMe), 5.13 (4H, s, 2 x OCH2 0), 
6.61 (1H, t, J  2.2, 4'-H), 6 . 6 8  (1H, dd, J  2.1 and 8.4, 5-H), 6.83 (1H, s, 3-H), 6.91 
(1H, d, J  1.7, 7-H), 7.07 (2H, d, /  2.2, 2'-H and 6 '-H), and 7.27 (1H, d, J  8.4, 4-H). 
5C(100 MHz, CDCI3 ) -4.03 (CH3), 18.66 (C), 26.12 (CH3), 56.46 (CH3), 94.88 
(CH2), 102.32 (CH), 103.26 (CH), 105.19 (CH), 106.30 (CH), 117.19 (CH), 121.22 
(CH), 123.52 (C), 133.00 (C), 154.14 (C), 155.26 (C), 156.08 (C), and 159.02 (C); 
m/z (Cl) 445 [100%, (M+H)+], and 444 (25%, M+); [Found: (M+H)+ 445.2042. 
Found: M+ 444.1955. C2 4 H3 3 0 6 Si requires M+H, 445.2046: C2 4 H3 3 0 6 Si requires 
A/, 444.1968).
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6-(te7tf-Butyldimethylsilyloxy)-2-[4,-deutero-3,,5,-fos(methoxymethoxy)phenyl]
benzo[Z>]furan 231
OMOM 
D
OMOM
Benzofuran 230 (0.203 g, 0.458 mmol) was dissolved in dry THF (10 cm3) and 
cooled to -78°C. n-Butyllithium (1.415 mol dm -3  in hexane, 0.50 cm3, 6 . 8 6  mmol,
1.5 eq) was added over 1 h. The reaction was then stirred at -30 °C for 1 h under 
nitrogen, then allowed to warm to RT before being quenched with D 2 O (20 cm3) and 
extracted into Et2 0  (2 x 50 cm3). The organic extract was washed with brine (2 x 50 
cm3), dried (Na2 SC>4 ) and concentrated in vacuo. The crude product was purified on 
alumina (deactivated with 6 % water) to give the benzofuran 231 (0.125 g, 0.282 
mmol, 82%) as a yellow oil; RF[CH2 Cl2-hexane (1:2)] 0.76; \)max (KBr)/cm-1 1620 
(Ar), 1606 (Ar), and 1564 (Ar); 5H(400 MHz, CDCI3 ) 0.14 (6 H, s, SiMe2), 0.92 (9H, 
s, Me3 C), 3.39 (6 H, s, 2 x OMe), 5.11 (4H, s, 2 x OCH2 0), 6.67 (1H, dd, J  2.1 and
8.4, 5-H), 6.77 (1H, s, 3-H), 6.91 (2H, s, 2'-H and 6 '-H), 7.07 (1H, d, J  2.2, 7-H), and
7.26 (1H, d, J  8.4, 4-H); 5C(100 MHz, CDCI3 ) -4.02 (CH3), 18.65 (C), 26.12 (CH3), 
56.51 (CH3), 94.91 (CH2), 102.28 (CH), 103.26 (CH), 105.03 (C-D, t, J  13.6),
106.32 (CH), 117.17 (CH), 121.18 (CH), 123.99 (C), 132.99 (C), 154.12 (C), 155.23 
(C), 156.06 (C), and 158.98 (C); m/z (El) 445 (M+, 100%), and 388 (40); (Found M+, 
445.2030. C2 4 H3 iD0 6Si requires M, 445.2031).
E-6-(terf-ButyldimethylsHyloxy)-2-[3,,5,-ftis(methoxymethoxy)-4,-(3M- 
methylbuta-l", 3"-dienyI)phenyI]benzo[ft]furan 232
OMOM
TBSO'
OMOM
Benzofuran 230 (0.210 g, 0.473 mmol) was dissolved in dry THF (20 cm3) and 
cooled to -78 °C. n-Butyllithiun (1.415 mol dm -3  in hexane, 0.50 cm3, 0.71 mmol,
1.5 eq) was added over 1 h. The reaction was then stirred under nitrogen for 1 h at 
-30 °C. A, AP-Dimethylpropyleneurea (0.12 cm3, 0.946 mmol, 2 eq) was added, 
followed by 3-methylbutenal (0.070 cm3, 0.71 mmol, 1.5 eq), and the reaction heated 
to reflux for 4 h. The reaction was cooled, poured into water, and extracted into Et20  
(3 x 50 cm3). The organic extract was washed with brine (2 x 50 cm3), dried 
(Na2 SC>4 ) and concentrated in vacuo to leave a yellow oil. This oil was dissolved in 
dry CH2 C12  (2 cm3) and dry pyridine (0.50 cm3, 5.68 mmol, 12 eq) and cooled to 0 
°C. Phosphorus oxychloride (0.050 cm3, 0.568 mmol, 1.2 eq) was added slowly, and 
the reaction stirred overnight under nitrogen. The solution was poured into saturated
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sodium bicarbonate and extracted into Et2 0  (3 x 50 cm3). The organic extract was 
washed with brine (2 x 50 cm3), dried (Na2 SC>4 ) and concentrated in vacuo. 
Chromatography of the residue on alumina (deactivated with 6 % water) gave the 
pure product which was recrystallised from propan-2-ol to give the diene 232 (0.145 
g, 0.284 mmol, 60%) as yellow plates; m.p. 86-89°C; i?F[hexane-CH2 Cl2  (1:1)]
0.69; umax (KBr)/cm_1 1618 (Ar), 1601 (Ar), and 1559 (Ar); 6H(400 MHz, CDC13)
0.26 (6 H, s, SiMe2), 1.01 (9H, s, Me3 C), 2.02 (3H, s, Me), 3.50 (6 H, s, 2 x OMe),
5.07 (1H, s, =CH), 5.10 (1H, s, =CH), 5.31 (4H, s, 2 x OCH2 0), 6.76 (1H, dd, J  2.1 
and 8.4, 5-H), 6.87 (1H, d, J  16.5, 2"-H), 6.92 (1H, s, 3-H), 7.01 (1H, d, J  1.7, 7-H), 
7.25 (2H, s, 2'-H), 7.37 (1H, d, J  8.4, 4-H), and 7.38 (1H, d, J  16.5, 1"-H); 6C(100 
MHz, CDCI3 ) -4.00 (CH3), 18.67 (C), 18.76 (CH3), 26.13 (CH3), 56.76 (CH3), 95.40 
(CH2), 102.31 (CH), 103.28 (CH), 105.23 (CH), 117.22 (CH), 117.38 (CH2), 120.07
(CH), 121.13 (CH), 123.65 (C), 130.55 (C), 136.69 (CH), 143.98 (C), 154.13 (C),
155.24 (C), 156.12 (C), 156.71 (C), and 159.03 (C); m/z (Cl) 511 [(M+H)+, 100%], 
510 (M+, 40%), and 445 (20) (Found M+, 510.2348. C29H360 6Si requires M, 
510.2348).
6-Acetoxy-2-(2'-formyl-3', 5'-dimethoxyphenyl)benzo[fc]furan 297
OHC Me
AcO'
Me
Phosphorus oxychloride (0.11 cm3, 1.16 mmol, 1.2 eq) was added dropwise to a 
flask containing dry DMF (0.20 cm3, 2.51 mmol, 2.6 eq) at 0 °C. After stirring at RT 
for 15 min, the resulting complex was slowly added to a solution of 6-acetoxy-2-(3\ 
5’-dimethoxyphenyl)benzofuran 212 (0.301 g, 0.965 mmol) in dry DMF (0.70 cm3) 
at 100 °C under nitrogen. Stirring was maintained at 100 °C and the reaction 
monitored by TLC. After 1 h, the reaction was cooled to RT, then quenched by 
pouring into water made slightly alkaline with aqueous NaHC03. This solution was 
extracted into EtOAc (3 x 50 cm3), and the combined extracts washed successively 
with aqueous HC1 (1 mol dm-3, 50 cm3), water (50 cm3) and brine (3 x 50 cm3). The 
extract was then dried (Na2 SC>4 ) and concentrated in vacuo. Chromatography on 
silica (5% EtOAc in DCM) followed by recrystallisation from hexane-chloroform 
gave aldehyde 297 (0.183 g, 0.54 mmol, 56%) as pale yellow plates: m.p. 104-106 
°C; RF (5% EtOAc in DCM) 0.36; u max (K B ^/cnr1 1763 (ester C=0), 1686 
(aldehyde C=0), 1597 (Ar), 1568 (Ar), and 1482 (Ar); 6H(400 MHz, CDCI3 ) 2.34 
(3H, s, OAc), 3.92 (3H, s, OMe), 3.93 (3H, s, OMe), 6.54 (1H, d, J  2.2, 4’-H), 6 . 8 6  
(1H, d, J  2.2, 6 ’-H), 6.95 (1H, s, 3-H), 6.99 (1H, dd, J  2.0 and 8.4, 5-H), 7.30 (1H, d, 
J  1.3, 7-H), 7.57 (1H, d, J  8.4, 4-H), and 10.24 (1H, s, CHO); 5C(100 MHz, CDCI3 )
21.60 (CH3), 56.17 (CH3), 56.74 (CH3), 99.54 (CH), 105.66 (CH), 106.85 (CH),
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108.58 (CH), 117.82 (CH), 121.80 (CH), 126.88 (C), 135.87 (C), 148.81 (C), 154.23 
(C), 155.28 (C), 161.18 (C), 162.90 (C), 164.47 (C), 170.11 (C), and 189.67 (CH); 
m/z (El) 340 (M+ 50%), 298 (100), 254 (45) and 228 (15); (Found M+, 340.0950. 
C 1 9H 1 6O6  requires M, 340.0947).
Attempted synthesis of 6-tert-Butyldimethylsilyloxy-2-(4'-formyl-3’,5'- 
dimethoxyphenyl)-benzo[£]furan 298
1. Using DMF
A solution of 6-terf-butyldimethylsilyloxy-2-(3', 5'-dimethoxyphenyl)-benzofuran 
213 (0.235 g, 0.61 mmol) in dry THF (5 cm3) under nitrogen was cooled to -78 °C. 
Over 1 h, w-BuLi (1.6M in hexane, 0.60 cm3, 0.92 mmol, 1.5 eq) was added, then the 
reaction warmed to -30 °C and stirred for a further 1 h. Dry DMF (0.10 cm3, 1.22 
mmol, 2 eq) was then added, and the reaction heated to reflux for 4 h. After cooling 
to RT, the reaction was quenched by addition of water, and this aqueous solution 
extracted with Et2 0  (3 x 30 cm3). The combined extracts were washed with brine (3 
x 50 cm3), dried (MgSC>4 ) and concentrated in vacuo to leave a pale brown oil. *H 
NMR and TLC (1:1 hexane:Et2 0 ) of this oil showed the presence of only starting 
material and desilylated material.
2. Using a boronate ester aldehyde equivalent
A solution of 6-te/Y-butyldimethylsilyloxy-2-(3', 5'-dimethoxyphenyl)-benzofuran 
213 (0.153 g, 0.40 mmol) in dry THF (3 cm3) under nitrogen was cooled to -35 °C. 
Over 15 min, n-butyllithium (1.44 mol dm-3  in hexane, 0.33 cm3, 0.48 mmol, 1.2 eq) 
was added, then the reaction stirred for a further 1 h. In a separate flask, a solution of 
dibromomethaneboronic acid propan-1,3-diol ester 299109 (0.100 g, 0.40 mmol, 1 
eq) in dry THF (2 cm3) was cooled to -35 °C. The aryllithium solution was then 
added dropwise to the boronate solution via canula, and allowed to warm slowly to 
RT. The reaction was the stirred at RT overnight. The reaction was quenched by 
addition of pH 9.2 phosphate buffer (0.20 cm3) followed by dropwise addition of 
30% H2 O2  solution (0.10 cm3). This was stirred for 15 min before being diluted with 
water. Extraction (Et2 0 ), washing (brine) and concentration as before gave a pale 
brown oil, *H NMR which showed only starting material and desilylated material.
3. Using paraformaldehyde
A solution of 6-terr-butyldimethylsilyloxy-2-(3', 5'-dimethoxyphenyl)-benzofuran 
213 (0.179 g, 0.46 mmol) in dry THF (4 cm3) under nitrogen was cooled to -35 °C. 
Over 15 min, /i-butyllithium (1.44 mol dm-3  in hexane, 0.36 cm3, 0.51 mmol, 1.1 eq) 
was added, then the reaction stirred for a further 1 h at -30 °C. Paraformaldehyde 
(0.03 g, 0.93 mmol, 2 eq) in THF (1 cm3) was then added, and the reaction heated to
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reflux for 4 h. After cooling to RT, the reaction was quenched by addition of water, 
and the reaction worked up as before to give colourless oil which proved to be 
starting material.
6-terf-ButyldiphenylsiIyloxy-2-(3,,5,-dimethoxyphenyI)-benzo[ft]furan 300
Me
TBDPSO'
Me
A solution of 6-hydroxy-2-(3',5'-dimethoxyphenyl)-benzofuran 202 (0.367 g, 1.36 
mmol), imidazole (0.231 g, 3.40 mmol, 2.5 eq) and terf-butyldiphenylsilylchloride 
(0.411 g, 1.49 mmol, 1.1 eq) in dry DMF (1 cm3) was heated at 50 °C under nitrogen 
for 16 h. After cooling, the reaction was quenched by addition of saturated aqueous 
sodium bicarbonate (50 cm3). This aqueous solution was extracted with CHCI3  (3 x 
30 cm3), and the combined extracts washed well with brine (3 x 50 cm3), then dried 
(K2 CO3 ) and concentrated in vacuo to leave a pale brown oil which solidified on 
standing. Recrystallisation from methanol gave benzofuran 300 (0.329 g, 0.648 
mmol, 48%) as plates: m.p. 116-118 °C; Rp [hexane-Et2 0  (2:1)] 0.51; T>max 
(KBr)/cm_1 1619 (Ar), 1598 (Ar), 1571 (Ar), 1257 and 885 (Si-C), and 1150 (Si-O); 
5h (400 MHz, CDCI3 ) 1.12 (9H, s, tert-Bu), 3.86 (6 H, s, 2 x OMe), 6.41 (1H, t, J
2.2, 4'-H), 6.76 (1H, dd, J  2.2 and 8.4, 5-H), 6.87 (1H, s, 3-H), 6.90 (2H, d, J  2.2, 2' 
and 5'-H), 7.26-7.28 (2H, m, 4-H and 7-H), 7.36-7.46 (6 H, m, 6  x Ph-H), and 7.75-
7.77 (4H, m, 4 x Ph-H); 6C(100 MHz, CDCI3 ) 19.47 (C), 26.47 (CH3), 55.43 (CH3), 
100.56 (CH), 101.62 (CH), 102.41 (CH), 116.35 (CH), 120.59 (CH), 122.83 (C),
127.80 (CH), 129.91 (CH), 132.34 (C), 132.74 (C), 134.77 (CH), 135.51 (CH), 
153.59 (C), 154,94 (C), 155.32 (C), and 160.94 (C); m/z (Cl) 509 [(M+H)+ 100%], 
508 (M+, 30), and 431 (15); (Found: C, 75.5; H, 6.4%; M+, 508.2063. C32H3204Si 
requires C, 75.51; H, 6.34% ; M, 508.2070).
Methyl 4-[(6' -fe/7-butyldiphenyIsilyloxybenzofuranyl)-2,6-dimethoxybenzoate
301
Me
TBDPSO'
Me
A solution of 300 (0.661 g, 1.30 mmol) in dry THF (30 cm3) was cooled to -30 °C 
under nitrogen, and to this was added «-butyllithium (1.86 mol dm-3  in hexane, 0.84 
cm3, 1.56 mmol, 1.2 eq) over 15 min. After stirring at -30 °C for 15 min, methyl 
chloroformate (0 . 2 0  cm3, 2.60 mmol, 2  eq) was added slowly and the resulting green 
solution stirred at RT for 2 h. The reaction was poured into saturated brine and
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extracted with Et2 0  (3 x 50 cm3), and the combined organic extract washed with 
water and brine (2 x 50 cm3 each), dried (Na2 SC>4 ) and concentrated in vacuo. 
Chromatography on silica [hexane-Et2 0  (1:2)] gave the ester 301 (0.550 g, 0.97 
mmol, 75%) as a solid foam: m.p. 60-62 °C; R$ [hexane-Et2 0  (1:2)] 0.44; Dmax 
(KBr)/cm_1 1736 (ester C=0), 1609 (Ar), 1567 (Ar), 1488 (Ar), 1269 and 884 (Si- 
C), and 1155 (Si-O); 5H(400 MHz, CDC13) 1.12 (9H, s, f-Bu), 3.84 (6 H, s, 2 x 
OMe), 3.90 (3H, s, C 0 2 Me), 6.80 (1H, dd, /  2.0 and 8.4, 5'-H), 6.89-6.91 (4H, m, 
3/5-H, 3'-H, and 7'-H), 7.28 (1H, d, J  8.4, 4'-H), 7.35-7.45 (6 H, m, 6  x Ph-H), and 
7.75-7.77 (4H, m, 4 x Ph-H); 8C(100 MHz, CDCI3 ) 19.91 (C), 26.91 (CH3), 52.91 
(CH3), 56.52 (CH3), 100.53 (CH), 102.90 (CH), 102.97 (CH), 112.80 (C), 117.10
(CH), 121.30 (CH), 123.15 (C), 128.28 (CH), 130.41 (CH), 133.14 (C), 133.79 (C),
135.95 (CH), 154.39 (C), 154.73 (C), 155.89 (C), 158.01 (C), and 167.19 (C); m/z
(CI) 567 [(M+H)+ 100%], 566 (M+, 20), and 489 (10); [Found: C, 72.2; H, 6.18%; 
(M+H)+, 567.2201. C3 4 H3 4 0 6 Si requires: C, 72.06; H, 6.05%; (M+H)+, 567.2203].
6-terf-ButyIdiphenyIsilyloxy-2-(4,-formy!-3f,5,-dimethoxyphenyl)-benzo[£]furan
302
iMe
CHO
TBDPSO-
OMe
1. By LiAIH4  reduction / Dess-Martin oxidation
A solution of benzofuran 301 (0.096 g, 0.17 mmol) in dry Et2 0  (0.50 cm3) was 
added to a suspension of lithium aluminium hydride powder (0.009 g, 0.24 mmol,
1.4 eq) in dry Et2 0  (0.50 cm3) at 0 °C under nitrogen. The reaction was heated at 
reflux for 4 h then quenched by the addition of water (1.0 cm3) and dilute aqueous 
HC1 (-0.5 mol dm-3, 1 cm3). The aqueous slurry was extracted into Et2 0  (2 x 20 
cm3), the combined organic extracts washed with brine ( 2  x 2 0  cm3), dried 
(Na2 S0 4) and concentrated in vacuo to give the crude alcohol as a colourless oil 
(0.087 g, 0.16 mmol, 95%). This oil was dissolved in dry CH2 CI2  (0.60 cm3) and 
added to a solution of Dess-Martin periodinane111 (0.076 g, 0.18 mmol, 1.1 eq) in 
dry CH2 CI2  (0.73 cm3) under nitrogen. The mixture was stirred at RT for 30 min 
then diluted with Et2 0  (2 . 0  cm3), poured into saturated aqueous Na2 S2 0 4  solution 
(5.0 cm3), and stirred for 10 min. This solution was then extracted with Et2 0  (2 x 30 
cm3). The combined organic extracts were washed with brine (3 x 30 cm3), dried 
(Na2 S0 4) and concentrated in vacuo to give a brown oil. Chromatography on silica 
(2:1 hexane-EtOAc) gave aldehyde 302 (0.038 g, 0.07 mmol, 42%) as a pale brown 
foam: m.p. 55-57 °C; /?f [hexane-EtOAc (2:1)] 0.27; umax (KBrVcnr1 1684 
(aldehyde C=0), 1604 (Ar), 1556 (Ar), 1487 (Ar), 1279 and 883 (Si-C), and 1156
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(Si-0); 8h (400 MHz, CDCI3 ) 1.13 (9H, s, f-Bu), 3.89 (6 H, s, 2 x OMe), 6.83 (1H, 
dd, J  2.0 and 8.4, 5-H), 6 . 8 6  (2H, s, 2'-and 6 '-H), 6.91 (1H, d, J  2.0, 7-H), 7.00 (1H, 
s, 3-H), 7.31 (1H, d, J  8.4, 4-H), 7.36-7.46 (6 H, m, 6  x Ph-H), 7.76-7.'78 (4H, m, 4 x 
Ph-H), and 10.46 (1H, s, CHO); 8C(100 MHz, CDCI3 ) 19.44 (C), 26.41 (CH3),
56.07 (CH3), 99.51 (CH), 102.45 (CH), 104.35 (CH), 113.28 (C), 117.00 (CH),
121.26 (CH), 122.48 (C), 127.85 (CH), 130.00 (CH), 132.51 (C), 135.48 (CH),
137.24 (C), 153.58 (C), 154.48 (C), 155.72 (C), 162.41 (C), and 186.69 (CH); m/z 
(El) 536 (M+, 45%), 479 (100), 451 (20), 149 (43), and 69 (43); (Found M+, 
536.2019. C3 3 H3 2 0 5Si requires: M, 536.2020).
2. By UAIH4  reduction / PDC oxidation
A solution of benzofuran 301 (0.230 g, 0.41 mmol) in dry Et2 0  (2.50 cm3) was 
added to a suspension of lithium aluminium hydride powder (0.022 g, 0.57 mmol,
1.4 eq) in dry Et2 0  (2.50 cm3) at 0 °C under nitrogen. The reaction was heated at 
reflux for 4 h then quenched by the addition of water (1.0 cm3) and dilute aqueous 
HC1 (-0.5 mol dm-3, 1 cm3). The aqueous slurry was extracted into Et2 0  (2 x 20 
cm3), the combined organic extracts washed with brine ( 2  x 2 0  cm3), dried 
(Na2 SC>4 ) and concentrated in vacuo to give the crude alcohol as a colourless oil 
(0.196 g, 0.36 mmol, 89%). A mixture of pyridine (0.35 cm3 , 4.37 mmol, 12 eq) and 
chromium trioxide (0.219 g, 2.19 mmol, 6  eq) were dissolved in dry CH2 CI2  (5.0 
cm3) under nitrogen, stirred at 0 °C for 5 min then allowed to warm to RT. A 
solution of the crude alcohol and Celite® in dry CH2 CI2  (1.0 cm3) was added slowly 
and the resulting dark orange solution stirred at RT for 3 h. The reaction was 
quenched by the addition of dilute aqueous HC1 (-0.5 mol dm-3, 10 cm3), and the 
mixture was then extracted with Et2 0  (3 x 50 cm3). The combined extracts were 
washed well with brine (3 x 50 cm3), dried (MgSC>4 ) and concentrated in vacuo to 
give a brown oil. Chromatography on silica (2:1 hexane:EtOAc) gave aldehyde 302 
(0.090 g, 0.17 mmol, 41%) as a pale brown foam. All data were identical to those 
reported above.
6-terf-ButyldiphenyIsilyIoxy-2-(3,-hydroxy-4,-formyl-5,-methoxyphenyl)- 
benzo[£]furan 303
OH
CHO
TBDPSO'
OMe
Aldehyde 302 (0.147 g, 0.27 mmol) was dissolved in dry CH2 CI2  (3.0 cm3) and 
cooled to -78 °C under nitrogen. Boron tribromide (1.10 cm3, 1 mol dm -3  in 
CH2 CI2 , 1.10 mmol, 4 eq) was added slowly and the reaction warmed to RT. After 1
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h, the reaction was quenched by addition of cold water, the extracted into EtOAc (2 
x 20 cm3). The combined organic extracts were washed with saturated aqueous 
sodium bicarbonate ( 1 0  cm3) and brine ( 2  x 2 0  cm3), dried (MgS0 4 ) and 
concentrated in vacuo to give aldehyde 303 (0.131 g, 0.25 mmol, 93%) as a pale 
brown oil; Rp [EtOAc-hexane (2:1)] 0.85; Umax (film)/cm_1 3384 (OH), 1638 
(aldehyde C=0), 1619 (Ar), 1487 (Ar), 1281 and 884 (Si-C), and 1156 (Si-O); 
5h (400 MHz, CDC13) 1.13 (9H, s, f-Bu), 3.88 (3H, s, OMe), 6.71 (1H, d, J  1.2, 2'- 
H), 6.89 (1H, dd, /  2.0 and 8.5, 5-H), 6.84 (1H, d, /  1.2, 6 '-H), 6.89 (1H, br s, 7-H), 
6.97 (1H, s, 3-H), 7.28 (1H, d, J  8.5, 4-H), 7.36-7.44 (6 H, m, 6  x Ph-H), 7.75-7.77 
(4H, m, 4 x Ph-H), 10.22 (1H, s, CHO), and 12.05 (1H, s, OH); 8C(100 MHz, 
CDCI3 ) 14.17 (C), 26.48 (CH3), 55.88 (CH3), 96.93 (CH), 102.48 (CH), 105.10 
(CH), 105.13 (CH), 110.13 (C), 117.09 (CH), 121.38 (CH), 122.48 (C), 127.86 
(CH), 130.02 (CH), 132.60 (C), 135.51 (CH), 139.44 (C), 153.41 (C), 154.69 (C),
155.90 (C), 162.64 (C), 163.72 (C), and 193.25 (CH); m/z (El) 522 (M+, 40%), 465 
(100), and 387 (10); (Found M+, 522.1861. C3 2 H3 o0 5Si requires: M, 522.1863).
D e m e t h y l a t i o n  o f  6 -teit-butyldiphenylsilyIoxy-2-(4'-formyl-3f,5'- 
dimethoxyphenyl)-benzo[Z>]furan 302
Aldehyde 302 (0.236 g, 0.44 mmol) was dissolved in dry CS2  (7.0 cm3) under 
nitrogen. A solution of AlBr3  (0.353 g, 1.32 mmol, 3 eq) in CH2 Br2 /CS2  (1:1, 6.0 
cm3) was added slowly and the viscous red slurry stirred at RT overnight. The 
reaction was quenched with dilute aqueous HC1 (3 mol dm-3, 20 cm3) and Et2 0  (20 
cm3) and stirred at RT for 10 min. The two layers were separated and the aqueous 
solution further extracted into Et2 0  (3 x 20 cm3). The combined organics were 
washed with brine and water (2 x 20 cm3 each), dried (MgSC>4 ) and concentrated in 
vacuo. Chromatography on silica (1:1 EtOAc/hexane) gave two products, 6-(phenyl- 
^/t-butylhydroxy)silyloxy-2-(4f-formyl-3',5'-dihydroxyphenyl)benzo[^]furan 
304 (0.075 g, 0.17 mmol, 38%), and 6-(te/f-butyIdihydroxy)silyloxy-2-(4'-formyl- 
3’,5'-dihydroxyphenyl)benzo[^]furan 305 (0.097 g, 0.25 mmol, 57%);
6-(phenyl-te/t-butylhydroxy)silyloxy-2-(4'-formyl-3,,5,-dihydroxyphenyl) 
benzo[£]furan 304
CHO
f-Bu(HO)PhSiO‘
OH
Yellow plates (EtOAc); m.p. 198-200 °C; Rp [hexane-EtOAc (1:1)] 0.70; u max 
(KBr)/cm-! 3247 (OH), 1627 (C=0), 1617 (Ar), 1474 (Ar), 1275 and 825 (Si-C), and 
1112 (Si-O); 8h (400 MHz, d6 -acetone) 0.92 (9H, s, f-Bu), 6.35 (1H, br s, OH), 6.74
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(2H, s, 2V6'-H), 6.87 (1H, dd, J  2.0 and 8.4, 5-H), 7.03 (1H, s, 7-H), 7.16 (1H, s, 3- 
H), 7.19-7.30 (3H, m, 3 x Ph-H), 7.32 (1H, d, /  8.4, 4-H), 7.57-7.63 (2H, m, 2 x Ph- 
H), 10.17 (1H, s, CHO), and 10.72 (2H, br s, 2 x OH); 6C(100 MHz, d6 -acetone)
19.61 (C), 26.57 (CH3), 103.64 (CH), 103.73 (CH), 106.65 (CH), 111.06 (C), 118.45 
(CH), 122.95 (CH), 124.10 (C), 128.95 (CH), 131.37 (CH), 134.07 (C), 136.34 (CH), 
140.68 (C), 154.68 (C), 155.65 (C), 157.17 (C), 163.83 (C), and 194.55 (CH); m/z 
(El) 448 (M+, 80%), 391 (100), 270 (30), 195 (10), and 139 (10); (Found: M+, 
448.1348. C2 5 H2 4 0 6Si requires M, 448.1341).
6-(^/t-Butyldihydroxy)silyloxy-2-(4'-formyl-3',5'-dihydroxyphenyl) 
benzo[£]furan 305
OH
X X V - O - ^
f-Bu(HO)2SOy* ^  ^ — \
OH
Yellow plates (EtOAc); m.p. 210-212 °C; R? [hexane-EtOAc (1:1)] 0.33; i)max 
(KBr)/cm_1 3323 (OH), 1642 (C=0), 1620 (Ar), 1489(Ar), 1279 and 823 (Si-C), and 
1115 (Si-O); 5h (400 MHz, d6-acetone) 0.94 (9H, s, f-Bu), 5.84 (2H, br s, 2 x OH), 
6.79 (2H, s, 276'-H), 6.87 (1H, dd, /2 .0  and 8.4, 5-H), 7.11 (1H, s, 7-H), 7.22 (1H, s,
3-H), 7.36 (1H, d, J  8.4, 4-H), 10.19 (1H, s, CHO), and 10.73 (2H, br s, 2 x OH); 
8C(100 MHz, d6 -acetone) 18.47 (C), 27.00 (CH3), 103.66 (CH), 106.70 (CH), 111.05 
(C), 114.42 (CH), 118.52 (CH), 122.78 (CH), 140.79 (C), 154.59 (C), 155.49 (C), 
157.28 (C), 163.87 (C), and 194.56 (CH); m/z (El) 388 (M+, 2%), and 270 (100); 
(Found: M+, 388.1258. C i9 H2 o0 7 Si requires M, 388.1256).
6-te/?-ButyldimethylsiIyloxy-2-[4'-formyl-3',5'-Zus(terf-butyldimethylsilyloxy) 
phenyl] benzo[Z>]furan 307
OTBS 
CHO 
OTBS
Aldehydes 304 (0.033 g, 0.074 mmol) and 305 (0.092 g, 0.24 mmol) were dissolved 
in dry THF (2.0 cm3) under nitrogen. TBAF (1 mol dm- 3  in THF, 1.0 cm3, 1.00 
mmol, 14 eq) were added and the reaction stirred at RT overnight. The solution was 
then diluted with aqueous HC1 (1 mol dm-3, 5 cm3), then extracted into EtOAc (3 x 
10 cm3). The combined extracts were washed with brine (3 x 10 cm3), dried 
(MgS0 4 ) and concentrated in vacuo to give a pale yellow oil (0.69 g, 0.26 mmol). 
This was taken up in dry DMF (1.50 cm3), imidazole (0.087 g, 1.28 mmol, 5 eq) and 
te/T-butyldimethylsilyl chloride (0.192 g, 1.28 mmol, 5 eq) added and the reaction 
stirred at 60 °C overnight under nitrogen. After cooling to RT, the reaction was
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quenched with H2 O (5 cm3) and extracted into Et2 0  (3 x 10 cm3). The combined 
extracts were washed with water and brine (2 x 10 cm3 each), dried (MgS0 4 ) and 
concentrated in vacuo to give crude aldehyde 307 (0.114 g, 0.19 mmol, 72%) as a 
pale yellow oil; RF [Et2 0-hexane (1:1)] 0.95; 5H(400 MHz, CDCI3 ) 0.26 (6 H, s, 
SiMe2), 0.32 (12H, s, 2  x SiMe2), 1.03 (9H, s, *Bu), 1.05 (18H, s, 2 x *Bu), 6.80 (1H, 
dd, J  2.0 and 8.4, 5-H), 6.90 (2H, s, 276'-H), 6.98 (1H, s, 3-H), 7.02 (1H, d, J  2.0, 7- 
H), 7.41 (1H, d, J  8.4,4-H) and 10.44 (1H, s, CHO).
Tributylmethallylphosphonium chloride 309
Methallylchloride 308 (3.30 cm3, 33.44 mmol, 1.01 eq) and tributylphosphine (8.20 
cm3, 33.11 mmol, 1 eq) were dissolved in dry toluene (30 cm3) under nitrogen and 
heated under reflux for 1 week. The solution was then cooled to RT, Et2 0  (5.0 cm3) 
added and the mixture cooled to -10 °C. The precipitate was filtered off, washed 
with Et2 0  and dried under suction to give phosphonium salt 309 (4.863 g, 16.62 
mmol, 50%) as very hygroscopic plates; 123 i ) m a x  (KBr)/cm_1 3074 (=C-H), 1631 
(C=C), 969 (=CH2), and 798 (C-P); 5H(400 MHz, CDCI3 ) 0.90-0.99 (9H, m, 3 x 
CH3), 1.50-1.64 (12H, m, 3 x CH2 CH2), 1.93 (3H, s, CH3), 2.43-2.60 (6 H, m, 3 x 
CH2), 3.52 (2H, d, J  16.2, CH2 P), 5.15 (1H, d, J  5.0, C=CtfAHB), and 5.17 (1H, d, /
5.0, C=CHA//B); 8c (100 MHz, CDCI3 ) 13.55 (CH3), 19.21 (d, J  46.3, CH2), 21.33 
(d J 49.6, CH2), 23.77 (m, CH2), 24.69 (CH3), 28.25 (d, J 44.5, CH2), 119.74 (CH2 ), 
and 133.45 (C); m/z (El) 257 (M+, 40%), 227 (100), 199 (30), 185 (20), 171 (30), 
144 (35), 116 (65), 101 (35) and 77 (25); (Found M+, 257.2390. C i6 H34P requires: 
M, 257.2399).
2,-[(2,-Methylprop-2’-enyl)thio]benzothiazoIe311
Methallylchloride 308 (6.60 cm3, 66.41 mmol, 1.1 eq) was added to a stirring 
suspension of 2-mercaptobenzothiazole 310 (10.083 g, 60.38 mmol, 1 eq) and 
potassium carbonate (9.165 g, 66.41 mmol, 1.1 eq) in dry acetone (150 cm3) and the 
reaction heated to reflux for 5 h. After this time the suspension was cooled to RT, 
poured into cold water and extracted into Et2 0  (3 x 70 cm3). The combined organic 
extracts were washed with water and brine (2 x 50 cm3 each), then dried (MgS04) 
and concentrated in vacuo to give the sulfide 311 (12.751 g, 57.69 mmol, 96%) as a 
pale yellow oil: Rp [hexane-Et2 0  (1:1)] 0.73; NMR and MS already
reported.106; 5H(400 MHz, CDCI3 ) 1.88 (3H, s, CH3), 4.00 (2H, s, CH2), 4.94 (1H, t, 
J  1.2, =C//a Hb), 5.10 (1H, s, =CHa//b), 7.24-7.29 (1H, m, 6 -H), 7.37-7.41 (1H, m,
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5-H), 7.73 (1H, d with fine splitting, J  8.0, 4-H), and 7.87 (1H, d with fine splitting, 
/8 .0 , 4-H).
New data: Umax (filmycnr1 3062 (=CH2 ), 1784 (C=N), 1650 (Ar), 1590 (Ar), 1560 
(Ar), and 902 (C=C).
2'-[(2,-Methylprop-2-enyl)sulfonyl]benzothiazole 290
2'-[(2'-Methylprop-2-enyl)thio]benzothiazole 311 (12.751 g, 57.69 mmol) was 
dissolved in aqueous EtOH (95%, 200 cm3) and cooled to 0 °C. A solution of 
ammonium molybdate(VI) tetrahydrate (2.638 g, 2.13 mmol, 0.037 eq) in aqueous 
H2 O2  (27.5% in water, 167.30 mmol, 2.9 eq) was added and the solution stirred at 0 
°C for 18 h. Most of the solvent was removed in vacuo and the residue taken up in 
CH2 CI2  (100 cm3). This was washed with dilute aqueous H2 SO4  (0.5 mol dm-3, 50 
cm3) and brine (2 x 50 cm3) then dried (MgSC>4 ). Concentration in vacuo followed 
by recrystallisation from EtOH gave the sulfone 290 (12.862 g, 50.84 mmol, 8 8 %) 
as pale yellow plates: m.p. 92-94 °C (Lit. 106 94 °C); Rp [hexane-Et2 0  (1:1)] 0.49;
NMR, MS(CI), and microanalysis already reported. 106 8h (400 MHz, CDCI3 ) 
1.96 (3H, s, CH3), 4.22 (2H, s, CH2), 4.92 (1H, t, J  1.2, =C/7AHB), 5.11 (1H, br t, J
1.6, =CHaHb), 7.58-7.67 (2H, m, 5-H and 6 -H), 8.01 (1H, d with fine splitting, J
8.0,4-H), and 8.23 (1H, d with fine splitting, J  8.0, 4-H).
New data: \)max (KB^/cnr1 3063 (=CH2), 1644 (Ar), 1552 (Ar), 1163 (S02), and 
989 (C=C).
£-6-te/?-Butyldimethylsilyloxy-2-[3',5'-Z>/s(te/t-butyIdimethylsilyloxy)-4'-(3M- 
methylbuta-lM, 3"-dienyl)phenyl] benzo[£]furan 312
OTBS
TBSO'
OTBS
A solution of LDA was prepared as follows: Diisopropylamine (0.14 cm3, 1.00 
mmol) was dissolved in dry THF (1.0 cm3) and cooled to 0 °C under nitrogen, n- 
Butyllithium (1.38 mol dm-3  in hexane, 0.72 cm3, 1.00 mmol) was added slowly and 
the pale yellow solution stirred at 0 °C for 15 min. In a separate flask, a solution of 
aldehyde 307 (0.023 g, 0.037 mmol) and sulfone 290 (0.011 g, 0.04 mmol, 1.1 eq) in 
dry THF ( 0.5 cm3) were cooled to -78 °C under nitrogen. The LDA solution (0.10 
cm3, 0.04 mmol, 1.1 eq) was injected slowly then the bright orange solution stiired at 
-78 °C for 3 h, then warmed to RT and stirred for 1 h. The reaction was quenched 
with water then extracted into Et2 0  (3 x 10 cm3). The combined organics were
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washed with water and brine ( 1 0  cm3 each), then dried (Na2 SC>4 ) and concentrated in 
vacuo to give the crude diene 312 (0.017 g, 0.026 mmol, 71%); Rp [Et2 0 -hexane
R-6-Hydroxy-2-(3',5'-dihydroxy-4'-(3"-methylbuta-r', 3"-dienyl)phenyl 
benzo[£]furan 96
OH
Diene 312 (0.014 g, 0.022 mmol) was dissolved in dry THF (1.0 cm3), TBAF (1 mol 
dm -3  in THF, 0.14 cm3, 0.14 mmol, 4 eq) was added slowly, and the dark orange 
slurry stirred at RT for 2 h. The reaction was quenched with phosphate buffer (pH 7) 
and extracted into EtOAc ( 3 x 5  cm3) then washed with water and brine (10 cm3 
each) and dried (Na2 SC>4 ). Concentration in vacuo gave the crude diene 96 (0.003 g, 
0.008 mmol, 38%) as a pale yellow oil; !H NMR indicated c.1% of 96 contaminated 
with excess TBAF; Rp [hexane-EtOAc (1:3)] 0.66; i)max (soln)/cm_1 3616 (OH), 
3001 (=CH), 1682 (Ar), 1598 (Ar), and 1440 (Ar); 6H(400 MHz, d6 -acetone) 1.81 
(3H, s, Me), 4.76 (1H, br s, =CtfAHB), 4.82 (1H, br s, =CHA//B), 6.72 (1H, s with 
fine splitting, 7-H), 6.80 (1H, dd, J  2.0 and 8.4, 5-H), 6.97 (1H, d, J  16.4, 1"-H), 7.17
3,4-Dihydro-2/7-pyran (9.50 cm3, 103.02 mmol, 4 eq) was cooled to 0°C then 2-3 
drops of conc. HC1 added. Methyl 3,5-dihydroxybenzoate 225 (4.327 g, 25.76 mmol, 
1 eq) was added portion wise over 1 0  min, then the ice bath removed and the 
solution stirred at RT. After 3 h, the reaction was diluted with Et2 0  (50 cm3) and 
washed with saturated aqueous sodium bicarbonate (3 x 20 cm3), brine (3 x 20 cm3), 
then dried (Na2 SC>4 ) and concentrated in vacuo to give a pale brown oil which 
crystallised on standing. The product was filtered off and washed with hexane and 
dried under suction. Recrystallisation from hexane gave the ester 313 (7.271 g, 21.63 
mmol, 84%) as off-white plates: m.p. 85-86 °C (Lit. 125 8 6 - 8 8  °C); Rp [hexane-Et2 0
(1:4)] 0.90; 8H(400 MHz, CDC13) 0.17 (6 H, s, SiMe2), 0.21 (12H, s, 2  x SiMe2), 
0.93 (9H, s, ^Bu), 0.96 (18H, s, 2 x *Bu), 1.90 (3H, s, Me), 4.96 (2H, br s, =CH2), 
6 . 6 6  (1H, d, J  16.8, 1"-H), 6.70 (1H, d„ /  2.0 and 8.4, 5-H), 6.76 (1H, s, 3-H), 6.84 
(1H, s, 7-H), 7.18 (2H, s, 2V6'-H), 7.22 (1H, d, J  16.8, 2"-H), and 7.29 (1H, d, J  8.4,
4-H).
OH
(1H, d, J  8.4,4-H), 7.39 (1H, s, 3-H), 7.47 (2H, s, 276'-H), 7.52 (1H, d. J  16.4, 2M-H),
11.03 (1H, s, OH), and 11.18 (2H, s, 2 x OH).
Methyl 3,5-fas(tetrahydropyran-2'-yIoxy)benzoate 313
Me0 2 C‘ OTHP
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(1:1)] 0.36; 1H NMR already reported. 125 8H(400 MHz, CDC13) 1.56-2.05 (12H, m, 
6  x -CH2-), 3.60-3.64 (2H, m, -OCH2_), 3.86-3.92 (2H, m, -OCH2-), 3.88 (3H, m, 
C 0 2 Me), 5.44-5.47 (2H, m, 2 x -OCHO-), 6.97 (1H, t, /  2.4, 4-H), and 7.37 (2H, d, 
J2A,  2-H and 6 -H).
New data: Dmax (KBrVcnr1 1720 (C=0), 1594 (Ar), 1450 (Ar), and 1023 (COC); 
8C(100 MHz, CDCI3 ) 19.03 (CH2), 25.53 (CH2), 30.62 (CH2), 52.53 (CH3), 62.37 
(CH2), 96.84 (CH), 110.49 (CH), 111.22 (CH), 132.23 (C), 158.32 (C), and 167.17 
(C); m/z (El) 336 (M+, 2%), 252 (12), 168 (30), 137 (10), 85 (100), and 84 (50); 
(Found: C, 64.3; H, 7.2%; M+, 336.1571. C i8 H2 4 0 6  requires C, 64.27; H, 7.19% ; 
M, 336.1573).
3,5-Z?A(tetrahydropyran-2'-yloxy)benzoic acid 314
OTHPxixH 02C ^ ^ ^ ^ 0T H P
Ester 313 (7.271 g, 21.63 mmol) was dissolved in EtOH (60 cm3). Aqueous 
potassium hydroxide (4 mol dm-3, 39.0 cm3, 154.56 mmol, 6  eq) was added and the 
solution stirred at RT. After 2 h, the reaction was poured into water/CHCb (50 cm3  
each), stirred vigorously and carefully acidified with dilute HC1 (1 mol dm-3). The 
CHCI3 layer was removed and the aqueous layer further extracted with CHCI3 (2 x 
50 cm3), the combined organic washings were washed with water (50 cm3) and brine 
(2 x 50 cm3) then dried (Na2 S04) and concentrated in vacuo. Recrystallisation from 
MeOH/water gave the acid 314 (5.642 g, 17.52 mmol, 81%) as plates: m.p. 114-116 
°C; Rf  [hexane-Et20  (1:1)] 0.14; o max (KBO/cnr1 3441 (OH), 1694 (C=0), 1593 
(Ar), 1451 (Ar), and 1024 (COC); 8H(400 MHz, CDCI3 ) 1.56-2.06 (12H, m, 6  x 
-CH2-), 3.63-3.64 (2H, m, -OCH2_), 3.87-3.93 (2H, m, -OCH2-), 5.46-5.49 (2H, m, 2 
x -OCHO-), 7.02 (1H, t, J  2.4, 4-H), and 7.43 (2H, d, J  2.4, 2-H and 6 -H); 8C(100 
MHz, CDCI3 ) 19.03 (CH2), 25.51 (CH2), 30.60 (CH2), 62.46 (CH2), 96.83 (CH),
111.26 (CH), 111.79 (CH), 131.45 (C), 158.37 (C), and 171.72 (C); m/z (El) 322 
(M+, 2%), 238 (7), 85 (100), and 84 (35); (Found: C, 63.2; H, 6.9%; M+, 322.1418. 
C i7 H2 2 0 6  requires C, 63.34; H, 6 .8 8 % ; Af, 322.1416).
6-Acetoxy-2-[3,,5f-bis(tetrahydropyran-2M-yIoxy)phenyl]-benzo[£]furan 315
OTHP
OTHP
Acid 314 (2.643 g, 8.21 mmol, 1 eq) was dissolved in dry CH2 C12  (100 cm3) under 
nitrogen. To this was added sequentially, dimethylaminopyridine (0.160 g, 1.31 
mmol, 0.16 eq), phosphonium salt 211 (5.576 g, 11.00 mmol, 1.34 eq), and
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dicyclohexylcarbodiimide (2.130 g, 10.34 mmol, 1.26 eq) as a solution in dry 
CH2 CI2  (10 cm3). The resulting slurry was stirred at RT. After 24 h, the solvent was 
removed in vacuo and the residue taken up in dry toluene (100 cm3). Dry 
triethylamine (6.50 cm3, 46.38 mmol, 5.65 eq) was added and the reaction heated to 
reflux for 6  h. After cooling to RT, the slurry was filtered, the precipitate washed 
with EtOAc (10 cm3) and the filtrate concentrated in vacuo. Chromatography on 
silica (hexane-Et2 0 , 1:1) gave the benzofuran 315 (2.499 g, 5.53 mmol, 67%) as a 
pale yellow oil: Rp [hexane-Et2 0  (1:1)] 0.47; i)max (film)/cm_1 1763 (C=0), 1597 
(Ar), 1572 (Ar), and 1020 (COC); 5H(400 MHz, CDCI3 ) 1.53-2.04 (12H, m, 6  x 
-CH2-), 2.34 (3H, s, OAc), 3.63-3.67 (2H, m, -OCH2.), 3.91-3.97 (2H, m, -OCH2-), 
5.49-5.51 (2H, m, 2 x -OCHO-), 6.80 (1H, t, J  2.0, 4'-H), 6.95-6.98 (2H, m, 3-H and
5-H), 7.19 (2H, d, J  2.0, 2-H and 6 -H), 7.27 (1H, s, 7-H), and 7.51 (1H, d, J  8.4, 4- 
H); 6C(100 MHz, CDCI3 ) 19.05 (CH2), 21.56 (CH3), 25.60 (CH2), 30.72 (CH2), 
62.39 (CH2), 96.87 (CH), 101.88 (CH), 105.49 (CH), 106.17 (CH), 106.82 (CH),
117.44 (CH), 121.21 (CH), 127.45 (C), 132.20 (C), 148.26 (C), 154.99 (C), 157.21 
(C), 158.79 (C), and 170.15 (C); m/z (El) 452 (M+, 3%), 368 (7), 284 (30), 242 
(100), 213 (10), and 85 (32); (Found M+, 452.1837. C2 6H2 80 7  requires M, 
452.1835).
6-hydroxy-2-[3’,5’-bis(tetrahydropyran-2"-yloxy)phenyl]-benzo[^]furan 316
OTHP
OTHP
Benzofuran 315 (2.499 g, 5.53 mmol) was dissolved in EtOH (30 cm3), aqueous 
potassium hydroxide (4 mol dm-3, 4.10 cm3, 16.6 mmol, 3 eq) added, and the 
solution stirred at RT for 2 h. The dark solution was diluted with water/CHCl3 
carefully acidified with dilute HC1 (1 mol dm-3). The CHCI3 layer was removed and 
the aqueous layer further extracted with CHCI3 (2 x 50 cm3), the combined organic 
washings were washed with water (50 cm3) and brine (2 x 100 cm3) then dried 
(Na2 SC>4 ) and concentrated in vacuo. Recrystallisation from hexane/EtOAc gave the 
benzofuran 316 (2.042 g, 4.98 mmol, 90%) as off-white plates: m.p. 154-156 °C; /?f 
[hexane-EtOAc (2:1)] 0.33; omax (KBr)/cm-1 3244 (OH), 1608 (Ar), 1572 (Ar), and 
1016 (COC); 5h (400 MHz, CDCI3 ) 1.60-2.08 (12H, m, 6  x -CH2-), 3.63-3.68 (2H, 
m, -OCH2_), 3.92-3.98 (2H, m, -OCH2-), 5.07 (1H, br s, OH), 5.49-5.52 (2H, m, 2 x 
-OCHO-), 6.73-6.77 (2H, m, 4'-H and 5-H), 6.89 (1H, s, 3-H), 6.96 (1H, d, J  2.0, 7- 
H), 7.16 (2H, d, J  2.4, 2'-H and 6 '-H), and 7.36 (1H, d, J  8.4, 4-H); 5C(100 MHz, 
CDCI3 ) 19.03 (CH2), 25.61 (CH2), 30.72 (CH2), 62.38 (CH2), 96.81 (CH), 98.66 
(CH), 101.98 (CH), 105.69 (CH), 106.49 (CH), 112.38 (CH), 122.50 (CH), 123.18
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(C), 132.62 (C), 154.06 (C), 155.48 (C), 156.07 (C), and 158.78 (C); m/z (El) 410 
(M+ 3%), 326 (7), 242 (100), 213 (10), and 85 (21); (Found: C, 69.9; H, 6.4%; M+, 
410.1732. C2 4 H2 6 0 6  requires C, 70.23; H, 6.38% ; M, 410.1730).
6-0-ButyldiphenylsilyIoxy)-2-[3',5'-bis(tetrahydropyran-2"-yIoxy)phenyl]- 
benzo[2>]furan 317
OTHP
Benzofuran 316 (4.350 g, 10.61 mmol), imidazole (1.082 g, 15.91 mmol, 1.5 eq) and 
r-butyldiphenylchlorosilane (3.30 cm3, 12.73 mmol, 1.2 eq) were dissolved in dry 
DMF (50 cm3) and stirred at 50 °C under nitrogen. After 24 h, the reaction was 
cooled to RT then quenched by pouring into water. The aqueous solution was 
extracted with Et2 0  ( 3  x 100 cm3), washed with water ( 2  x 100 cm3) and brine (3 x 
100 cm3), dried (Na2 SC>4 ) and concentrated in vacuo. Chromatography on alumina 
(deactivated with 6 % w/w H2 O, hexane-Et2 0 , 1:1) gave the benzofuran 317 (5.310 
g, 8.19 mmol, 77%) as a pale yellow oil; Rp [hexane-Et2 0  (1:1)] 0.57; Dmax 
(KBr)/cm-l 1612 (Ar), 1570 (Ar), 1487 (Ar), 1278 and 882 (Si-C), and 1156 (Si-O); 
6h (400 MHz, CDCI3 ) 1.12 (9H, s, tBu), 1.55-2.00 (12H, m, 6  x -CH2-), 3.60-3.62 
(2 H, m, -OCH2 -), 3.88-3.93 (2 H, m, -OCH2-), 5.45-5.47 (2 H, m, 2  x -OCHO-),
6.74-6.76 (2H, m, 4'-H and 5-H), 6.84 (1H, s, 3-H), 6.90 (1H, br s, 7-H), 7.11 (2H, d, 
J  2.0, 2'-H and 6 '-H), 7.24 (1H, d, J  8.4, 4-H), 7.34-7.43 (6 H, m, 6  x Ph-H), and
7.74-7.76 (4H, m, 4 x Ph-H); 6C(100 MHz, CDCI3 ) 19.08 (CH2), 19.94 (C), 25.65
155.83 (C), and 158.83 (C); m/z (El) 648 (M+, 2%), 564 (30), 480 (40), 423 (100), 
345 (10), and 199 (40); (Found: C, 73.6; H, 7.0%; M+, 648.2908. C4 oH4 4 C>6 Si 
requires C, 74.04; H, 6.84% ; M, 648.2907).
Methyl 4-[(6'-terf-butyIdiphenyIsilyloxybenzofuranyl)-2,6-bis(tetrahydropyran- 
2f,-yloxy)benzoate 318
HP
Benzofuran 317 (1.449 g, 2.24 mmol) was dissolved in dry THF (20 cm3) and 
cooled to -30 °C under nitrogen. rc-Butyllithium (2.15 mol dm-3, 1.25 cm3, 2.68 
mmol, 1.2 eq) was added slowly, then the resulting yellow solution stirred at -30 °C
TBDPSO
OTHP
(CH2), 26.99 (CH3), 32.03 (CH2), 62.35 (CH2), 96.81 (CH), 102.00 (CH), 102.98 
(CH), 105.66 (CH), 106.54 (CH), 116.75 (CH), 120.98 (CH), 123.42 (C), 128.26 
(CH), 130.37 (CH), 132.67 (C), 133.28 (C), 135.98 (CH), 153.98 (C), 155.56 (C),
TBDPSO
^ n— C02Me 
OTHP
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for 15 min. Methyl chloroformate (0.26 cm3, 3.35 mmol, 1.5 eq) was added and the 
reaction warmed to RT then heated to reflux for 2 h. After cooling to RT, the 
reaction was quenched by pouring into water, and this aqueous solution then 
extracted with Et2 0  (3 x 20 cm3). The combined organic layers were washed with 
water (2 x 20 cm3) and brine (3 x 20 cm3) then dried (Na2 SC>4 ) and concentrated in 
vacuo. Chromatography on alumina (deactivated with 6 % w/w H2 O, hexane-Et2 0 , 
2:1) gave the ester 318 (1.538 g, 2.18 mmol, 97%) as a pale yellow foam: m.p. 56-58 
°C; R¥ [hexane-Et20  (2:1)] 0.27; Dmax (KBrVcnr1 1736 (C=0), 1609 (Ar), 1567 
(Ar), 1487 (Ar), 1269 and 881 (Si-C), and 1156 (Si-O); 5H(400 MHz, CDCI3 ) 1.12 
(9H, s, fBu), 1.56-1.97 (1 2 H, m, 6  x -CH2-), 3.60-3.62 (2 H, m, -OCH2.), 3.87-3.94 
(2H, m, -OCH2 -), 3.91 (3H, s, C 0 2 Me), 5.58-5.60 (2H, m, 2 x -OCHO-), 6.76 (1H, 
dd, J  2.0 and 8.4, 5-H), 6.84 (1H, s, 3-H), 6.89 (2 x 1H, 2 overlapping s, 3-H and 7- 
H), 7.20 (2H, s, 2'- and 6 '-H), 7.25 (1H, d, J  8.4, 4-H), 7.32-7.44 (6 H, m, 6  x Ph-H), 
and 7.74-7.76 (4H, m, 4 x Ph-H); 5C(100 MHz, CDCI3 ) 18.46 (CH2), 19.91 (C),
25.62 (CH2), 26.94 (CH3), 30.40 (CH2), 52.49 (CH3), 61.92 (CH2), 96.45 (CH),
96.58 (CH), 103.02 (CH), 105.04 (CH), 115.22 (C), 116.95 (CH), 121.13 (CH),
123.25 (C), 128.25 (CH), 130.37 (CH), 133.18 (C), 133.63 (C), 135.95 (CH), 154.23 
(C), 154.83 (C), 155.11 (C), 155.93 (C), and 167.01 (C); m/z (El) 706 (M+, 2%), 538 
(50), 481 (100), 449 (40), 300 (35), 242 (37), 85 (50), and 44 (40); (Found: M+, 
706.2964. C4 2 H4 6 0 gSi requires M, 706.2962).
Methyl 4-[(6l-terf-butyldiphenyIsilyloxybenzofuranyl)-2,6 -dihydroxy benzoate
319
TBDPSO-
Benzofuran 318 (0.103 g, 0.14 mmol) was dissolved in 95% aqueous MeOH (2.0 
cm3), 5% aqueous oxalic acid (1.0 cm3) added and the reaction stirred at RT 
overnight, during which time a white precipitate had formed. Most of the solvent 
was then removed under reduced pressure and the residue taken up in CHCI3 (10 
cm3). The organic solution was washed with water (10 cm3) and brine (10 cm3), 
dried (MgSC>4 ) and concentrated in vacuo. Recrystallisation from EtOH gave the 
ester 319 (0.059 g, 0.11 mmol, 75%) as off-white needles: m.p. 139-141 °C; R¥ 
[hexane-Et2 0  (1:1)] 0.28; Dmax (KBr)/cm_1 3436 (OH), 1635 (C=0 chelated to 
hydroxyl), 1642 (Ar), 1622 (Ar), 1592 (Ar), 1257 and 883 (Si-C), and 1157 (Si-O); 
5h (400 MHz, CDCI3 ) 1.12 (9H, s, fBu), 4.08 (3H, s, C 0 2 Me), 6.77 (1H, dd, J  2.1 
and 8.5, 5-H), 6.89 (3H, 2 overlapping s, 276’-H and 7-H), 6.99 (1H, s, 3-H), 7.29 
(1H, d, J  8.5, 4-H), 7.36-7.46 (6 H, m, 6  x Ph-H), 7.73-7.76 (4H, m, 4 x Ph-H), and
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9.72 (2H, br s, 2  x OH); 5C(100 MHz, CDC13) 19.50 (C), 26.51 (CH3 ), 52.89 (CH3),
99.09 (C), 102.54 (CH), 103.91 (CH), 104.69 (CH), 116.88 (CH), 121.18 (CH), 
122.50 (C), 127.86 (CH), 130.01 (CH), 132.64 (C), 135.53 (CH), 137.93 (C), 138.12 
(C), 153.27 (C), 154.48 (C), 155.81 (C), and 169.63 (C); m/z (El) 538 (M+, 50%), 
481 (100), 449 (50), 371 (10), 224 (15), and 44 (18); (Found: C, 71.2; H, 5.5%; M+, 
538.1813. C3 2 H3 o0 6 Si requires; C, 71.36; H, 5.61%; M, 538.1811).
Methyl 4-[(6,-terf-butyldiphenylsiIyloxybenzofuranyl)-2,6-bis(te/t- 
butyldimethylsilyloxy)benzoate 320
TBS
TBDPSO'
TBS
Benzofuran 319 (0.152 g, 0.28 mmol), imidazole (0.077 g, 1.13 mmol, 4 eq) and t- 
butyldimethylchlorosilane (0.128 g, 0.85 mmol, 3 eq) were dissolved in dry DMF (3 
cm3) and stirred at 50 °C under nitrogen. After 24 h, the reaction was cooled to RT 
then quenched by pouring into water. The aqueous solution was extracted with Et20  
(3 x 10 cm3), washed with water (2 x 10 cm3) and brine (3 x 10 cm3), dried 
(Na2 SC>4 ) and concentrated in vacuo. Chromatography on silica (hexane-Et2 0 , 1:1) 
gave the benzofuran 320 (0.187 g, 0.24 mmol, 8 6 %) as a colourless oil; /?f [hexane- 
Et20  (1:1)] 0.67; Dmax (fiM /c n r 1 1736 (C=0), 1607 (Ar), 1557 (Ar), 1265 and 840 
(Si-C), and 1156 (Si-O); 6H(400 MHz, CDC13) 0.30 (12H, s, 2 x SiMe2), 1.02 (18H, 
s, 2 x *Bu), 1.16 (9H, s, riBu), 3.87 (3H, s, COzMe), 6.77 (1H, dd, J  2.1 and 8.4, 5- 
H), 6 . 8 6  (1H, s, 3-H), 6 . 8 8  (2H, s, 2'- and 6 ’-H), 7.01 (1H, d, J  1.8, 7-H), 7.28 (1H, d, 
J 8.4, 4-H), 7.39-7.49 (6 H, m, 6  x Ph-H), and 7.79-7.81 (4H, m, 4 x Ph-H); 6C(100 
MHz, CDC13) -4.37 (CH3), 17.99 (C), 19.47 (C), 25.48 (CH3), 26.47 (CH3), 51.92 
(CH3), 102.17 (CH), 102.63 (CH), 107.31 (CH), 116.47 (CH), 118.98 (C), 120.56 
(CH), 122.73 (C), 127.79 (CH), 129.92 (CH), 132.58 (C), 132.77 (C), 134.49 (CH),
138.44 (C), 153.81 (C), 154.17 (C), 155.60 (C), and 166.65 (C); m/z (Cl) 767 
[(M+H)+, 100%], 735 (15), 709 (20), and 689 (10); [Found: (M+H)+, 767.3619. 
C4 4 H5 9 0 6 Si3 requires (M+H)+ , 767.3620).
6-(f-ButyldiphenylsiIyloxy)-2-(3,-terf-butyIdimethylsilyloxy-3,-hydroxy-4,“ 
formylphenyl)-benzofuran 321
jCQKlr™0TBDPSO u  \
OTBS
Lithium aluminium hydride (0.056 g, 1.47 mmol, 1.5 eq) was suspended in dry Et20  
(8.0 cm3) under nitrogen and cooled to 0 °C. Ester 320 (0.750 g, 0.98 mmol) in dry
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Et2 0  (8.0 cm3) was added slowly, and the resulting slurry stirred at RT for 1.5 h. 
The solution was then cooled to 0 °C then H2 O (10 cm3) added slowly. The two 
layers were separated and the aqueous solution further extracted into Et2 0  (3 x 30 
cm3). The combined organics were washed with dilute aqueous HC1 (1 mol dm-3, 10 
cm3) and brine (2 x 10 cm3), then dried (MgSC>4 ) and concentrated in vacuo. The 
residue was then taken up in dry CH2 CI2  (8 . 0  cm3), activated MnC>2 (0.256 g, 2.94 
mmol, 3 eq) added, and the resulting black suspension stirred for 2 h at RT under 
nitrogen. After this time, further MnC>2 (0.170 g, 1.99 mmol, 2  eq) added and the 
reaction stirred at RT overnight. TLC showed the presence of remaining alcohol, so 
further MnC>2 (0.17 g, 1.98 mmol, 2  eq) was added and stirring continued for a 
further 12 h. The slurry was then filtered and the filtrate concentrated in vacuo. 
Chromatography on silica eluting with diethyl ether-hexane (1-1) gave the aldehyde 
321 (0.302 g, 0.49 mmol, 50%) as a yellow oil; Rp [hexane-Et2 0  (1:1)] 0.78; i)max 
(film)/cm-1  3072 (OH), 1643 (C=0), 1620 (Ar), 1590 (Ar), 1282 and 834 (Si-C), and 
1157 (Si-O); 6h (400 MHz, CDCI3 ) 0.31 (6 H, s, SiMe2), 1.01 (9H, s, *Bu), 1.17 (9H, 
s, fBu), 6 . 6 8  (1H, d, J  1.2, 6 ’-H), 6.74 (1H, dd, J  2.1 and 8.5, 5-H), 6 . 8 8  (1H, s, 3-H),
6.90 (1H, d, J  1.8, 7-H), 6.97 (1H, d, J  1.2, 2'-H), 7.30 (1H, d, J  8.5, 4-H), 7.34-7.44 
(6 H, m, 6  x Ph-H), 7.70-7.75 (4H, m, 4 x  Ph-H), 10.25 (1H, s, CHO), and 11.88 (1H, 
s, OH); 5C(100 MHz, CDCI3 ) -4.23 (CH3), 18.37 (C), 21.50 (C), 25.69 (CH3), 26.49 
(CH3), 102.63 (2 x CH), 105.05 (CH), 105.51 (CH), 112.79 (C), 117.02 (CH),
121.22 (CH), 122.48 (C), 127.85 (CH), 130.01 (CH), 132.64 (C), 135.69 (CH), 
139.38 (C), 153.31 (C), 154.67 (C), 156.05 (C), 159.60 (C), 163.75 (C), and 193.62
(CH); m/z (Cl) 623 [(M+H)+, 100%], and 595 (10); [Found: (M+H)+, 623.2641. 
C3 7 H4 3 0 5 Si2  requires (M+H)+ , 623.2649).
6-(M5utyldiphenylsilyIoxy)-2-[3,,5,-bis(te/f-butyldimethylsilyloxy)-4’-
for my 1 phenyl]-benzofuran 322
OTBS
j(X )^ C r CH0TBDPSO ^  — \
OTBS
Aldehyde 321 (0.031 g, 0.05 mmol) was dissolved in dry CH2 CI2  (1.0 cm3) under 
nitrogen. Dry Et3 N (0.05 cm3, 0.36 mmol, 7 eq) was added followed by tert- 
butyldimethylsilyl triflate (0.08 cm3, 0.36 mmol, 7 eq) then the yellow solution 
stirred at RT for 2 h. The reaction was quenched with water then extracted into Et2 0  
(3 x 50 cm3). The combined organics were washed with water (10 cm3) and brine (2 
x 10 cm3) then dried (Na2 SC>4 ) and concentrated in vacuo. Drying under high 
vacuum gave the aldehyde 322 (0.026 g, 0.035 mmol, 70%) as a pale yellow oil; Rp 
[hexane-Et20  (3:1)] 0.72; i)max (solnVcnr1 1703 (C=0), 1603 (Ar), 1419 (Ar), 1262 
and 8 8 8  (Si-C), and 1162 (Si-O); 5H(400 MHz, CDCI3 ) 0.27 (12H, s, 2 x SiMe2),
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1.02 (18H, s, 2 x *Bu), 1.12 (9H, s, tB u \ 6.74 (1H, dd, 72.0 and 8.4, 5-H), 6.79 (1H, 
d, J  8.4, 4-H), 6.84 (2H, s, 276'-H), 6.91 (1H, s, 3-H), 6.96 (1H, d, J  2.0, 7-H), 7.35- 
7.46 (6 H, m, 6  x Ph-H), 7.73-7.76 (4H, m, 4 x Ph-H), and 10.43 (1H, s, CHO); m/z
(Cl) 737 [(M+H)+, 65%], 679 (65), 613 (100), 555 (75), 499 (15), 391 (20), 373 
(20), and 133 (35); [Found: (M+H)+, 737.3509. C4 3 H5 7 0 5 Si3 requires (M+H)+, 
737.3514).
2,2,8,8-TetramethyI-2//, 8/7-pyranochromene 325
Resorcinol 109 (0.300 g, 2.72 mmol), phenylboronic acid (0.333 g, 2.73 mmol) and 
3-methylbutenal 216 (0.26 cm3, 2.73 mmol) were dissolved in a mixture of dry 
toluene (100 cm3) and glacial acetic acid (13.5 cm3) and heated under reflux in 
Dean-Stark apparatus under nitrogen overnight. After cooling to RT, the solvent was 
removed in vacuo and the residue taken up in water. The aqueous solution was 
extracted into DCM (3 x 50 cm3), washed with water (20 cm3), saturated aqueous 
sodium bicarbonate (20 cm3), and brine (20 cm3) and then dried (MgS04). Removal 
of the solvent under reduced pressure gave a yellow oil which was purified by flash 
chromatography on silica (9:1 hexane-EtOAc). Recrystallisation from hexane gave 
chromene 325 (0.080 g, 0.331 mmol, 12%) as plates: m.p. 79-81 °C (Lit. 126 77-79 
°C); Rf  [hexane-EtOAc (9:1)] 0.72; i)max (KBrycnr1 1627(Ar), 1561 (Ar), and 1489 
(Ar); 6h (400 M H z, CDC13) 1.40 (12H, s, 4 x Me), 5.45 (2H, d, /  9.8, 3-H and 7-H),
6.22 (2H, d, J  9.8, 4-H and 6 -H), 6.24 (1H, s, 5-H), and 6.59 (1H, s, 10-H); 5C(100 
MHz, CDC13) 28.42 (CH3), 76.72 (C), 105.05 (CH), 114.88 (C), 122.17 (CH),
124.09 (CH), 128.28 (CH), and 154.50 (C); m/z (El) 242 (M+, 25%), 227 (100), 211 
(10), and 106 (10); (Found: C, 79.3; H, 7.45%; M+, 242.1309. Ci6Hi80 2 requires: 
C, 79.31; H, 7.49%; M, 242.1307).
Moracin M 326
OH
6-Acetoxy-2-(3',5'-dimethoxyphenyl)-benzofuran 212 (0.500 g, 1.60 mmol) was 
dissolved in dry CH2 CI2  (20 cm3) and cooled to -78 °C under nitrogen. Boron 
tribromide (4.81 cm3, 1 mol dm-3  in CH2 CI2 , 4.81 mmol, 3 eq) was added slowly 
over 15 min, then the reaction allowed to warm slowly up to RT. After stirring 
overnight, the reaction was quenched by pouring into cold water, followed by 
stirring for 10 min. This aqueous solution was extracted with EtOAc (3 x 50 cm3),
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washed well with water (50 cm3) and brine (3 x 50 cm3), then dried (MgSC>4 ) and 
concentrated in vacuo. Chromatography on silica (2:1 EtOAc-hexane) followed by 
recrystallisation from Me0 H-H2 0  gave benzofuran 326 (0.380 g, 1.57 mmol, 98%) 
as pale yellow needles: m.p. 259-261 °C (Lit. 127 259-262 °C); Rp [EtOAc-hexane 
(2:1)] 0.61; \)max (K B ^/cnr1 3290 (OH), 1616 (Ar), 1578 (Ar), and 1506 (Ar); 
5h [400 MHz, (CD3 )2 CO] 6.39 (1H, t, J  2.0, 4'-H), 6.83 (1H, dd, J  8.4 and 2.0, 5-H),
6 . 8 8  (2H, d, J  2.0, 2' and 6 ’-H), 7.00 (1H, br s, 7-H), 7.04 (1H, s, 3-H), 7.41 (1H, d, J
8.4, 4-H), 7.81 (2H, br s, 2 x OH), and 7.83 (1H, br s, OH); 8C(100 MHz, 
(CD3 )2 CO) 98.44 (CH), 102.32 (CH), 103.56 (CH), 103.84 (CH), 113.25 (CH),
122.01 (CH), 122.58 (C), 133.40 (C), 155.56 (C), 156.70 (C), 156.74 (C), and
159.82 (C); m/z (El) 242 (M+, 100%), 213 (11), and 121 (10); (Found M+, 242.0580. 
C 1 4H 1 0O4  requires: M, 242.0579).
6-tert-Butyldiphenylsilyloxy-2-(3',5'-dihydroxyphenyl)-benzo[£]furan 327
TBDPSO'
OH
Benzofuran 300 (1.148 g, 2.26 mmol) was dissolved in dry CH2 C12  (20 cm3) and 
cooled to -78 °C under nitrogen. Boron tribromide (1 mol dm-3  in CH2 C12, 6.80 cm3, 
6.78 mmol, 3 eq) was added slowly then the reaction stirred at RT. After 2 h, the 
reaction was quenched with water and extracted into EtOAc (3 x 30 cm3), the 
combined extracts were washed with brine (2 x 50 cm3), dried (MgSC>4 ), and 
concentrated in vacuo. Chromatography on silica (1:1 EtOAc/hexane) gave the 
benzofuran 327 (0.755 g, 1.57 mmol, 70%) as plates; m.p. 131-133 °C; Rp [hexane- 
EtOAc (1:1)] 0.50; \)max (KBrycnr1 3410 (OH), 1618 (Ar), 1575 (Ar), 1489 (Ar), 
1277 and 823 (Si-C), and 1113 (Si-O); 8H(400 MHz, MeOD) 1.08 (9H, s, fBu), 5.08 
(2H, br s, 2 x OH), 6.33 (1H, br s, 3-H), 6.71 (1H, br d, J  8.4, 5-H), 6.80-6.85 (4H, 
m, 7-, 276'- and 4’-H), 7.20 (1H, d, J 8.4, 4-H), 7.30-7.41 (6 H, m, 6  x Ph-H), and 
7.63-7.74 (4H, m, 4 x Ph-H); 8C(100 MHz, MeOD) 20.72 (C), 27.56 (CH3), 102.67 
(CH), 103.68 (CH), 104.24 (CH), 104.64 (CH), 117.85 (CH), 122.21 (CH), 124.93 
(C), 129.43 (CH), 131.95 (CH), 133.99 (C), 134.04 (C), 137.09 (CH), 155.29 (C),
156.95 (C), 157.30 (C), and 160.36 (C); m/z (El) 480 (M+, 30%), 423 (100), 345
(15), and 211 (10); (Found: M+, 480.1755. C3 oH2 s0 4 Si requires M, 480.1757).
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Experimental for Chapter 5
2,4-Dihydroxy-3-(3'-methyIbut-2'-enyl)-acetophenone 331
Potassium hydroxide (12.910 g, 230.61 mmol, 3.5 eq) was dissolved in MeOH (80 
cm3), and cooled to 0 °C. A solution of 2,4-dihydroxyacetophenone 330 (10.015 g, 
65.89 mmol) in MeOH (20 cm3) was added followed by prenyl bromide (21.50 cm3,
184.48 mmol, 2.8 eq), and the resulting brown solution warmed to 40 °C and stirred 
under nitrogen overnight. The solution was quenched with water, acidified with 
dilute aqueous HCL (1 mol dm-3), then extracted into EtOAc (3 x 50 cm3). The 
combined organic extracts were washed with water and brine (2 x 50 cm3 each), 
dried (MgS0 4 ) and concentrated in vacuo. The dark red oil solidified on standing 
and was recrystallised from toluene to give the acetophenone 331 (1.919 g, 8.72 
mmol, 13%) as pale orange plates; m.p. 150-153 °C (Lit. 128 149-151 °C; 157-158 
°C); [hexane-Et20  (1:1)] 0.32; Dmax (KBr)/cm-1 3425 (OH), 1623 (C=0), 1584 
(Ar), 1496 (Ar), and 792 (C=C); 8H(400 MHz, CDC13) 1.76 (3H, s, Me), 1.83 (3H, s, 
Me), 2.56 (3H, s, COMe), 3.44 (2H, d, J  7.2, =CHCH 2), 5.26 (1H, t, J  7.2, 
=CHCH2), 6.04 (1H, s, OH), 6.38 (1H, d, J  8 .8 , 5-H), 7.53 (1H, d, J  8 .8 , 6 -H), and
13.20 (1H, s, OH); 6C(100 MHz, CDCI3 ) 17.89 (CH3), 21.58 (CH2), 25.79 (CH3),
26.20 (CH3), 107.73 (CH), 107.91 (C), 113.70 (C), 114.02 (C), 121.04 (CH), 130.30 
(CH), 135.52 (C), 161.54 (C), and 162.52 (C); m/z (El) 220 (M+, 65%), 205 (20), 
177 (40), 165 (100), and 149 (45); (Found: C, 70.79; H, 7.24%; M+, 220.1098. 
C 1 3H 1 6O3  requires: C, 70.91; H, 7.27%; M, 220.1100). 1H, IR, microanalysis and 
MS agree with data reported. 128
2,4,2',4'-Tetramethoxychalcone 334
2,4-Dim ethoxybenzaldehyde 332 (1.521 g, 9.16 m m ol) and 2,4- 
dimethoxyacetophenone 333 (1.649 g, 9.16 mmol) were dissolved in EtOH (25 cm3) 
and sodium hydroxide (2-3 pellets) added and the reaction stirred at RT under 
nitrogen. After 16 h, the yellow solid product was filtered off, and washed under
OMe O
Me
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suction with water and cold EtOH. Recrystallisation from ethanol gave chalcone 334 
(1.858 g, 5.66 mmol, 62%) as yellow needles: m.p. 120-123 °C (Lit. 9 4  128-129 °C); 
Rf  [EtOAc-hexane (3:1)] 0.66; Dmax (KBrVcnr1 1645 (C=0), 1501 (Ar), 1452 (Ar), 
and 937 (C=C); 6H(400 MHz, CDC13) 3.84 (3H, s, OMe), 3.86 (6 H, s, 2  x Me), 3.89 
(3H, s, OMe), 6.45 (1H, d, J  2.3, 3'-H), 6.49 (1H, d, J  2.4, 3-H), 5.51 (1H, dd, J  2.3 
and 8 .6 , 5'-H), 6.55 (1H, dd, J  2.4 and 8 .6 , 5-H), 7.46 (1H, d, J  15.9, COCtf=CH), 
7.54 (1H, d, J  8 .6 , 6 '-H), 7.72 (1H, d, J  8 .6 , 6 -H), and 7.94 (1H, d, J  15.9, 
COCH=CH)\ 8C(100 MHz, CDCI3 ) 55.45 (CH3), 55.51 (2 x CH3), 55.67 (CH3), 
98.30 (CH), 98.64 (CH), 104.91 (CH), 105.26 (CH), 117.49 (C), 122.75 (C), 125.37 
(CH), 130.23 (CH), 132.62 (CH), 137.93 (CH), 160.08 (C), 160.09 (C), 162.60 (C), 
163.67 (C), and 191.32 (C); m/z (El) 328 (M+, 15%), 297 (100), 165 (22), and 151
(16); (Found: C, 69.49; H, 6.17%; M+, 328.1312. C 1 9H2 0 O5 requires: C, 69.50; H, 
6.14%; M, 328.1311).
2,4,2' ,4'-Tetrahydroxychalcone 335
HO'
Chalcone 334 (0.512 g, 1.56 mmol) was dissolved in CH2 CI2  (20 cm3) and cooled to 
-78 °C under nitrogen. Boron tribromide (9.40 cm3, 1 mol dm-3  in CH2 CI2 , 9.40 
mmol, 6  eq) was added slowly, and the reaction allowed to warm to RT. After 
stirring for 3 h, the reaction was quenched by the addition of saturated aqueous 
sodium bicarbonate and the resulting slurry was stirred for 30 min at RT. This 
aqueous solution was extracted into EtOAc (3 x 70 cm3), washed well with brine (3 
x 50 cm3), dried (MgS0 4 ), and concentrated in vacuo to give a bright orange solid. 
Chromatography on silica (3:1 EtOAc-hexane) gave a bright orange solid which was 
recrystallised from EtOH/water to give chalcone 335 (0.251 g, 0.92 mmol, 59%) as 
orange plates: m.p. 310-311 °C(dec) (Lit. 117 >320 °C); Rp [EtOAc-hexane (3:1)] 
0.35; Dmax (K B^/cnr1 3375 (OH), 1636 (C=0), 1550 (Ar), 1506 (Ar), 1466 (Ar), 
and 958 (C=C); 5H(400 MHz, de-acetone) 6.31-6.43 (4H, m, 3',3,5’- and 5-H), 7.58 
(1H, d, J  8 .6 , 6 '-H), 7.68 (1H, d, J  15.4, COCH=CH), 7.95 (1H, d, J  8 .6 , 6 -H), and 
8.12 (1H, d, J  15.4, COCH=C//); 5C(100 MHz, CDCI3 ) 102.10 (CH), 104.00 (CH), 
108.33 (CH), 109.58 (CH), 115.51 (C), 117.63 (CH), 132.24 (CH), 132.85 (CH),
141.48 (C), 141.85 (CH), 160.59 (C), 162.97 (C), 167.28 (C), 167.01 (C), and
193.81 (C).
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2,4-Dimethoxy-3-(3'-methyIbut-2'-enyl)-acetophenone 336
OMe O
MeO
Ketone 331 (0.203 g, 0.923 mmol) and potassium carbonate (0.765 g, 5.54 mmol, 6  
eq) were dissolved in dry acetone (10 cm3) and dimethyl sulfate (0.26 cm3, 2.77 
mmol, 3 eq) added slowly. This was heated under reflux under nitrogen for 24 h. 
After cooling, the reaction mixture was concentrated in vacuo then the residue taken 
up in water. This aqueous solution was extracted with Et2 0  (3 x 20 cm3), then the 
combined extracts washed with brine (3 x 30 cm3), dried (MgSC>4 ) and concentrated 
in vacuo. The mixture was filtered through a short silica plug eluting with Et2 0 - 
hexane (1:1) and concentrated to give ketone 336 (0.184 g, 0.742 mmol, 80%), as a 
pale orange oil: R f  [Et2 0 -hexane (1:1)] 0.56; 8h (400 MHz, CDCI3 ) 1.68 (3H, s, 
Me), 1.74 (3H, s, Me), 2.61 (3H, s, COMe), 3.37 (2H, d, J  6.9, =CHCtf2), 3.74 (3H, 
s, OMe), 3.86 (3H, s, OMe), 5.17 (1H, t, J  6.9, =CtfCH2), 6.69 (1H, d, J  8 .8 , 5-H), 
and 7.60 (1H, d, J  8 .8 , 6 -H); !H NMR data agreed with those reported. 114 ; 5c(100 
MHz, CDCI3 ) 18.20 (CH3), 23.18 (CH2), 30.32 (CH3), 32.21 (CH3), 56.12 (CH3), 
63.13 (CH3), 106.58 (CH), 122.95 (CH), 124.43 (C), 126.11 (C), 129.82 (CH),
133.95 (C), 159.51 (C), 162.26 (C), and 199.31 (C); m/z (El) 248 (M+, 37%), 233 
(100), 179 (17), and 43 (15); (Found M+, 248.1412. C 1 5 H 2 0 O3 requires: AT, 
248.1413).
2,4,2,,4'-Tetramethoxy-3-(3"-methylbut-2”-enyI) chalcone 337
OMe O
OMe
MeO'
Me
2,4-Dimethoxybenzaldehyde 332 (1.067 g, 0.403 mmol) and ketone 336 (0.100 g, 
0.403 mmol) were dissolved in EtOH (1 cm3) and sodium hydroxide (1 pellets) 
added and the reaction stirred at RT under nitrogen. After 16 h, the reaction was 
quenched by addition of water (30 cm3), and then extracted with Et2 0  (3 x 30 cm3). 
The combined extracts were washed with water (30 cm3), and brine (3 x 30 cm3), 
then dried (MgSC>4 ) and concentrated in vacuo to give chalcone 337 (0.147 g, 0.370 
mmol, 92%) as a yellow oil; Rp [Et2 0 -hexane (1:1)] 0.28; Dmax (film)/cm_1 1676 
(C=0), 1653 (C=C), 1588 (Ar), 1504 (Ar), and 1481 (Ar); 8H(400 MHz, CDCI3 ) 
1.63 (3H, s, Me), 1.71 (3H, s, Me), 3.32 (2H, d, J  6.9, =CHCtf2), 3.62 (3H, s, OMe),
3.75 (3H, s, OMe), 3.78 (3H, s, OMe), 3.79 (3H, s, OMe), 5.11 (1H, t, J  6.9, 
CH=CH2), 6.37 (1H, d, J 2.3, 3-H), 6.45 (1H, dd, J  2.3 and 8 .6 , 5'-H), 6.62 (1H, d, J
8 .6 , 5-H), 7.40 (1H, d, J  15.9, COCtf=CH), 7.49 (2H, d, J  8 .6 , 6 -H and 6 '-H), and
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7.93 (1H, d, J 15.9, COCH=C//); 5c(100 MHz, CDC13) 16.82 (CH3), 21.77 (CH2),
24.76 (CH3), 54.43 (CH3), 54.46 (CH3), 54.77 (CH3), 61.94 (CH3), 97.30 (CH),
104.31 (CH), 105.13 (CH), 116.22 (C), 121.74 (CH), 122.69 (C), 123.30 (CH), 
125.52 (C), 128.47 (CH), 129.09 (CH), 130.47 (C), 137.65 (CH), 157.72 (C), 159.12 
(C), 160.10 (C), 161.80 (C), and 191.24 (C); m/z (El) 396 (M+, 40%), 362 (100), 
217 (65), 163 (30), and 151 (70); (Found M+, 396.1937. C2 4 H 2 8 O5  requires: M, 
396.1936).
2.4-J?w(methoxymethoxy)-3-(3f-methylbut-2'-enyl)acetophenone 340
I MOMO O 
M O M O ^ ^
Sodium hydride (0.551 g, 60% dispersion in mineral oil, 13.8 mmol, 3 eq) was 
washed with dry hexane (3 x 10 cm3), dried under vacuum, then suspended in dry 
DMF (10 cm3) under nitrogen and cooled to 0 °C. Ketone 331 (1.010 g, 4.59 mmol) 
in dry DMF (25 cm3) was added slowly and the solution stirred at RT for 30 min. 
The reaction was cooled to 0°C once more and chloromethylmethyl ether (1.05 cm3,
13.77 mmol, 3 eq) added slowly, then the solution was stirred at 60 °C overnight. 
The reaction was cooled then quenched by pouring into water, and extracted into 
diethyl ether (3 x 100 cm3). The organic extract was washed with brine (3 x 50 cm3) 
dried (K2 C 0 3) and concentrated in vacuo. The residue was poured through a short 
silica plug eluting with dichloromethane giving the ketone 340 (1.040 g, 3.38 mmol, 
74%) as a pale brown oil; /?F [hexane:E t20  (1:1)] 0.55; \)max (soln)/cm_1 1674 (C=0), 
1632 (Ar), and 1586 (Ar); 5H(400 MHz, CDC13) 1.67 (3H, s, Me), 1.78 (3H, s, Me),
2.58 (3H, s, COMe), 3.41 (2H, m, =CH-CH2), 3.46 (3H, s, OMe), 3.52 (3H, s, OMe),
5.10 (2H, s, OCH2 0), 5.18 (1H, m, C=CH), 5.24 (2H, s, OCH2 0), 6.90 (1H, d, J 8.7,
5-H), and 7.49 (1H, d, J  8.7, 6 -H); 6C(100 MHz, CDC13) 18.26 (CH3), 23.78 (CH2), 
26.06 (CH3), 30.39 (CH3), 56.55 (CH3), 58.21 (CH3), 94.15 (CH2), 101.72 (CH2),
109.22 (CH), 122.72 (CH), 125.55 (C), 128.03 (C), 129.05 (CH), 132.07 (C), 155.92 
(C), 159.34 (C), and 199.84 (C). m/z (Cl) 309 [(M+H)+, 100%), 277 (15), 265 (20), 
and 235 (15); [Found (M+H)+, 309.1703. C 1 7H2 5 O5  requires (M+H)+ , 309.1702].
2.4-Bis (methoxymethoxy)benzaldehyde 341
MOMOxrMOMCr
Sodium hydride (2.623 g, 60% dispersion in mineral oil, 65.59 mmol, 3 eq) was 
washed with dry hexane (3 x 10 cm3), dried under vacuum, suspended in dry DMF 
(50 cm3) under nitrogen and cooled to 0 °C. 2,4-Dihydroxybenzaldehyde 188 (3.017
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g, 21.86 mmol) in dry DMF (20 cm3) was added slowly, then the solution stirred at 
RT for 30 min. The reacion was cooled to 0 °C once more, and chloromethylmethyl 
ether (5.00 cm3, 65.59 mmol, 3 eq) added slowly, then the solution was stirred at RT 
overnight. The reaction was quenched by pouring into water which was then 
extracted into diethyl ether (3 x 100 cm3). The organic extract was washed with 
NaOH (1 mol dm-3, 50 cm3), brine (2 x 50 cm3), then dried (K2 CO 3 ) and 
concentrated in vacuo. Recrystallisation from hexane gave the aldehyde 341 (3.096 
g, 13.70 mmol, 63%) as needles; m.p. 44-45°C (Lit. 129 47-49°C); Rp[hexane:Et20  
(1:1)] 0.58; Dmax (KBrycnr1 1682 (C=0), 1602 (Ar), 1578 (Ar), and 1492 (Ar); 
8h (400 MHz, CDCI3 ) 3.49 (3H, s, OMe), 3.53 (3H, s, OMe), 5.22 (2H, s, OCH2 0),
5.32 (2H, s, OCH2 0), 6.74 (1H, dd, J  2.0 and 8.7, 5-H), 6.83 (1H, d, 72.0, 3-H), 7.80 
(1H, d, J  8.7, 6 -H), and 10.35 (1H, s, CHO); 5C(100 MHz, CDCI3 ) 56.78 (CH3),
56.92 (CH3), 94.54 (CH2). 95.05 (CH2), 103.00 (CH), 109.83 (CH), 120.60 (C),
130.55 (CH), 161.67 (C), 163.90 (C), and 188.71 (CH); m/z (El) 226 (M+, 100%), 
181 (40), 166 (30) and 165 (20); (Found: C, 58.3; H 6.24%; Requires C, 58.4; H, 
6.20%).
2,4,2',4'-7>fra(methoxymethoxy)-3-(3"-methylbut-2"-enyl)chalcone 342
MOMO
MOM
MOMO'
OMOM
Ketone 340 (0.428 g, 1.39 mmol) and aldehyde 341 (0.314 g, 1.39 mmol) were 
dissolved in dry ethanol (5 cm3) with a catalytic amount of NaOH (0.056 g, 0.139 
mmol, 0.10 eq), and stirred under nitrogen at RT overnight. The solution was diluted 
with water and extracted into Et2 0  (3 x 50 cm3). The organic extract was washed 
with brine (2 x 50 cm3), dried (K2 CO3 ), and concentrated in vacuo. Chromatography 
on silica eluting with ethyl acetate-hexane (1:1) gave the chalcone 342 (0.300 g, 
0.581 mmol, 42%) as a bright yellow oil; Rp[hexane-Et20  (1:1)] 0.58; D max 
(soln)/cm_1 1729 (C=0), 1657 (C=C), 1571 (Ar), 1524 (Ar), and 1500 (Ar); 8H(400 
MHz, CDCI3 ) 1.69 (3H, s, Me), 1.80 (3H, s, Me), 3.46-3.50 (14H, m, 4 x OMe and 
=CHC//2), 4.96 (2H, s, OCH2 0), 5.17 (2H, s, OCH2 0 ), 5.18-5.28 (5H, m, 2 x 
OCH20  and C=CH), 6.72 (1H, dd, J  2.4 and 8 .8 , 5’-H), 6.84 (1H, d, J  2.4, 3’-H), 6.94 
(1H, d, J  8.4, 5-H), 7.34 (1H, d, J  16.0, COCtf=CH), 7.49 (1H, d, J  8 .8 , 6 '-H), 7.57 
(1H, d, J  8.4, 6 -H), and 7.99 (1H, d, J  16.0, COCH=Ctf); 8C(100 MHz, CDCI3 )
17.94 (CH3), 23.45 (CH3), 56.14 (CH3), 56.26 (CH3), 56.39 (CH3), 57.89 (CH3), 
65.86 (CH2), 94.09 (CH2), 94.30 (CH2), 94.65 (CH2), 101.32 (CH2), 103.36 (CH), 
109.41 (CH), 109.53 (CH), 118.69 (C), 122.66 (CH), 124.91 (C), 125.17 (CH),
128.31 (C), 128.88 (CH), 129.63 (CH), 131.61 (C), 138.42 (CH), 155.54 (C), 157.72
152
(C), 158.54 (C), 160.24 (C), and 192.51 (C); m/z (Cl) 517 [(M+H)+, 100%), and 473
(10); [Found (M+H)+, 517.2442. C2 8 H3 7O9  requires (M+H)+ , 517.2438].
2-Hydroxy-3-(3,methylbut-2'-enyl)-4-(tetrahydropyran-2"-yloxy)acetophenone
3.4-Dihydro-2//-pyran (0.15 cm3, 1.58 mmol, 4 eq) was cooled to 0°C then 2-3 drops 
of conc. HC1 added. 2,4-Dihydroxy-3-(3'-methylbut-2'enyl)acetophenone 331 (0.087 
g, 0.40 mmol, 1 eq) was added portion wise over 10 min, then the ice bath removed 
and the solution stirred at RT. After 3 h, the reaction was diluted with Et2 0  (10 cm3) 
and washed with saturated aqueous sodium bicarbonate (3 x 10 cm3), brine (3 x 10 
cm3), then dried (Na2 S0 4 ) and concentrated in vacuo to give a pale brown oil. 
Chromatography on silica (1:1 hexane/Et2 0 ) gave the ketone 343 (0.133 g, 0.34 
mmol, 8 6 %) as a brown/orange oil; Rf [hexane-Et2 0  (1:1)] 0.63; Dmax (film)/cm_1 
3371 (OH), 1624 (C=0), 1598 (Ar), 1493 (Ar), and 968 (C=C); 5H(400 MHz, 
CDCI3 ) 1.51-1.89 (6 H, m, 3 x -CH2-), 1.73 (3H, s, Me), 1.83 (3H, s, Me), 2.55 (3H, 
s, COMe), 3.42 (2H, d, 7 6.0, =CHCH2), 3.50-3.58 (2H, m, -OCH2-), 4.92-4.97 (1H, 
m, -OCHO-), 5.24-5.28 (1H, m, =C/fCH2), 6.37 (1H, d, J  8 .8 , 5-H), 7.50 (1H, d, J  
8 .8 , 6 -H), and 13.03 (1H, s, OH); 6C(100 MHz, CDCI3 ) 18.26 (CH3), 20.10 (CH2),
2 2 . 0 0  (CH2), 25.80 (CH2), 26.17 (CH3), 26.54 (CH3), 31.31 (CH2), 63.34 (CH2),
95.10 (CH), 108.00 (CH), 114.10 (C), 114.79 (C), 121.70 (CH), 130.56 (CH), 135.08 
(C), 161.94 (C), 163.03 (C), and 203.16 (C); m/z (El) 304 (M+, 5%), 220 (85), 205 
(30), 165 (100), 149 (40), 147 (25), 85 (35), and 43 (40); (Found: M+, 304.1679. 
C 1 8H2 4 O4  requires M, 304.1675).
2.4-Zh’s(tetrahydropyran-2'' -yloxy)benza!dehyde 344
3,4-Dihydro-2//-pyran (4.00 cm3, 44.22 mmol, 6  eq) was cooled to 0°C then 2-3 
drops of conc. HC1 added. 2,4-Dihydroxybenzaldehyde 188 (1.017 g, 7.37 mmol, 1 
eq) was added portion wise over 1 0  min, then the ice bath removed and the solution 
stirred at RT. After 3 h, the reaction was diluted with Et2 0  (50 cm3) and washed with 
saturated aqueous sodium bicarbonate (3 x 20 cm3), brine (3 x 20 cm3), then dried 
(Na2 S0 4 ) and concentrated in vacuo to give a pale brown oil. Chromatography on 
silica (2:1 hexane/Et2 0 ) gave the aldehyde 344 (1.691 g, 5.53 mmol, 75%) as a 
colourless oil; Rp [hexane-Et2 0  (2:1)] 0.40; Dmax (film)/cm_1 1725 (C=0), 1683 
(Ar), 1601 (Ar), and 1500 (Ar); 6H(400 MHz, CDCI3 ) 1.54-2.04 (12H, m, 6  x -CH2-
343
THPO
OTHP
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), 3.48-4.48 (4H, m, 2 x -OCH2-), 5.10-5.57 (2H, m, 2 x -OCHO-), 6.59 (1H, d, J
2.0, 3-H), 6 . 8 8  (1H, dd, J  2.0 and 8 .8 , 5-H), 7.79 (1H, d, J  8 .8 , 6 -H), and 10.40 (1H, 
s, CHO); 8C(100 MHz, CDC13) 18.73 (CH2), 20.01 (CH2), 25.39 (CH2), 25.70 
(CH2), 30.35 (CH2), 31.31 (CH2), 62.39 (CH2), 63.71 (CH2), 96.65 (CH), 98.85 
(CH), 102.22 (CH), 109.68 (CH), 130.13 (CH), 138.51 (C), 161.59 (C), 163.99 (C), 
and 188.73 (CH); m/z (El) 306 (M+, 10%), 204 (65), 174 (20), 85 (100), 84 (20), and 
41 (13); (Found: M+, 306.1465. C nH 2 2 0 5  requires M, 306.1468).
2,4-Z?A(te/t-butyldimethylsilyloxy)acetophenone 349
2.4-Dihydroxyacetophenone 330 (0.527 g, 3.47 mmol), imidazole (0.943 g, 13.87 
mmol, 4 eq) and terr-butyldimethylchlorosilane (1.304 g, 8.67 mmol, 2.5 eq) were 
dissolved in dry DMF (25 cm3) and heated at 60 °C under nitrogen. After 16 h, the 
reaction was cooled to RT then quenched by the addition of water, then extracted 
into Et20  (3 x 20 cm3). The combined organic extracts were washed with water (2 x 
50 cm3) and brine (2 x 50 cm3), dried (MgSC>4 ) and concentrated in vacuo. 
Purification by flash chromatography on silica gave ketone 349 (1.235 g, 3.25 mmol, 
94%) as a pale brown oil; /?p  [Et2 0-hexane (2:1)] 0.80; u m ax (film)/cm-1 1673 
(ketone C=0), 1640 (Ar), 1561 (Ar), 1261 and 896 (Si-C) and 1179 (Si-O); 8H(400 
MHz, CDCI3 ) 0.02 (6 H, s, SiMe2), 0.07 (6 H, s, SiMe2), 0.76 (9H, s, tert-Bu), 0.79 
(9H, s, tert-Bu), 2.35 (3H, s, COMe), 6.11 (1H, d, J  2.2, 3-H), 6.26 (1H, dd, J  2.2 
and 8 .6 , 5-H), and 7.41 (1H, d, J  8 .6 , 6 -H); 8C(100 MHz, CDCI3 ) -4.25 (CH3), 
-3.84 (CH3), 18.25 (C), 18.55 (C), 25.71 (CH3), 25.92 (CH3), 31.33 (CH3), 111.44 
(CH), 113.58 (CH), 124.54 (C), 131.90 (CH), 156.83 (C), 160.27 (C), and 198.85 
(C); m/z (Cl) 381 [(M+H)+ 100%], and 323 (30); [Found: (M+H)+, 381.2279. 
C3 oH3 7 0 3 Si2  requires M, 381.2281).
2.4-2fis(te/f-butyldimethylsiIyloxy)benzaldehyde 350r^H0
tb so ^ ^ ^ o tbs
2.4-dihydroxybenzaldehyde 188 (0.510 g, 3.70 mmol), imidazole (1.005 g, 14.78 
mmol, 4 eq) and terf-butyldimethylchlorosilane (1.390 g, 9.24 mmol, 2.5 eq) were 
dissolved in dry DMF (25 cm3) and heated at 60 °C under nitrogen. After 16 h, the 
reaction was cooled to RT then quenched by the addition of water, then extracted 
into Et20  (3 x 20 cm3). The combined organic extracts were washed with water (2 x 
50 cm3) and brine (2 x 50 cm3), dried (MgSC>4 ) and concentrated in vacuo. 
Purification by flash chromatography on silica gave aldehyde 350 (1.101 g, 3.01
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mmol, 81%) as a pale brown oil; Rp [Et2 0 -hexane (2:1)] 0.89; Umax (film)/cm_1 
1686 (aldehyde C=0), 1651 (Ar), 1625 (Ar), 1596 (Ar), 1256 and 898 (Si-C) and 
1178 (Si-O); 5h (400 MHz, CDC13) 0.23 (6 H, s, SiMe2), 0.27 (6 H, s, SiMe2), 0.95 
(9H, s, tert-Bu), 0.98 (9H, s, tert-Bu), 6.29 (1H, d, J  2.2, 3-H), 6.50 (1H, dd, J  2.2 
and 8 .6 , 5-H), 7.71 (1H, d, J  8 .6 , 6 -H), and 10.28 (1H, s, CHO); NMR data 
agreed with those reported. 128 ; 8C(100 MHz, CDCI3 ) -4.30 (CH3), -2.93 (CH3),
18.28 (C), 18.36 (C), 25.66 (CH3), 25.71 (CH3), 110.99 (CH), 114.35 (CH), 121.83 
(C), 129.92 (CH), 160.69 (C), 162.65 (C), and 188.91 (CH); m/z (Cl) 367 [(M+H)+ 
100%], and 309 (40); [Found: (M+H)+, 367.2122. C i9 H 3 5 0 3 Si2  requires M, 
367.2124).
2,4-Dibenzyloxy-3-(3'-methyIbut-2,-enyl)-acetophenone 351
1 OBn O
Ketone 331 (0.873 g, 3.97 mmol), benzyl bromide (1.42 cm3, 11.90 mmol, 3 eq) and 
potassium carbonate (2.190 g, 15.87 mmol, 4 eq) were stirred in dry DMF (15 cm3) 
at 60 °C overnight under nitrogen. After cooling to RT, the reaction was quenched 
with water then extracted into Et20  (3 x 50 cm3). The combined extracts were 
washed with dilute aqueous HC1 (1 mol dm’3, 50 cm3), and brine (2 x 50 cm3) then 
dried (MgSC>4 ) and concentrated in vacuo. Chromatography on silica (1:1 
hexane/Et2 0 ) gave the ketone 351 (1.112 g, 2.78 mmol, 70%) as an orange oil; Rp 
[hexane-Et20  (1:1)] 0.57; umax (film)/cm_1 1672 (C=0), 1628 (Ar), and 1589 (Ar); 
8h (400 MHz, CDCI3 ) 1.60 (3H, s, Me), 1.70 (3H, s, Me), 2.55 (3H, s, COMe), 3.45 
(2H, m, =CH-CH2), 4.87 (2H, s, PhCH2), 5.12 (2H, s, PhCH2), 5.23 (1H, m, C=CH), 
6.75 (1H, d, J  8.7, 5-H), 7.29-7.45 (10H, m, 2 x Ph), and 7.56 (1H, d, J  8.7, 6 -H); 
5C(100 MHz, CDCI3 ) 15.70 (CH3), 23.64 (CH2), 26.22 (CH3), 32.47 (CH3), 70.68 
(CH2), 78.08 (CH2), 103.74 (CH), 108.75 (CH), 122.41 (CH), 123.01 (CH), 127.66 
(CH), 128.20 (CH), 128.95 (CH), 129.66 (CH), 130.54 (CH), 132.34 (C), 137.28 (C), 
136.97 (C), 157.90 (C), 162.32 (C), 162.70 (C), 163.91 (C) and 203.29 (C); m/z (El) 
400 (M+, 3%), 344 (7), 309 (20), 255 (15), and 91 (100); (Found: M+, 400.2039. 
C27 H28 C>3 requires M, 400.2038).
2,4-DibenzyIoxybenzaldehyde 352
2,4-Dihydroxybenzaldehyde 188 (2.000 g, 14.50 mmol), benzyl bromide (5.20 cm3, 
43.50 mmol, 3 eq) and potassium carbonate (8.000 g, 58.00 mmol, 4 eq) were stirred 
in dry DMF (30 cm3) at 60 °C overnight under nitrogen. After cooling to RT, the
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reaction was quenched with water then extracted into Et2 0  (3 x 50 cm3). The 
combined extracts were washed with dilute aqueous HC1 (1 mol dm-3, 50 cm3), and 
brine (2 x 50 cm3) then dried (MgS0 4 ) and concentrated in vacuo. Recrystallisation 
from hexane gave the aldehyde 352 (4.380 g, 13.78 mmol, 95%) as plates; m.p. 8 6 - 
8 8  °C (Lit. 1 3 0  87-88 °C); RF [hexane-Et20  (1:1)] 0.50; 8H(400 MHz, CDC13) 5.09 
(2H, s, PhCH2), 5.13 (2H, s, PhCH2), 6.59 (1H, d, J  2.1, 3-H), 6.63 (1H, dd, J  2.1 
and 8 .6 , 5-H), 7.33-7.43 (10H, m, 2 x Ph), 7.83 (1H, d, J  8 .6 , 6 -H), and 10.38 (1H, s, 
CHO); mp, lH NMR, IR and microanalysis match existing data. 130 
New Data: 8C(100 MHz, CDCI3 ) 70.78 (CH2), 70.84 (CH2), 100.50 (CH), 107.41 
(CH), 119.90 (C), 127.67 (CH), 127.94 (CH), 128.69 (CH), 128.78 (CH), 129.14 (2 
overlapping CH), 130.90 (CH), 136.29 (C), 136.32 (C), 163.14 (C), 165.56 (C), and 
188.63 (CH); m/z (El) 318 (M+, 20%), 91 (100), 83 (13), and 65 (10); (Found: M+,
318.1258. C2 iH i80 3  requires M, 318.1256).
2,4,2,,4,-tefrabenzyloxy-3-(3"-methylbut-2"-enyl)chalcone 353
OBn O
iBn
BnO‘
OBn
Ketone 351 (1.033 g, 2.58 mmol, 1.3 eq) and aldehyde 352 (0.636 g, 2.00 mmol) 
were dissolved in EtOH (20 cm3) under nitrogen. Crushed NaOH (2 pellets) was 
added and the orange solution stirred overnight at RT. Most of the solvent was 
removed in vacuo and the residue taken up in CHCI3  (50 cm3). The organic solution 
was washed with water and brine (2 x 30 cm3 each), dried (MgS0 4 ) and 
concentrated in vacuo. Chromatography on silica (1:1 hexane/Et2 0 ) gave the 
chalcone 353 (0.999 g, 1.43 mmol, 72 %) as a bright yellow oil; Rp [hexane-Et20  
(1:1)] 0.28; \)max (solnVcnr1 1651 (C=0), 1593 (Ar), 1493 (Ar), and 1020 (=CH); 
5h (400 MHz, CDCI3 ) 1.64 (3H, s, Me), 1.70 (3H, s, Me), 3.45 (2H, d, J  7.0, 
=CHCH2), 4.78 (2H, s, PhCH2), 5.03 (4H, 2s, 2 x PhCH2), 5.17 (2H, s, PhCH2), 
5.20 (1H, t, J  7.0, =CHCH2), 6.49 (1H, dd, J  2.4 and 8.4, 5'H), 6.54 (1H, d, J  2.4, 3'- 
H), 6.74 (1H, d, J  8 .8 , 5-H), 7.16-7.43 (XH, m, 4 x Ph and 6 '-H), 7.52 (1H, d, J  16.0, 
COCtf=CH), 7.54 (1H, d, 78.8, 6 -H), and 8.09 (1H, d, J  16.0, COCH=Ctf); 5C(100 
MHz, CDCI3 ) 18.38 (CH3), 23.63 (CH2), 26.15 (CH3), 65.64 (CH2), 70.61 (CH2),
70.78 (CH2), 78.36 (CH2), 100.99 (CH), 107.18 (CH), 108.11 (CH), 118.22 (C), 
123.34 (CH), 124.94 (CH), 125.26 (C), 127.39 (CH), 127.63 (CH), 127.71 (CH),
127.96 (CH), 127.99 (CH), 128.36 (CH), 128.62 (C), 128.71 (CH), 128.83 (CH),
128.94 (CH), 128.98 (CH), 129.03 (CH), 129.11 (CH), 130.02 (CH), 130.81 (CH),
132.03 (C), 136.82 (C), 137.18 (C), 137.31 (C), 139.39 (CH), 141.38 (C), 157.67
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(C), 159.58 (C), 160.85 (C), 162.22 (C), and 192.70 (C); m/z (El) 700 (M+, 3%), 609
(5), and 91 (100); (Found: M+, 700.3185. C4 8 H4 4 O5 requires Af, 700.3189).
2,4-Diacetoxyacetophenone 360
2,4-Dihydroxyacetophenone 330 (2.310 g, 15.20 mmol) and potassium carbonate 
(8.389 g, 60.79 mmol, 4 eq) were suspended in dry Et2 0  (60 cm3) under nitrogen. 
Dry acetic anhydride (5.75 cm3, 60.79 mmol, 4 eq) was added and the mixture 
stirred at RT for 48 h. The residue was filtered off and washed well with Et2 0 , then 
the combined organics were washed with aqueous HC1 (1 mol dm-3, 20 cm3), 
saturated aqueous sodium bicarbonate (20 cm3) and brine (20 cm3). The solution 
was then dried (MgSC>4 ) and concentrated in vacuo to give the ketone 360 (3.071 g, 
13.01 mmol, 8 6 %) as a pale yellow oil; Rp [Et2 0 -hexane (2:1)] 0.35; i)max 
(film)/cm_1 1774 (ester C=0), 1666 (broad, ketone C=0), 1604 (Ar), 1579 (Ar), and 
1492 (Ar); 8H(400 MHz, CDCI3 ) 2.26 (3H, s, OAc), 2.30 (3H, s, OAc), 2.50 (3H, s, 
COMe), 6.93 (1H, d, J  2.3, 3-H), 7.06 (1H, dd, 7 2.3 and 8 .6 , 5-H), and 7.82 (1H, d, 
J  8 .6 , 6 -H); IR and NMR data agreed with those reported. 131 ; 8c(100 MHz, 
CDCI3 ) 21.43 (2 x CH3), 29.62 (CH3), 117.75 (CH), 119.54 (CH), 128.34 (C), 
131.79 (CH), 150.44 (C), 154.36 (C), 168.75 (C), 169.45 (C), and 196.71 (C); m/z 
(El) 236 (M+, 5%), 194 (40), 152 (90), and 137 (100); (Found: M+, 236.0685. 
C 1 2H 1 2O5 requires M, 236.0685).
NB: If the reaction time was shorter (stirring at RT for 1 h under nitrogen), a mixture 
of desired product and 2-hydroxy-4-acetoxyacetophenone was isolated in a 
combined yield of 93% (ratio approx. 1.6:1 mono:bis-acetylated).
Data for 2-hydroxy-4-acetoxyacetophenone:
o
Compound exists as needles; m.p. 71-72 °C (Lit.130a 70-72 °C); Rf [Et2 0 -hexane 
(1:1)] 0.30; Dmax (KBrVcnr1 3479 (OH), 1745 (ester C=0), 1642 (ketone C=0), 
1594 (Ar), 1565 (Ar), and 1503 (Ar); 5H(400 MHz, CDCI3 ) 2.31 (3H, s, OAc), 2.62 
(3H, s, COMe), 6 . 6 8  (1H, dd, 72.2 and 8.7, 5-H), 6.73 (1H, d, 72.2, 3-H), 7.76 (1H, 
d, 7 8.7, 6 -H), and 12.45 (1H, s, OH); 8C(100 MHz, CDCI3 ) 21.57 (CH3), 27.09 
(CH3), 111.53 (CH), 113.31 (CH), 118.09 (C), 132.35 (CH), 156.97 (C), 164.29 (C),
168.92 (C), 203.97 (C); m/z (El) 194 (M+, 15%), 152 (45), and 137 (100); (Found:
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C, 61.72; H, 5.14%; M+ 194.0580. C i0 H i0 O4  requires: C, 61.90; H, 5.20%; Af, 
194.0580). All data agreed with those reported. 132a>b
a-Bromo-2,4-diacetoxyacetophenone 361
o
AcO
.Br
2,4-Diacetoxyacetophenone 360  (0.410 g, 1.74 mmol) was dissolved in 
Et2 0 :dioxane (2:1, 7.50 cm3) under nitrogen. A solution of bromine (0.045 cm3, 
0.87 mmol, 0.5 eq) in dry Et2 0  (2.0 cm3) was added dropwise with the reaction 
vessel being regularly opened to the atmosphere. After addition of the bromine 
mixture, the reaction was quenched with saturated aqueous sodium bicarbonate and 
extracted with Et2 0  (3 x 50 cm3). The combined organic extracts were washed with 
saturated sodium bicarbonate solution (50 cm3), water (50 cm3) and brine (2 x 50 
cm3), then dried (MgS04) and concentrated in vacuo to give ketone 361 (0.446 g,
1.42 mmol, 81%) as a pale yellow oil; Rp [Et2 0 -hexane (2:1)] 0.35; umax (film)/cnr 
1 1774 (ester C=0), 1687 (broad, ketone C=0), 1605 (Ar), 1580 (Ar), and 1421 (Ar);
H); 5C(100 MHz, CDC13) 21.07 (CH3), 21.13 (CH3), 33.93 (CH2), 116.44 (CH),
(C), and 189.46 (C); m/z (Cl) 317 [(M+H)+, 8 1Br, 5%], 315 [(M+H)+, 7 9Br, 5), 274 
(25), 272 (25), 232 (40), 230 (40), 179 (5), 137 (100), and 123 (15); [Found (M+H)+, 
8 1 Br, 316.9810. C i2 H n 0 581Br requires: Af, 316.9847: Found (M+H)+, 7 9 Br, 
314.9825. C i2 H i2 0 579Br requires: Af, 314.9868].
(2',4'-Diacetoxyphenyl)ethanoyl-2-triphenylphosphonium bromide 362
Triphenylphosphine (0.371 g, 1.42 mmol) in dry toluene (3.5 cm3) was added 
dropwise to a solution of bromoketone 361 (0.446 g, 1.42 mmol) in dry toluene (3.5 
cm3) under nitrogen. The reaction was stirred at RT overnight during which time a 
precipitate formed. This was filtered off, washed with Et2 0  and dried under suction. 
Recrystallisation from MeOH/H2 0  gave salt 362 (0.490 g, 0.85 mmol, 60%) as 
plates; m.p. 170-172 °C; Dmax (film)/cm_1 1775 (ester C=0), 1683 (broad, ketone 
C=0), 1604 (Ar), 1578 (Ar), and 690 (C-P); 8H(400 MHz, CDC13) 1.94 (3H, s, 
OAc), 2.29 (3H, s, OAc), 6.36 (2H, d, J  12.2, CH2 P), 6.89 (1H, d, /  2.3, 3-H), 7.20 
(1H, dd, J  2.3 and 8.4, 5-H), 7.54-7.77 (9H, m, 3 x Ph), 7.87-7.93 (6 H, m, 3 x Ph),
5h (400 MHz, CDC13) 2.29 (3H, s, OAc), 2.35 (3H, s, OAc), 4.41 (2H, s, CH2 Br),
7.02 (1H, d, J  2.2, 3-H), 7.09 (1H, dd, J  2.2 and 8 .6 , 5-H), and 7.85 (1H, d, J  8 .6 , 6 -
119.17 (CH), 124.87 (C), 131.65 (CH), 150.48 (C), 154.55 (C), 168.21 (C), 168.70
o
158
and 9.06 ( 1H, d, J  8.4, 6 -H); SC(100 MHz, CDCI3 ) 20.81 (CH3), 21.18 (CH3), 40.78 
(d, J  60.2, CH2), 116.76 (CH), 118.15 (C), 119.44 (d, J  77.8, C), 129.14 (CH), 
130.05 (d, J  13.3, CH), 133.81 (CH), 134.35 (d, J  10.7, CH), 134.68 (d, 7 2.4, CH), 
149.44 (C), 155.09 (C), 168.18 (C), 168.95 (C), and 191.07 (d, J  5.7, C); m/z (FAB) 
497 [(M-Br)+ 100%], 455 (10), 262 (10), and 183 (7); [Found: C, 62.4; H, 4.4%; 
(M-Br)+, 497.1517. C3 0 H2 6 O5P requires: C, 62.40; H, 4.54%; (M-Br)+ , 497.1518].
a-Bromo-2,4-dihydroxyacetophenone 365
o
Br
Bromoketone 361 (0.537 g, 1.70 mmol) was dissolved in methanol (20 cm3) and 
potassium carbonate (0.706 g, 5.10 mmol, 3 eq) added. The reaction was stirred at 
RT for 1 h, then diluted with water, acidified with aqueous HC1 (1 mol dm-3) then 
extracted into EtOAc (3 x 30 cm3), the combined organic extracts were washed with 
brine (2 x 50 cm3), dried (MgSC>4 ) and concentrated in vacuo to give ketone 365 
(0.122 g, 0.53 mmol, 31%) as an amorphous yellow solid; m.p. >200 °C (dec); umax 
(KBr)/cm_1 1664 (C=0), 1617 (Ar), 1585 (Ar), and 1524 (Ar); 8H(400 MHz, 
CD3 OD) 4.54 (2H, s, CH2 Br), 6.35 (1H, d, J  1.9, 3-H), 6.47 (1H, dd, J  1.9 and 8 .6 , 
5-H), 7.38 (1H, d, J  8 .6 , 6 -H); JH NMR data agreed with those reported. 133 ; 8c(100 
MHz, CD3 OD) 77.07 (CH2), 99.75 (CH), 113.66 (CH), 114.54 (C), 126.64 (CH), 
169.61 (C), 178.75 (C), and 200.47 (C).
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Experimental for Chapter 6
10
l,3-Z?A(tetrahydropyran-2'-yloxy)benzene 62
OTHP
iTHP
Dihydropyran (16.60 cm3, 0.18 mol, 4 eq) was cooled to 0 °C and then 2-3 drops of 
conc. HC1 added. Resorcinol 109 (5.000 g 45.4 mmol, 1 eq) was then added slowly. 
The reaction was then left to stir for 3 hours at RT. After this time, Et2 0  (100 cm3) 
was added, the organic solution washed with 1 0 % aqueous sodium hydroxide 
solution (50 cm3) and brine (2 x 50 cm3) and dried (MgSC>4 ). Concentration in vacuo 
gave a colourless oil which solidified under vaccum. Recrystallisation from hexane 
gave the acetal 368 (11.359 g, 40.86 mmol, 90%) as plates; m.p. 72-75 °C.(Lit. 136 
76-77 °C); 6h(200MHz; CDCI3 ) 1.57 (12H, m, 6  x CH2), 3.64 (4H, m, 2 x CH2 0),
5.40 (2H, m, 2 x OCHO), 6 . 6 8  (2H, dd, J  2.1 and 8.1,4- and 6 -H), 6.76 (1H, d, J  2.1, 
2-H), and 7.16 (1H, t, J  8.1, 5-H). All other data matched that reported. 134
2-(3'-Methylbut-2'-enyl)resorcinol 366
THP-protected resorcinol 368 (2.506 g, 9.01 mmol) was dissolved in dry THF (20 
cm3) and cooled to -30°C under nitrogen. «-Butyllithium (1.40 mol dm - 3  in hexane, 
7.70 cm3, 10.82 mmol, 1.2 eq) was added over 15 min then the reaction stirred at 
-30°C for a further 15 min. Bromo-3-methylbut-2-ene (1.60 cm3, 13.52 mmol, 1.5 
eq) was added and the reaction stirred at RT. After 2 h, the reaction was quenched by 
pouring into water. This was then extracted into Et20  (3 x 30 cm3), the combined 
extracts washed with aqueous NaOH (1 mol dm-3, 50 cm3), water (50 cm3) and 
brine (2 x 50 cm3), then dried (MgS0 4 ) and concentrated in vacuo. This crude oil 
was taken up in MeOH-H20  (9:1, 20 cm3) and aqueous oxalic acid (5%, 2.0 cm3) 
added slowly. The resulting slurry was stirred at RT overnight. The solution was 
diluted with water and extracted into Et20  (3 x 50 cm3), the combined organic 
extracts washed with water and brine ( 2  x 2 0  cm3 each), dried and concentrated in 
vacuo. Chromatography on silica (Et2 0-hexane, 1:1) followed by recrystallisation 
from hexane/CHCl3 gave the phenol 366 (0.964 g, 5.41 mmol, 60%) as plates: m.p. 
69-70 °C (Lit. 10 71.5-72.5 °C); RF [hexane-EtOAc (1:1)] 0.71; NMR, IR and MS 
already reported.io,57,i35; 5H(400 MHz, CDCI3 ) 1.72 (3H, s, Me), 1.88 (3H, s, Me),
OH
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3.41 (2H, d, 77.1, =CU-CH2- \  5.26 (1H, t, 77.1, =Q7-CH2), 6.38 (2H, d, 78.1, 4-H 
and 6 -H), and 6.90 (1H, t, 7 8.1, 5-H).
New data: 5C(100 MHz, CDC13) 18.27 (CH3), 23.10 (CH2), 26.17 (CH3), 108.81 
(CH), 114.30 (C), 122.03 (CH), 127.72 (CH), 135.83 (C), and 155.34 (C).
(3',5'-Dimethoxyphenyl)benzo[Z>]furan 370
Me
Me
Dicyclohexylcarbodiimide (1.900 g, 14.2 mmol, 1.26 eq) in dry CH2 C12  (30 cm3) 
was added to a solution of 2-hydroxybenzyltriphenylphosphonium bromide 369 (6.60 
g, 15.0 mmol, 1.34 eq), 4-dimethylaminopyridine (0.220 g, 1.8 mmol, 0.16 eq), and
3,5-dimethoxybenzoic acid 187 (2.000 g, 11.0 mmol) in dry CH2 C12  (100 cm3) under 
nitrogen, and the mixture was stirred overnight. The solution was concentrated in 
vacuo and the residue dissolved in dry toluene (100 cm3). Triethylamine (8.60 cm3,
62.0 mmol, 5.65 eq) was added and the mixture heated under reflux under nitrogen 
overnight. After cooling, the solution was filtered and the solvent removed in vacuo. 
Flash column chromatography (S i02, CH2 C12) followed by recrystallisation from 
propan-2-ol gave the benzofuran 370 (1.820 g, 7.17 mmol, 65%) as needles; m.p. 57- 
59 °C; flF(CH2 Cl2) 0.65; Dmax (KB^/cnr1: 1599 (Ar), 1570 (Ar ring), and 1156 (C- 
O-C); 5h(200MHz; CDC13) 3.88 (6 H, s, 2 x OMe), 6.51 (1H, t, 7 2.3, 4'-H), 7.01 
(1H, s, 3-H), 7.07 (2H, d, 7 2.3, 2’-H), and 7.22-7.56 (4H, m, 4 x Ar-H); 5c(50MHz; 
CDC13) 55.45 (CH3), 100.99 (CH), 101.83 (CH), 102.93 (CH), 111.17 (CH), 120.97 
(CH), 122.96 (CH), 124.38 (CH), 129.10 (C), 132.18 (C), 154.78 (C), 155.67 (C), 
and 161.06 (C); m/z (El) 254 (M+, 100%), 211 (9), and 169 (11); (Found: C, 75.8; 
H 5.6% ; M+, 254.0943; C i6 H i4 0 3 requires C, 75.59; H 5.55%; M, 294.0944).
2-(3\5'-Dihydroxyphenyl)-benzo[&]furan 371
OH
OH
Benzofuran 370 (0.751 g, 2.96 mmol) was dissolved in dry CH2 C12  (25 cm3) and 
cooled to -78 °C under nitrogen. Boron tribromide (1 mol dm-3  in CH2 C12, 8.80 cm3,
8.87 mmol, 3 eq) was added slowly then the reaction stirred at RT. After 2 h, the 
reaction was quenched with water and extracted into EtOAc (3 x 30 cm3), the 
combined extracts were washed with brine (2 x 50 cm3), dried (MgS04), and 
concentrated in vacuo. Chromatography on silica (1:1 EtOAc/hexane) gave the 
benzofuran 371 (0.434 g, 1.92 mmol, 65%) as plates; m.p. 140-143 °C; Rf [hexane-
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EtOAc (1:1)] 0.40; omax (KBr)/cm-l 3332 (OH), 1621 (Ar), 1577 (Ar), and 1500 
(Ar); 6h (400 MHz, cfc-acetone) 6.29 (1H, t, J  2.0, 4'-H), 6.80 (2H, d, J  2.0, 276'-H),
7.03 (1H, s, 3-H), 7.08-7.19 (2H, m, 5- and 6 -H), 7.42 (1H, d, J  8.0, 4- or 7-H), 7.48 
(1H, d with fine splitting, J  8.0, 7- or 4-H) and 8.34 (2H, br s, 2 x OH); 5c(100 MHz, 
d6 -acetone) 102.77 (CH), 104.57 (CH), 104.76 (CH), 112.15 (CH), 122.28 (CH),
124.29 (CH), 125.63 (CH), 130.54 (C), 133.39 (C), 155.95 (C), 157.27 (C), and
160.29 (C); m/z (El) 226 (M+, 100%), 197 (15), 113 (10), and 83 (50); (Found: M+, 
226.0630. C 1 4H 1 0O3 requires M, 226.0630).
2-[3,,5'-Z?/s(tetrahydropyran-2"-yloxy)phenyl]-benzo[7>]furan 372
OTHP
OTHP
Acid 314 (2.348 g, 7.29 mmol, 1 eq) was dissolved in dry CH2 CI2  (80 cm3) under 
nitrogen. To this was added sequentially, dimethylaminopyridine (0.142 g, 1.17 
mmol, 0.16 eq), phosphonium salt 369 (4.387 g, 9.77 mmol, 1.34 eq), and 
dicyclohexylcarbodiimide (1.893 g, 9.19 mmol, 1.26 eq) as a solution in dry CH2 CI2  
(10 cm3). The resulting slurry was stirred at RT. After 24 h, the solvent was removed 
in vacuo and the residue taken up in dry toluene (50 cm3). Dry triethylamine (5.50 
cm3, 41.20 mmol, 5.65 eq) was added and the reaction heated to reflux for 6  h. After 
cooling to RT, the slurry was filtered, the precipitate washed with EtOAc (10 cm3) 
and the filtrate concentrated in vacuo. Chromatography on silica (hexane-CH2 Cl2 , 
1:1) followed by recrystallisation from propan-2-ol gave the benzofuran 372 (1.900 
g, 4.82 mmol, 6 6 %) as colourless plates: m.p. 110-112 °C; Rp [hexane-CH2 Cl2  
(1:1)] 0.24; i)max (filmVcnr1 1612 (Ar), 1590 (Ar), and 1567 (Ar); 6H(400 MHz, 
CDCI3 ) 1.57-2.08 (12H, m, 6  x -CH2-), 3.63-3.67 (2H, m, -OCH2.), 3.92-3.98 (2H, 
m, -OCH2 -), 5.50-5.52 (2H, m, 2  x -OCHO-), 6.79 ( 1 H, t, J  2.4, 4'-H), 6.99 (1H, s,
3-H), 7.19-7.29 (4H, m, 5-H, 6 -H, 2'-H and 6 ’-H), 7.59 (1H, d with fine splitting, J 
8.4, 4-H), and 7.56 (1H, d with fine splitting, J  8.4, 7-H); 8C(100 MHz, CDCI3 )
19.02 (CH2), 25.62 (CH2), 30.72 (CH2), 62.37 (CH2), 96.85 (CH), 1 0 2 . 1 2  (CH),
105.87 (CH), 106.90 (CH), 111.58 (CH), 121.28 (CH), 123.25 (CH), 124.65 (CH),
129.56 (C), 132.47 (C), 155.19 (C), 156.17 (C), and 158.86 (C); m/z (El) 394 (M+, 
3%), 226 (100), and 83 (70); (Found: C, 73.0; H, 6.5%; M+, 394.1777. C2 4 H2 6 O5 
requires C, 73.08; H, 6.64% ; Af, 394.1780).
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Alternative preparation of 2-[3',5,-bis(tetrahydropyran-2,f-yloxy)phenyl]- 
benzo[£]furan 372
3,4-Dihydro-2//-pyran (1.10 cm3, 11.58 mmol, 4 eq) was cooled to 0°C then 2-3 
drops of conc. HC1 added. Benzofuran 371 (0.654 g, 2.89 mmol, 1 eq) was added 
portion wise over 10 min, then the ice bath removed and the solution stirred at RT. 
After 3 h, the reaction was diluted with Et2 0  (20 cm3) and washed with saturated 
aqueous sodium bicarbonate (3 x 10 cm3), brine (3 x 10 cm3), then dried (Na2 SC>4 ) 
and concentrated in vacuo to give an off-white oil which crystallised on standing. 
The product was filtered off and washed with hexane and dried under suction. 
Recrystallisation from hexane gave the benzofuran 372 (0.393 g, 1.00 mmol, 35%). 
All data matched those reported above.
2-[3,,5’-Dihydroxy-4t-(3M-methylbut-2"-enyl)phenyl]-benzo[£]furan 367 
(6-deoxymoracin C)
r \ L i
Benzofuran 372 (1.404 g, 3.56 mmol) was dissolved in dry THF (10 cm3) and 
cooled to -30°C under nitrogen. rc-Butyllithium (1.16 mol dm-3  in hexane, 3.70 cm3,
4.28 mmol, 1.2 eq) was added over 15 min then the reaction stirred at -30°C for a 
further 15 min. Bromo-3-methylbut-2-ene (0.85 cm3, 7.13 mmol, 2 eq) was added 
and the reaction stirred at RT. After 2 h, the reaction was quenched by pouring into 
water. This was then extracted into Et2 0  (2 x 30 cm3), the combined extracts 
washed with water (50 cm3) and brine (2 x 50 cm3), then dried (MgSC>4 ) and 
concentrated in vacuo. This crude oil was taken up in MeOH-H2 0  (9:1, 10 cm3) and 
aqueous oxalic acid (5%, 1.0 cm3) added slowly. The resulting slurry was stirred at 
RT for 2 h. Most of the solvent was removed in vacuo, then the residue taken up in 
EtOAc (50 cm3). This was then washed with water and brine (2 x 20 cm3 each), 
dried and concentrated in vacuo. Recrystallisation from CHCI3  gave the benzofuran 
372 (0.645 g, 2.19 mmol, 62%) as off-white plates: m.p. 158-160 °C; Rf  [hexane- 
EtOAc (2:1)] 0.65; u max (KBr)/cm-l 3462 (OH), 1624 (Ar), 1575 (Ar), 1505 (Ar), 
and 1043 (=C-H); 5H(400 MHz, d6 -acetone) 1.52 (3H, s, Me), 1.65 (3H, s, Me), 3.27 
(2H, d, J  7.1, =CH-CH2- \  5.19 (1H, t, J  7.1, =CH-CU2-), 6.85 (2H, s, 2'-H and 6 '- 
H), 6.90 (1H, s, 3-H), 7.03-7.16 (2H, m, 5-H and 6 -H), 7.37 (1H, d with fine 
splitting, J  8.1,4-H), 7.46 (1H, d with fine splitting, J  8.1, 7-H), and 8.22 (2H, br s, 2 
x OH); 8C(100 MHz, d6 -acetone) 18.32 (CH3), 23.52 (CH2), 26.31 (CH3), 101.90 
(CH), 101.91 (CH), 104.80 (CH), 112.03 (CH), 117.49 (C), 122.12 (CH), 124.22 
(CH), 125.38 (CH), 129.83 (C), 130.64 (C), 131.52 (C), 155.87 (C), 157.49 (C), and
OH
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157.68 (C); m/z (El) 294 (M+, 85%), 279 (35), 239 (100), and 57 (35); (Found; M+,
294.1258. C 1 9H 18O3  requires; M, 294.1256).
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Cell Culture Feeding Experiments
General details
All feeding experiments were conducted in a sterile cabinet. For all 
experiments, cell cultures were stored in sterile 1 0 0  cm3 conical flasks stoppered 
with sterile cotton wool. Samples were taken with Sterile Gilson apparatus into 5 
cm3 epindorphs. Centrifugations were done on Mistral 3000E or Sanyo 
'Microcentaur' centrifuges spinning at 2500 and 13000 rpm, respectively. Mass 
spectrometry was carried out on a Micromass Platform LCMS with a Cis column 
(4.6 x 150 mm) using solvent A (10 mM ammonium acetate/0.1% fomic acid) and 
solvent B (10 mM ammonium acetate/90% acetonitrile/0.07% formic acid) in a 30 
min gradient (100%A->100%B). Chromatography was carried out on a Gilson 
Unipoint Autopreparative HPLC system with a Spherisil ODS2 (Cis) column (10 x 
150 mm, particle size, 5 pm), using solvent A (0.1 M ammonium dihydrogen 
phosphate/0.003% ortho-phosphoric acid) and solvent B (75% acetonitrile/25% 
solvent B). Solvent systems were isocratic (70% solvent B/30% solvent A) or on a 
40 min gradient (100%A—>100%B) with a flow rate of 5 cm3 /min.
165
CELL CULTURE FEEDING EXPTS
Six experiments were carried out in total, three experiments with each of the 
substrates:
Suspension Solvent Substrate Addition 
Solvent
1 . h 2o DMSO
2. H2 O/MS4  Growth Medium DMSO
3. h 2o Aqueous Tween 80
Typical Procedure (under sterile conditions):
90-100 cm3 of original cell suspension was centrifuged gently and the supernatant 
carefully decanted. The cell pellet was then gently resuspended in 30 cm3 of sterile 
H2 O (or 30 cm3 of 1:1 H2 O/MS4  growth medium) in a 100 cm3 conical flask.
The substrate (for solvents, see below) was then added in one protion.
5 mg substrate in 0.3 cm3 DMSO (expts. 1 and 2)
5 mg substrate in 1 cm3 Tween solution (10 cm3 of sterile H2 O + 2 drops Tween 
80).
The cell suspensions were then shaken at 25 °C.
Sampling Technique (sterile)
(Samples taken after 2, 6 and 9 days.)
0.5 cm3 of each cell suspension was pipetted into a 2 cm3 epindorph. This was 
centrifuged at 13,000 rpm for 5 min, then the supernatant A decanted and analysed. 
The cell pellet was then resuspended in 0.5 cm3 MeOH and vortexed for -30 s. The 
MeOH solution was then centrifuged as before and the supernatant B analysed by 
LCMS.
[NB. In each experiment, supernatant A (the original cell liquid) was analysed after 
2 days, but contained no starting material, desired product, or naturally-occurring 
chalcomoracin.]
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Work-up
The cell suspension was transferred to Falcon 50 cm3 centrifuge tubes, the 
experiment flask rinsed with a small amount of sterile H2 O, and the combined 
solution centrifuged at 2500 rpm for 30 min. The supernatant was decanted off and 
stored. 10 cm3 of sterile water was added to the cell pellet and vortexed. This was 
centrifuged as before, the supernatant decanted off and this process repeated. After a 
second wash with sterile H2 O, 10 cm3 of MeOH was added to the pellet, vortexed 
well (~1 min) and centrifuged at 13000 rpm for 10 min.. The supernatant was 
transferred to a preweighed glass vial and dried, either by speedivac, or by blowing 
with N2 .
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